Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.7843468690582781,-2.740184919606194,0.0,0.0,0.0,15/29,9.47%,GABRB3;GRIA4;GRIK2;GRID2;GABRB2;GABRB1;GLRA3;GRIK3;GABRG3;GRID1;GRIA2;GRIK4;GABRA2;GLRA2;GABRG1
prerank,glutamate receptor activity (GO:0008066),-0.8307191576998154,-2.5335311550647264,0.0,0.0,0.0,12/19,8.45%,GRIA4;GRIK2;GRID2;GRM7;GRM1;GRIK3;GRM5;GRID1;GRIA2;GRM3;GRIK4;GRM8
prerank,ligand-gated ion channel activity (GO:0015276),-0.653586597447331,-2.279782504540238,0.0,0.0006382592216183307,0.002,13/30,5.28%,GRIA4;GRIK2;GRID2;GRIA3;GABRB1;GRIN3A;GRIN2B;GRIK3;GRIN2A;GRID1;GRIA2;GRIK4;GRIN1
prerank,ligand-gated channel activity (GO:0022834),-0.6535898639518528,-2.260555105961011,0.0,0.0007180416243206221,0.003,13/29,5.28%,GRIA4;GRIK2;GRID2;GRIA3;GABRB1;GRIN3A;GRIN2B;GRIK3;GRIN2A;GRID1;GRIA2;GRIK4;GRIN1
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.7181468120607376,-2.209863225546108,0.0,0.0011488665989129953,0.005,9/19,13.97%,GRIK2;GRID2;GRIK3;GABRG3;GRID1;GRIK4;GABRA2;GABRG1;GRIK5
prerank,ligand-gated anion channel activity (GO:0099095),-0.7060886620931593,-2.066836840033011,0.0,0.006063462605374143,0.035,8/17,9.47%,GABRB3;GABRB2;GABRB1;GLRA3;GABRG3;GABRA2;GLRA2;GABRG1
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.6938822814785467,-2.0538051959339425,0.0,0.006428182160584617,0.043,10/17,5.28%,GRIA4;GRIK2;GRIA3;GRIN3A;GRIN2B;GRIK3;GRIN2A;GRIA2;GRIK4;GRIN1
prerank,chemokine receptor activity (GO:0004950),-0.6080823323892869,-2.037057956328569,0.0,0.00682139543104591,0.052,17/24,35.57%,CX3CR1;CCR5;CCR2;CCR1;CCR6;GPR75;CCRL2;ACKR3;CXCR5;CCR9;GPR35;CXCR6;CMKLR1;XCR1;CXCR3;CXCR2;GPR17
prerank,C-C chemokine receptor activity (GO:0016493),-0.615749117527482,-2.009936516876805,0.0,0.008616499491847465,0.072,14/21,34.51%,CX3CR1;CCR5;CCR2;CCR1;CCR6;GPR75;CCRL2;ACKR3;CXCR5;CCR9;CXCR6;XCR1;CXCR3;CXCR2
prerank,GABA receptor activity (GO:0016917),-0.6213313417276246,-1.9833384915790546,0.0,0.010818493806430705,0.1,7/21,9.47%,GABRB3;GABRB2;GABRB1;GABBR1;GABRG3;GABRA2;GABRG1
prerank,C-C chemokine binding (GO:0019957),-0.5949324418646428,-1.9430179810677524,0.0,0.01749410502890243,0.162,13/22,34.51%,CX3CR1;CCR5;CCR2;CCR1;CCR6;CCRL2;ACKR3;CXCR5;CCR9;CXCR6;XCR1;CXCR3;CXCR2
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.7324804802497276,-1.9385357806120855,0.003968253968253968,0.016913869372885765,0.171,6/12,9.47%,GABRB3;GABRB2;GABRB1;GABRG3;GABRA2;GABRG1
prerank,GABA-A receptor activity (GO:0004890),-0.6277519039107549,-1.901551584084576,0.0,0.023640139631478947,0.251,6/18,9.47%,GABRB3;GABRB2;GABRB1;GABRG3;GABRA2;GABRG1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.6562057563340989,-1.8586721492537457,0.0,0.032482835385932905,0.342,6/15,18.73%,CX3CR1;CCR5;CCR2;CCR1;CCR6;CCRL2
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.6804735570474837,1.8028406296311783,0.0011695906432748538,0.2475531957047193,0.194,19/37,17.39%,EPRS1;AARS1;VARS1;VARS2;CARS1;FARSB;EARS2;FARSA;NARS1;GARS1;RARS2;RARS1;YARS1;LARS1;TARS1;FARS2;QARS1;SARS1;SARS2
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6876601704198613,-1.7973025704048977,0.0,0.0567412448018696,0.538,4/11,8.08%,KCND2;KCND1;KCND3;KCNK2
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.605118205462563,-1.788818622302627,0.007692307692307693,0.05361377461593978,0.568,9/17,22.61%,EPHA4;EPHA5;EPHA6;EPHB1;EPHA7;EFNA3;EPHA2;EPHB6;EPHB4
prerank,ephrin receptor activity (GO:0005003),-0.605118205462563,-1.788818622302627,0.007692307692307693,0.05361377461593978,0.568,9/17,22.61%,EPHA4;EPHA5;EPHA6;EPHB1;EPHA7;EFNA3;EPHA2;EPHB6;EPHB4
prerank,chemoattractant activity (GO:0042056),0.7030787887689867,1.7815003543105075,0.0012578616352201257,0.19096960811506916,0.278,5/26,5.56%,LGALS3;GPNMB;FGF2;VEGFA;DEFB130A
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5586375454125659,-1.7806585706152196,0.00558659217877095,0.04911404710353055,0.595,6/22,8.03%,CHRM2;HTR1F;HTR2C;HRH2;HTR2A;CHRM3
prerank,serotonin receptor activity (GO:0099589),-0.5586375454125659,-1.7806585706152196,0.00558659217877095,0.04911404710353055,0.595,6/22,8.03%,CHRM2;HTR1F;HTR2C;HRH2;HTR2A;CHRM3
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5586375454125659,-1.7806585706152196,0.00558659217877095,0.04911404710353055,0.595,6/22,8.03%,CHRM2;HTR1F;HTR2C;HRH2;HTR2A;CHRM3
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.514359934797101,-1.7556861660506737,0.0,0.05735215005684714,0.663,8/28,9.47%,GRIK2;GRID2;GRIK3;GABRG3;GRID1;GRIK4;GABRA2;GABRG1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.7676802272652049,1.742775856125004,0.0013550135501355014,0.24923723104964932,0.484,4/14,17.23%,DHRS3;RDH12;AKR1A1;RDH10
prerank,sterol transfer activity (GO:0120015),0.7406210245487892,1.741179937495184,0.0013227513227513227,0.19172742402028767,0.493,6/17,10.39%,ABCA1;ABCG1;APOA2;NPC2;OSBPL2;OSBP
prerank,protein phosphatase inhibitor activity (GO:0004864),0.678609994498056,1.7354047625344446,0.0,0.17015493125173356,0.522,7/26,9.68%,LGALS3;MGAT5;PPP1R14B;CABIN1;PPME1;BOD1L1;PPP1R14A
prerank,semaphorin receptor activity (GO:0017154),0.802768339123691,1.7349212390287845,0.0014347202295552368,0.14246939018108334,0.523,4/11,2.23%,PLXNC1;NRP2;NRP1;PLXNA2
prerank,chemorepellent activity (GO:0045499),-0.5169412971426904,-1.711626469650604,0.01675977653631285,0.0753726117165647,0.788,10/25,18.32%,NRG3;SEMA6D;SEMA6A;SEMA5A;DPP4;SEMA4B;SEMA4A;EPHA7;SEMA6C;SEMA3B
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.6968022013729818,1.7087691188293548,0.0037593984962406013,0.18851572804102817,0.666,11/22,14.42%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B;ATP2A2;ATP6V0A4;ATP6V0C
prerank,phosphotyrosine residue binding (GO:0001784),0.6321123554334307,1.702001448219997,0.0035294117647058825,0.1811180013472283,0.701,12/37,10.10%,BCAR3;SH3BP2;ABL2;FGR;STAP1;GRB2;SAMSN1;SYK;CRKL;PIK3R2;YES1;RASA1
prerank,cholesterol transfer activity (GO:0120020),0.7311596870248337,1.6982569321214533,0.005277044854881266,0.1690771486309783,0.72,5/16,10.16%,ABCA1;ABCG1;APOA2;NPC2;OSBPL2
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6323076559838805,-1.6978437424867714,0.020242914979757085,0.07954652429430197,0.822,8/13,21.35%,GLRA3;GABRG3;GABRA2;GLRA2;GABRG1;GLRA1;GABRE;GABRA1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.7454155191678628,1.6959651490510264,0.005298013245033113,0.1431123854946021,0.728,8/16,6.74%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.7454155191678628,1.6959651490510264,0.005298013245033113,0.1431123854946021,0.728,8/16,6.74%,TCIRG1;ATP6V1C1;ATP6V0D2;ATP6V1A;ATP6V0A1;ATP6V1B2;ATP6V0D1;ATP6V0B
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6448405975823479,1.694844685167861,0.0024067388688327317,0.13371240638744702,0.733,11/32,12.64%,MFSD12;SLC38A6;SLC38A1;SLC36A4;SLC6A6;SLC3A2;SLC6A7;SFXN1;SLC38A7;SLC7A8;SFXN2
prerank,receptor antagonist activity (GO:0048019),0.7245298841384178,1.6930547575643309,0.005148005148005148,0.12669127441089242,0.744,3/17,5.73%,DKK2;WFIKKN1;LRPAP1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.6171516157355131,1.688432905363362,0.0034924330616996507,0.12543657554950496,0.761,20/42,21.06%,BCAR3;SH3BP2;ABL2;FGR;STAP1;GRB2;FBXW7;SAMSN1;SYK;CRKL;PIK3R2;YES1;RASA1;VAV1;CRK;PIN1;PFN1;PTPN6;NEDD4;NCK2
prerank,cation transmembrane transporter activity (GO:0008324),0.598446737820684,1.6808528382674828,0.0,0.12973808297341205,0.799,13/48,12.64%,MFSD12;SLC38A6;SLC38A1;SLC36A4;SLC6A6;SLC3A2;SLC6A7;SLC7A1;SFXN1;SLC8B1;SLC38A7;SLC7A8;SFXN2
prerank,phosphatase inhibitor activity (GO:0019212),0.6830116527689818,1.6794340082518462,0.005095541401273885,0.12402920315409915,0.802,5/20,8.63%,LGALS3;MGAT5;CABIN1;PPME1;BOD1L1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7740442786371821,1.6672447054643147,0.008595988538681949,0.1381899591869081,0.846,4/11,10.48%,SLC23A2;SLC23A1;SLC17A5;SLC5A3
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.6267155214862371,-1.6603045855939451,0.025454545454545455,0.10008702419002449,0.888,5/11,29.41%,SLC25A47;SLC22A5;SLC25A20;SLC25A29;SLC22A3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.7156717497473706,1.6410794679849217,0.011004126547455296,0.18546842598829757,0.924,3/15,9.79%,SH3PXD2B;VEPH1;SESTD1
prerank,ion channel activity (GO:0005216),-0.3801201785456035,-1.635635441829205,0.0,0.11419733993195173,0.936,20/80,8.80%,GRIA4;GRIK2;GRID2;TRPM3;GRIA3;GABRB1;UNC80;GRIN3A;CALHM2;GRIN2B;GRIK3;GRIN2A;GRID1;GRIA2;GRIK4;GRIN1;TRPM6;NALCN;TMEM63A;LRRC8A
prerank,translation initiation factor activity (GO:0003743),0.6131165145945715,1.631276542067213,0.008073817762399077,0.20006339897769151,0.949,18/36,21.12%,EIF4A1;EIF3A;EIF1;AGO2;EIF4G1;EIF4G2;EIF3L;EIF4G3;EIF4A2;EIF2S2;EIF3M;EIF4E;EIF5B;EIF4E2;EIF2B2;EIF3B;EIF2S1;EIF2A
prerank,tRNA binding (GO:0000049),0.5923191295397986,1.629875419337424,0.004540295119182747,0.1926368031065499,0.952,22/43,24.78%,PUS1;AARS1;CARS1;IGHMBP2;XPOT;TRMT10C;YRDC;EEF1A1;ALKBH1;NAT10;TERT;FARS2;SARS1;SARS2;ALKBH8;ELP5;TRMT10A;EIF2A;ELP1;EIF2AK4;NSUN2;NSUN6
prerank,alanine transmembrane transporter activity (GO:0022858),0.7417038292514853,1.6241389502707348,0.008633093525179856,0.1984755942239003,0.958,5/12,10.44%,SLC36A4;SLC6A6;SLC3A2;SLC38A7;SLC7A8
prerank,cholesterol binding (GO:0015485),0.5796695713482048,1.621066128154379,0.005567928730512249,0.19606764238653926,0.961,14/47,14.88%,OSBPL8;ABCA1;ABCG1;APOA2;SOAT1;VDAC2;SOAT2;NPC1;CAV1;NPC2;OSBPL2;SULT2B1;PROM1;SCP2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5734109941234555,1.618790098760292,0.004464285714285714,0.19325403866993077,0.965,19/47,22.36%,SLC38A6;SLC38A1;SLC36A4;SLC6A6;SLC3A2;SLC7A1;PDPN;SLC38A7;SLC7A6;SLC7A8;SLC38A10;SLC38A2;SLC1A5;SLC7A3;SLC43A2;SLC16A2;SLC7A7;SLC7A2;SLC7A10
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.6525439174727806,1.6021570709739452,0.015523932729624839,0.21772556167531798,0.983,6/21,11.29%,CDK14;CDK6;CDK5;CDK8;CDK11B;CDK13
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.6525439174727806,1.6021570709739452,0.015523932729624839,0.21772556167531798,0.983,6/21,11.29%,CDK14;CDK6;CDK5;CDK8;CDK11B;CDK13
prerank,cAMP binding (GO:0030552),-0.6322862922104089,-1.5865358231549558,0.03194888178913738,0.1528139867143888,0.973,8/11,18.76%,HCN1;RAPGEF2;PDE10A;PDE4D;RAPGEF4;PDE4B;PDE2A;POPDC3
prerank,beta-tubulin binding (GO:0048487),0.6056102982914804,1.5832061954072543,0.011848341232227487,0.26072753374928753,0.995,12/31,19.31%,FGF13;UXT;EML4;HTT;ARL8B;ARL8A;IFT74;VAPB;PEX14;CCT5;PACRG;TAOK1
prerank,ribosome binding (GO:0043022),0.5622078138410141,1.5787925620441823,0.011481056257175661,0.2640567420850339,0.997,22/46,21.25%,SHFL;EIF6;IGHMBP2;CPEB4;CPEB2;EEF2;ETF1;C1QBP;GEMIN5;CPEB1;NAA16;EFL1;CPEB3;PYM1;GTPBP6;NAA15;SEC61A1;ZC3H12A;NCLN;EIF2S1;EIF2A;TMCO1
prerank,metal ion:proton antiporter activity (GO:0051139),0.7026989719268104,1.5723217262765892,0.0260989010989011,0.2740406659156907,0.997,5/13,7.56%,SLC9A1;SLC9A8;SLC9A7;SLC9A6;SLC11A1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.623728813559322,-1.5713229283462782,0.05,0.16165687729766498,0.978,9/11,37.66%,KCNJ3;KCND3;KCNH2;KCNQ1;KCNE3;KCNE4;KCNJ5;KCNJ8;KCNE2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6774186688389839,1.5695309225762821,0.02631578947368421,0.2729530943210092,0.998,10/15,23.86%,CXXC1;KMT2A;RBBP5;PRDM9;SETMAR;WDR5;KMT2B;KMT2D;SETD3;SETD4
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5449216582276706,1.5628463613460137,0.007865168539325843,0.2829516186551492,0.998,21/55,21.80%,SLC38A6;SLC38A1;SLC23A2;SLC23A1;SLC36A4;SLC6A6;SLC46A1;SLC7A1;PDPN;SLC38A7;SLC16A3;SLC7A6;SLC7A8;SLC38A10;SLC16A13;SLC19A1;SLC38A2;SLC25A32;SLC7A3;SLC16A2;SLC7A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.6041137690357645,1.5628163949672484,0.018495684340320593,0.2738567413181108,0.998,8/27,6.65%,SLC9A1;SLC23A1;ASIC3;SLC3A2;SLC9A8;SLC9A7;SLC9A6;SLC8B1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5041787190735519,1.5596296913519667,0.0,0.27391887407378057,0.999,47/134,22.06%,MFSD12;SLC38A6;SLC38A1;SLC26A1;SLC23A2;SLC23A1;SLC36A4;SLC6A6;SLC27A1;SLC25A25;SLC3A2;SLC6A7;SLC46A1;SLC7A1;PDPN;SFXN1;SLC25A1;SLC52A2;SLC38A7;SLC26A4;SLC7A8;SLC25A18;SFXN2;SLCO5A1;SLC2A6;SLC13A5;SLC35B3;SFXN5;SLC19A1;SLC35B1;SLCO2A1;SLC25A21;SLC35D2;SLC38A2;MFSD10;SLC2A8;CTNS;SLC5A6;SLC25A32;SLC25A13;SLC1A5;SLC6A8;SLC17A9;SLC7A3;SLC7A2;SLC17A8;ABCC5
prerank,potassium:proton antiporter activity (GO:0015386),0.7371193174854441,1.5538175424317908,0.020588235294117647,0.28392835915520864,1.0,4/10,6.19%,SLC9A1;SLC9A8;SLC9A7;SLC9A6
prerank,manganese ion binding (GO:0030145),0.552581044500357,1.5413882069715363,0.011350737797956867,0.31275508182430556,1.0,15/48,17.30%,FAM20C;LARGE1;ABL2;MGAT5;B4GALT7;ATP13A2;DYRK2;PCK2;PAPOLA;GYG1;GALNT3;HMGCL;B4GALT1;XYLT2;XPNPEP1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5406964703901402,1.5398776495945752,0.0066815144766146995,0.30878472084637637,1.0,21/53,22.36%,SLC38A6;SLC38A1;SLC36A4;SLC3A2;SLC6A7;SLC7A1;SFXN1;SLC38A7;SLC7A6;SLC7A8;SLC25A18;SLC38A2;CTNS;SLC25A13;SLC1A5;SLC7A3;SLC43A2;SLC7A7;SLC7A2;SLC17A8;SLC7A10
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.5632479426018955,1.5366257472232427,0.01261467889908257,0.31042384858210825,1.0,21/44,24.44%,CXXC1;KMT2A;DOT1L;KMT5A;RBBP5;KMT5B;SMYD3;SMYD2;TTLL12;EED;EHMT1;PRDM9;SETMAR;WDR5;ASH1L;KMT2B;NSD1;KMT2D;SETD3;SETD4;SMYD1
prerank,solute:anion antiporter activity (GO:0140323),0.6800434240514305,1.5331528073509884,0.036241610738255034,0.31262978316907075,1.0,4/14,10.74%,SLC26A1;SLC26A11;SLC26A4;SLC4A2
prerank,triglyceride lipase activity (GO:0004806),0.6312999480737387,1.5321720589440917,0.027672955974842768,0.3076998475504846,1.0,3/20,6.67%,LPL;CEL;ABHD5
prerank,sterol binding (GO:0032934),0.5375998282517146,1.5299895905542498,0.009857612267250822,0.3060280845279062,1.0,15/56,14.88%,OSBPL8;ABCA1;ABCG1;APOA2;SOAT1;VDAC2;SOAT2;NPC1;CAV1;NPC2;OSBPL2;OSBP;SULT2B1;PROM1;SCP2
prerank,semaphorin receptor binding (GO:0030215),-0.47432769358169646,-1.5285629740129059,0.030303030303030304,0.20118842464297812,0.992,9/23,18.32%,SEMA6D;SEMA6A;RIT2;SEMA5A;SEMA4B;SEMA4A;PLXNB1;SEMA6C;SEMA3B
prerank,death domain binding (GO:0070513),0.7109025281489834,1.5249985583182777,0.023842917251051893,0.3140641716527321,1.0,8/11,22.98%,BCL2;BCL2L1;MCL1;BAX;CRADD;IRGM;DAP;RACK1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.47946453061133515,-1.5238609829747107,0.01652892561983471,0.1994670112250666,0.994,9/21,14.93%,PDE3B;PDE7B;PDE10A;PDE1A;PDE4D;PDE8B;PDE7A;PDE4B;PDE2A
prerank,phospholipase inhibitor activity (GO:0004859),0.722103723275053,1.5235076869389823,0.04316546762589928,0.3113083094218032,1.0,2/10,1.80%,ANXA5;ANXA4
prerank,MAP-kinase scaffold activity (GO:0005078),0.7011232509032644,1.5217085617732906,0.039886039886039885,0.30911671638580546,1.0,5/11,18.99%,IQGAP1;AKAP13;SPAG9;MAP2K2;MAPK8IP3
prerank,tropomyosin binding (GO:0005523),-0.5343451778120493,-1.5181489620225759,0.04878048780487805,0.19996661413302302,0.994,13/16,43.57%,TMOD2;S100A6;TNNT3;SMTNL2;NEBL;TMOD3;LMOD3;LMOD1;TNNT2;TMOD4;TNNT1;CALD1;TMOD1
prerank,channel activity (GO:0015267),0.5469402405540482,1.5101723291132192,0.014976958525345621,0.33806813731407653,1.0,5/41,6.24%,BCL2;TMEM120B;PDPN;BAX;PANX1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.6874442158892508,1.50426870707896,0.04591104734576758,0.3490316346489822,1.0,4/12,6.19%,SLC9A1;SLC9A8;SLC9A7;SLC9A6
prerank,histone methyltransferase activity (GO:0042054),0.5739722020985474,1.5036765491540622,0.03237410071942446,0.34313904188294964,1.0,13/32,12.34%,DOT1L;KMT5A;KMT5B;SMYD3;SMYD2;TTLL12;CARM1;EED;EHMT1;PRMT6;PRMT7;PRDM9;PRMT2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.7139764576957046,1.5007132463984854,0.040345821325648415,0.34501491081934565,1.0,3/10,11.84%,SIRPA;PKP2;JUP
prerank,aspartic-type peptidase activity (GO:0070001),0.714077195542084,1.5005292272094086,0.04512372634643377,0.33825462277186735,1.0,3/10,5.89%,CTSD;NAPSA;DDI2
prerank,hormone receptor binding (GO:0051427),0.6578645940204116,1.5004398345068308,0.044058744993324434,0.33146025676585966,1.0,5/14,15.95%,NPPA;VIP;JAK1;SOCS2;NPPC
prerank,potassium ion antiporter activity (GO:0022821),0.6510056926070112,1.4964888232927929,0.027700831024930747,0.3359959825749851,1.0,5/15,6.19%,SLC9A1;SLC9A8;SLC24A4;SLC9A7;SLC9A6
prerank,sodium:proton antiporter activity (GO:0015385),0.6961046214998524,1.4878364883838666,0.04252199413489736,0.3559915996354559,1.0,4/11,6.19%,SLC9A1;SLC9A8;SLC9A7;SLC9A6
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.55290041993739,1.4850227274291803,0.02564102564102564,0.35760985854103106,1.0,11/38,17.03%,SH3PXD2B;TECPR1;RUFY4;NCF4;WDR45;SESTD1;ZFYVE19;ATG2B;SNX27;HIP1;KIF16B
prerank,lipase activity (GO:0016298),0.5383938572493902,1.478606176518632,0.02346368715083799,0.3715629676817615,1.0,7/43,6.67%,LPL;DDHD1;ABHD12;MGLL;CEL;LIPA;ABHD5
prerank,cytokine receptor activity (GO:0004896),-0.3466778197650485,-1.475014014238806,0.0,0.245091541101439,0.999,39/83,25.12%,CX3CR1;IL6R;IFNGR1;CCR5;IL10RA;IL15RA;CCR2;GFRA1;CD74;LEPR;IL1RAPL2;LIFR;IL13RA1;IL7R;CCR1;PRLR;IL1RL1;F3;FLT3;EBI3;IL18RAP;IL31RA;CCR6;GHR;IL20RA;CCRL2;IL4R;IL10RB;IL2RG;IFNLR1;IL6ST;IL27RA;IL2RB;IL18R1;IL17RD;IL1R2;IL20RB;GFRA2;OSMR
prerank,receptor tyrosine kinase binding (GO:0030971),0.5177904860295831,1.470987083226187,0.01533406352683461,0.39086142613308855,1.0,21/56,18.30%,ITGAX;STAP1;BLNK;ALKAL2;GAB2;SQSTM1;TRAT1;PTPN2;LRP4;GAS6;PIK3R2;SOCS5;RNF41;NCK1;CPNE3;ANGPT2;CBL;SH2B1;ELMO2;DUSP3;PTPN1
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.59751428033394,-1.4691104550255936,0.08143322475570032,0.24416407067002488,1.0,8/10,40.28%,SLC6A11;SLC6A1;SLC10A1;SLC10A6;SLC10A3;SLC6A12;SLC6A13;SLC10A2
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.5664531868679719,1.468293290548458,0.02888086642599278,0.39279188845302093,1.0,11/29,13.14%,GAA;GALC;GLA;NEU1;GUSB;GBA2;IDUA;ABHD10;ADPRS;HPSE;MGAM
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5919324865918699,-1.4682910061340535,0.09352517985611511,0.23751946579042157,1.0,5/10,21.35%,GABRG3;GABRA2;GABRG1;GABRE;GABRA1
prerank,peptidase inhibitor activity (GO:0030414),0.5532759334310141,1.4667686415272114,0.03132530120481928,0.3910330070927606,1.0,12/33,20.59%,RENBP;A2M;CST7;PROS1;TFPI;TIMP2;SERPINF2;CSTB;USP14;CAST;TIMP1;SERPIND1
prerank,RNA cap binding (GO:0000339),0.6281423044128581,1.4629771649086318,0.06141522029372497,0.3972759666928942,1.0,7/16,16.40%,EIF4A1;AGO2;LARP1;CYFIP1;GEMIN5;EIF4E;EIF4E2
prerank,CCR chemokine receptor binding (GO:0048020),0.5612385533327827,1.4625872420309898,0.0425,0.3917952546699395,1.0,6/28,9.76%,CCL4;NES;DEFB130A;CCL13;NARS1;CCL14
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6865355746321404,1.461584329872741,0.05625879043600562,0.38868116462828933,1.0,4/11,8.00%,RDH12;AKR1A1;AKR1B10;RDH13
prerank,neuropeptide binding (GO:0042923),-0.4920823784095877,-1.4613959531544185,0.05286343612334802,0.23900930616601726,1.0,6/18,23.56%,SORL1;GPR149;GPR37;OPRD1;SSTR2;NMUR2
prerank,androgen receptor binding (GO:0050681),0.574292723081346,1.4609944472409648,0.04534005037783375,0.38368604611335394,1.0,15/25,24.10%,KDM3A;PRKCB;RNF6;TMF1;RNF14;PRMT2;SNW1;PRPF6;TGFB1I1;NSD1;CALR;SMARCA4;KDM1A;DAXX;EP300
prerank,sequence-specific mRNA binding (GO:1990825),0.6884192217723203,1.457784077265288,0.0420899854862119,0.38847327336846693,1.0,3/10,12.69%,SHFL;ETF1;DHX9
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5495076297113021,1.4573035958577572,0.03229665071770335,0.38361220872034746,1.0,10/35,13.32%,PEAK1;ABL2;FGR;TEC;PTK2B;SYK;YES1;PKDCC;BTK;FYN
prerank,lysophospholipase activity (GO:0004622),0.5996008660328779,1.457258043310359,0.054758800521512385,0.3776041833099635,1.0,7/20,15.18%,ABHD12;PNPLA7;MGLL;GDPD3;ABHD4;LYPLA2;PNPLA6
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.6743179933577992,1.4542240710726562,0.0594059405940594,0.38105710247803204,1.0,1/11,1.57%,CHRNB2
prerank,syntaxin-1 binding (GO:0017075),-0.4521808742625794,-1.447444866480506,0.05263157894736842,0.2502340868299067,1.0,11/22,16.34%,SNAP25;UNC13B;SYT1;CPLX1;STXBP3;STXBP1;LRRK2;NSF;SNPH;UNC13C;SYP
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6343619857212055,1.442389144812416,0.055858310626702996,0.4142569070214368,1.0,6/14,12.62%,MICAL1;CYBA;NCF4;CYB5R4;CYBB;NCF2
prerank,Tat protein binding (GO:0030957),0.6953666857367851,1.4416195618340226,0.061813186813186816,0.41027764484989987,1.0,2/10,5.68%,MDFIC;SMARCB1
prerank,deoxyribonuclease activity (GO:0004536),0.6238603447090523,1.441552326978174,0.06429548563611491,0.40416848278321515,1.0,5/14,11.54%,ZRANB3;DNASE1L1;DFFB;MBD4;ERCC4
prerank,SUMO transferase activity (GO:0019789),0.6189198915479628,1.441337553801678,0.048302872062663184,0.39872427299647106,1.0,8/16,24.08%,NSMCE2;HDAC4;TRIM28;EGR2;MDM2;PIAS4;RANBP2;PIAS1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.6544568924326272,1.4405092810369606,0.07303370786516854,0.39584736696120776,1.0,7/11,20.38%,GNPTAB;SGMS1;DPAGT1;PIGN;SAMD8;AASDHPPT;SGMS2
prerank,chloride transmembrane transporter activity (GO:0015108),0.6227153746245142,1.439502197122418,0.059895833333333336,0.39346387550370315,1.0,3/16,10.16%,SLC26A1;CLCN7;SLC26A4
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.43969325770855805,-1.4389257100662358,0.047619047619047616,0.2543462998149048,1.0,9/23,14.93%,PDE3B;PDE7B;PDE10A;PDE1A;PDE4D;PDE8B;PDE7A;PDE4B;PDE2A
prerank,protein heterodimerization activity (GO:0046982),0.45793490055439967,1.438920585355745,0.0030181086519114686,0.38957511363700686,1.0,36/178,12.14%,BCL2;ABCG1;HIF1A;BCL2L1;ATF3;RRAGD;ZHX2;IRAK2;SDCBP;PDGFA;ADCY8;APOA2;HEXA;RALGAPA2;MCL1;CYBA;BHLHE41;NOLC1;BHLHE40;BAX;GTF2A2;FZD4;DGKD;PIK3R2;QTRT1;P4HB;DDIT3;CYBB;FXR2;TAF7;PPP2R1A;VAPB;NPAS4;ITGA3;TCOF1;ATP1A1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.6564726524371166,1.438823556295163,0.07692307692307693,0.3843300720437855,1.0,5/12,17.13%,CDK6;CDK8;BRD4;CDK13;CDK4
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.5651706690735839,-1.438534855625916,0.12422360248447205,0.2481189598418179,1.0,6/10,15.60%,SLCO2B1;SLCO1B1;SLCO3A1;SLCO4C1;SLCO4A1;SLCO1C1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6558866426905571,1.433994257937421,0.08134642356241234,0.3934748583429092,1.0,7/12,21.48%,AGO2;LARP1;CYFIP1;GEMIN5;EIF4E;EIF4E2;CYFIP2
prerank,sodium channel activity (GO:0005272),-0.3997444077271874,-1.4280592622854125,0.014492753623188406,0.25504334607009327,1.0,11/37,14.03%,GRIK2;SCN1A;GRIK3;SCN8A;HCN1;GRIK4;CACNA1I;KCNK1;SCN2A;GRIK5;SCN7A
prerank,ribonuclease activity (GO:0004540),0.5074958077476109,1.4260954738944234,0.04072398190045249,0.4139128188064817,1.0,22/56,21.88%,AGO2;PIWIL2;ERN2;RNASEH2A;RNASE12;ERN1;SND1;RNASEH1;ZC3H12B;RNASE7;RNASEL;RNASE3;EXOSC9;CNOT6;AGO3;EXOSC10;EXOSC5;ZC3H12C;ZC3H12A;PPP1R8;EXOSC4;ZC3H12D
prerank,phospholipase activity (GO:0004620),0.49127141855337825,1.4227011797973013,0.028169014084507043,0.4193930725907586,1.0,11/67,5.53%,LPL;DDHD1;PLD3;ABHD12;PNPLA7;PLCB4;MGLL;PLAAT3;GDPD3;PLCB2;SMPD4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.5557196619639755,1.4210338831232463,0.0759493670886076,0.418785909577208,1.0,4/24,12.92%,OSBPL8;SESTD1;OSBP;GOLPH3
prerank,lipoprotein particle receptor binding (GO:0070325),0.5571951990213064,1.4164009298977085,0.05048076923076923,0.4283521166708029,1.0,4/27,5.73%,LRP1;APOE;APOA2;LRPAP1
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.5301904381730131,1.410393485814774,0.07544910179640718,0.4424726321742607,1.0,10/34,12.31%,DOT1L;KMT5A;ETFBKMT;KMT5B;SMYD3;SMYD2;TTLL12;EEF1AKMT3;EHMT1;PRDM9
prerank,histone methyltransferase binding (GO:1990226),0.6551214658682699,1.4097099515161526,0.0841799709724238,0.43926118854795004,1.0,6/11,23.50%,CTNNB1;PHF1;CBX3;LCORL;LCOR;HSP90AB1
prerank,ubiquitin binding (GO:0043130),0.48086481907043804,1.4080339348287159,0.03225806451612903,0.4390471996360578,1.0,29/73,22.60%,HSPB1;SQSTM1;FBXW7;USP5;DDI2;UBAP1;UBE2L6;ILRUN;RAE1;PLAA;MDM2;ASCC2;MARK4;TNFAIP3;MVB12B;RNF185;MVB12A;UBAP1L;SHARPIN;FBXO7;USP13;USPL1;BIRC2;USP16;USP33;NEDD4;SIRT2;RNFT1;RNF19B
prerank,mRNA binding (GO:0003729),0.44664466987445417,1.405820775799101,0.003006012024048096,0.4401268474858343,1.0,91/249,23.09%,RBM47;PKM;ADARB1;SNRNP35;UNK;EIF4A1;SHFL;EIF3A;PABPC5;AGO2;EIF4G1;CPEB4;SNIP1;RBM25;EIF4G2;CPEB2;LUC7L2;DXO;HNRNPM;LARP4;LARP1;NCL;NOCT;LSM14A;DENR;CELF1;HNRNPLL;GRSF1;HNRNPC;DHX33;ZC3H12B;EIF4G3;ETF1;RBPMS;PPIE;HNRNPK;FXR2;GNL3;YTHDF2;THOC2;EIF4ENIF1;EIF2S2;NOVA2;RBM4B;C1QBP;PTBP3;GEMIN5;DHX9;HNRNPL;RPL13A;CPEB1;HNRNPA2B1;TPR;RPS26;UPF3B;CCT5;TRA2B;PABPC4;PUM1;RIDA;CPEB3;PABPC1;MRPS7;FUBP1;PCBP1;CIRBP;CELF6;RBFOX2;CNBP;RPS13;PUM3;G3BP1;ZC3H12C;EDC3;HNRNPU;ZC3H12A;PPP1R8;ARC;YBX3;RPS2;RNF20;EIF2A;SRSF1;HDLBP;ZC3H12D;CALR;PUM2;PCBP4;SECISBP2L;RPS7;METTL3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4630933408425159,1.4050683441295049,0.015625,0.4370258835131839,1.0,27/100,17.03%,OSBPL8;SH3PXD2B;MYO10;SNX24;IQGAP1;TECPR1;RUFY4;GAB2;ARAP2;VEPH1;NCF4;WDR45;HIP1R;SESTD1;OSBP;ZFYVE19;ATG2B;OGT;BTK;GOLPH3;SNX27;MAPKAP1;RUBCN;PLEKHN1;HIP1;ARHGAP9;KIF16B
prerank,protein phosphatase binding (GO:0019903),0.4602813587099382,1.404921201407469,0.015463917525773196,0.4322631212205849,1.0,25/117,12.85%,LGALS3;CTNNB1;IQGAP1;ANK1;SIRPA;SLC9A1;MFHAS1;CD22;ADCY8;TRAF2;SPHK1;IKBKE;TRAF3;PTPA;PPME1;VCP;BOD1L1;PIK3R2;GTF2F1;MVP;LILRB1;JUP;JAK1;KCNN4;PPP1R3F
prerank,cyclic nucleotide binding (GO:0030551),-0.440232821482138,-1.4048932285815183,0.07981220657276995,0.279385700047624,1.0,9/21,18.76%,HCN1;RAPGEF2;PDE10A;PDE4D;KCNH1;RAPGEF4;PDE4B;PDE2A;POPDC3
prerank,kinase activator activity (GO:0019209),0.5356486270920314,1.397545672891103,0.0683453237410072,0.4511835032804674,1.0,13/30,24.20%,FGF13;MALT1;CAB39;NCKAP1L;TREM2;GPRC5B;IL2;MARK2;EPO;STK11;MOB1B;DAXX;SPDYA
prerank,anion:anion antiporter activity (GO:0015301),0.5930820064754865,1.394915193863215,0.08072916666666667,0.4544489666532699,1.0,5/17,15.76%,SLC26A1;SLC26A11;SLC26A4;SLC4A2;SLC19A1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.5603175223163461,1.3922743718342454,0.07808564231738035,0.4573641875024765,1.0,2/21,1.57%,P2RX4;CHRNB2
prerank,ATP hydrolysis activity (GO:0140603),0.5067003752306914,1.391812572883245,0.07110091743119266,0.4533853948291131,1.0,12/41,19.14%,MYO1E;ATP2B1;CHD3;ABCD2;VCP;VPS4B;DHX9;TOR3A;TOR1B;RUVBL2;MYO19;VWA8
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6212324964004642,1.39139357008388,0.09523809523809523,0.4494516125065414,1.0,4/13,6.25%,ITGA5;PDGFA;VEGFA;ERN1
prerank,kinesin binding (GO:0019894),0.5425665385774607,1.3810745492532506,0.08233890214797136,0.47900854445312985,1.0,9/27,20.80%,PLEKHM2;NEK6;SPAG9;IFT88;FAM83D;AP1G1;TOR1B;MAPK8IP3;KIF1B
prerank,carboxylic ester hydrolase activity (GO:0052689),0.4630631903559663,1.3806115711527163,0.03563941299790356,0.4750569099320465,1.0,16/85,13.31%,LPL;AARS1;ABHD12;PNPLA7;MGLL;PON1;CEL;LIPA;PLAAT3;GDPD3;PAFAH2;ABHD5;PGAP1;ABHD4;LYPLA2;PGLS
prerank,pseudouridine synthase activity (GO:0009982),0.6264411627255475,1.3782415208043015,0.09615384615384616,0.4777496004543593,1.0,6/13,25.74%,PUS1;TRUB2;DKC1;RPUSD1;PUSL1;TRUB1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.6133805584918159,1.3781945009442096,0.09673024523160763,0.4726328472019323,1.0,6/13,21.80%,SLC7A1;SLC38A7;SLC7A6;SLC7A3;SLC7A7;SLC7A2
prerank,voltage-gated cation channel activity (GO:0022843),-0.3074301877804719,-1.375085936723492,0.0,0.31675209520863706,1.0,26/97,9.68%,CACNB2;CACNA2D1;KCNQ5;KCND2;GRIN3A;GRIN2B;KCNB2;GRIN2A;KCND1;CACNA2D3;HCN1;KCNH7;NCS1;KCNA6;CACNG3;KCNB1;GRIN1;KCNC2;KCNQ3;CACNA1B;KCND3;KCNA1;CACNA1C;CACNA1I;KCNK1;KCNH1
prerank,hormone activity (GO:0005179),0.4842553560813873,1.374893539349803,0.05016722408026756,0.4782367503889217,1.0,10/54,18.33%,IGF1;TRH;NPPA;POMC;CRH;VIP;GNRH1;AGRP;NPPC;METRNL
prerank,potassium channel activity (GO:0005267),-0.3102845303584483,-1.3740849373074187,0.0,0.31066100064915636,1.0,23/89,10.87%,GRIK2;KCNQ5;KCND2;GRIK3;KCNB2;KCND1;KCNK12;HCN1;KCNH7;KCNA6;KCNN2;KCNB1;GRIK4;KCNC2;KCNQ3;KCNK10;KCNMB2;KCND3;KCNA1;KCNK2;KCNK1;KCNH1;ABCC9
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.5380795496654923,1.3718899140558098,0.07616707616707617,0.48280750101936865,1.0,5/27,10.16%,ANKH;SLC26A1;SLC26A11;GET3;SLC26A4
prerank,regulatory RNA binding (GO:0061980),0.4966762215013869,1.3696253425911977,0.08584686774941995,0.48480869442788743,1.0,12/38,19.57%,AGO2;ZNF346;PIWIL2;DDX21;ZC3H7B;DHX9;AGO3;HNRNPA2B1;AGO4;PUM1;TLR7;ZC3H12A
prerank,galactosyltransferase activity (GO:0008378),0.6352908918249887,1.3651384343717028,0.10072992700729927,0.49413851425329974,1.0,2/11,1.35%,B4GALT5;B4GALT7
prerank,RNA binding (GO:0003723),0.42276681911007186,1.3640529608942227,0.0,0.4927697923683481,1.0,474/1321,25.00%,LGALS3;APOBEC1;RFTN1;MYO5A;RBM47;DDX31;LRP1;C1D;SNTB2;PUS1;PKM;TSR1;MACF1;ADARB1;EPRS1;AARS1;SNRNP35;UNK;EIF4A1;SHFL;CNOT4;EIF3A;CCDC9;LLPH;DYNC1H1;EIF1AX;EIF1;GRB2;IPO5;UBAP2;PABPC5;C4BPA;CARS1;RBM28;NOC2L;HNRNPA3;KNOP1;GRWD1;IGHMBP2;AGO2;SLC3A2;FNDC3B;RRP7A;EIF4G1;NUDT5;BRIX1;HSPB1;CPEB4;SNIP1;ZNF346;GOLGB1;SON;OTUD4;XPOT;RBM25;MSN;LRRFIP1;CHD3;AKAP1;NFX1;MRPL23;TRMT10C;EIF4G2;FLNA;DDX56;DDX21;PSMA1;CPEB2;HNRNPUL1;LUC7L2;ZNF326;UBTF;DDX49;ASCC3;ZC3H7B;NOLC1;SAFB2;SYNE1;VIM;NPM3;DXO;RRBP1;HNRNPM;PATL2;DUSP14;ESF1;LARP4;EIF3L;KRI1;PATL1;DDX50;DDX39B;LARP1;NCL;MRM1;NOCT;LSM14A;MAK16;SAMSN1;PNN;TRIM28;RBM39;DENR;ALDOA;IMMT;SMNDC1;CELF1;DDX18;TRUB2;LGALS1;HNRNPLL;MRM3;GRSF1;CFAP65;IBA57;VCP;GTPBP4;DAP3;RCC1L;SND1;MRPL4;HNRNPC;EEF2;LONP1;SRSF11;DHX34;MRPS15;CCAR1;ANXA7;YRDC;RNASEH1;DDX52;DHX33;TAF15;NOL6;PABPN1;NSA2;FARSA;BCCIP;ZC3H12B;EIF4G3;BRCA1;TRAP1;RRP12;SART1;SRP9;JUN;PUF60;SLC16A3;ETF1;DDX17;RPL10A;CRKL;FAM120A;SRPK1;RBPMS;P4HB;PPIE;ISG20L2;GTF2F1;RAE1;ARHGEF1;HSPA9;HNRNPK;ERI3;MRPS28;MRPS35;FXR2;CHCHD1;RNASEL;WDR43;GNL3;SRF;BTF3;PKN2;EEF1A1;YTHDF2;ATXN2;ACIN1;RPL12;ALKBH1;UBAP2L;BICC1;RBM15B;ENO1;TNPO1;PPAN;THOC2;EIF4ENIF1;SRPK2;CDK11B;CPNE3;UTP14A;LYAR;EIF4A2;CDK13;EIF2S2;RARS2;PRDX1;KIN;NOVA2;UTP20;RBM4B;C1QBP;RBM19;TCOF1;PTBP3;CHTOP;DHX29;RPL36;FNDC3A;NOL8;USO1;ZNF638;RAD51AP1;YWHAG;CSTB;SRP14;GEMIN5;ZFR;EXOSC9;RPS6;DHX9;PPIG;HNRNPL;ZCCHC9;KRR1;EIF4E;NUP42;SRSF2;RPS28;USP36;RPL13A;AGO3;MRPL37;HNRNPA2B1;TPR;YARS1;HSPD1;FASTKD2;EXOSC10;MYBBP1A;RRP9;FLNB;R3HDM1;HUWE1;MRPS30;DUSP11;SEC63;CS;ZRANB2;RBM26;SUCLG1;RPS26;RPP38;GAR1;CPSF7;UPF3B;MRPL11;R3HDM2;HEATR6;GTPBP10;DQX1;MRPL1;NAT10;TRA2B;RRP1B;RRP1;CMSS1;ACTN1;DKC1;UBE2L3;RPS27A;UBC;FAU;SNU13;MRPS12;RPS12;DNAJC2;POLR2D;AGO4;EIF5A;GTF2E2;PABPC4;SUPV3L1;ZCCHC8;PUM1;MKRN2;YY1;BST2;RIDA;WDR3;CPEB3;NOC3L;SREK1;TERT;PPARGC1B;SNW1;DDX1;FASTKD5;DCP2;SRSF7;EIF5B;UTP11;EIF4E2;PABPC1;TBCA;CAPRIN1;PDAP1;TFRC;PURA;MRPS7;FUBP1;DIMT1;PCBP1;CHERP;FARS2;S100A16;LSM6;POLR1G;CAST;UTP4;CIRBP;PRPF40A;GPATCH4;SF3B5;PYM1;MAP3K20;SARS1;SARS2;ACAA2;SRRM1;CELF6;RPL18;MAPRE1;RBFOX2;CNBP;RBM22;PFN1;NAA15;RPS13;SNRPF;BYSL;ALKBH8;RNMT;ZC3H15;DDX59;PTPN1;CKAP4;POP1;ELP5;ADAR;HSPE1;DEK;NOA1;PUM3;PPP1R10;ARL6IP4;MARK2;EIF3B;PRPF6;SART3;NUFIP2;SAFB;TLR7;G3BP1;ZC3H12C;ATP5F1C;EDC3;SIDT1;SRFBP1;FUS;HNRNPU;ZC3H12A;PPP1R8;SNRNP40;SMG1;POLRMT;MRPL42;MBNL2;NOL3;ARC;ZC3HAV1;TRMT2A;PRRC2C;YBX3;RPF1;DNTTIP2;NXF1;DDX42;RPS2;XRN2;RALY;MTDH;TRMT10A;EIF2S1;EIF2A;SRSF1;SUMO1;WBP11;ALG13;PDCD11;RBM45;HMGN2;RPS19;HDLBP;ZC3H12D;CSNK1E;SUMO2;NVL;ZGRF1;MCAT;SRSF10;TRMT1L;CALR;PUM2;XRCC5;EWSR1;SNRPD3;SNRPD2;SNRPD1;NGRN;TES;PCBP4;MRPS9;PARP1;PIN4;FTSJ3;MTPAP;TOE1;TSFM;MRPL39;LSM8;KDM1A;WDR33;ELP1;SECISBP2L;RPS7;HSP90B1;RACK1;PSMA6;METTL3;RBM34;MTO1;DHX32;GIGYF2;ACTN4;HSP90AB1;XRN1;RO60;CSDE1;PSMD4;SURF6;RTCB;EIF2AK4;NUP98;NSUN2;TOP1;EIF5;MAZ;PPRC1;SAMD4B;MYO18A;HNRNPF;NOP14;NPM2;NSUN6;SYNCRIP;EIF4B;RPL17;RPL23;LSM4;TEP1;BMS1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.6213412940816987,1.3598242937457734,0.1258741258741259,0.5022522568524613,1.0,5/12,15.12%,TRAF2;TRAF3;TRAP1;TNF;BABAM2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.6077259567860868,1.3574618636163767,0.1155433287482806,0.5049837742284773,1.0,7/13,23.27%,METTL1;TRMT10C;WDR4;TRMT5;TRMT10A;TRMT1L;THUMPD2
prerank,protein kinase C binding (GO:0005080),0.49592529963706183,1.3556656481696625,0.07454128440366972,0.5059352489910797,1.0,9/43,9.04%,NELL2;PLEK;NELL1;HSPB1;SQSTM1;PRKCB;HDAC9;HDAC7;PKP2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.3822045898886212,-1.3516288079263574,0.06432748538011696,0.3371376388476826,1.0,19/32,30.34%,KCNQ5;KCNB2;KCNA6;KCNB1;KCNC2;KCNQ3;KCNA1;KCNH1;KCNC1;KCNH2;KCNC3;KCNS3;KCNG2;KCNQ1;KCNG1;KCNE3;KCNS1;KCNE4;KCNG3
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.45600605567015573,1.351316634786705,0.05211726384364821,0.5153350239727384,1.0,13/74,8.80%,FAM20C;DGKZ;PKM;PIK3CB;SPHK1;GK;CHKB;SPHK2;GALK2;PDXK;PI4KA;DGKH;DGKD
prerank,endoribonuclease activity (GO:0004521),0.5165951003910262,1.3499277028470966,0.07926829268292683,0.5150447029487194,1.0,12/32,21.88%,AGO2;PIWIL2;ERN2;ERN1;SND1;ZC3H12B;RNASEL;AGO3;RIDA;ZC3H12C;ZC3H12A;ZC3H12D
prerank,methyltransferase activity (GO:0008168),0.4839160348807551,1.3477894767095933,0.08342857142857144,0.5173158457819867,1.0,20/46,24.06%,AS3MT;MGMT;COQ5;PRMT3;EEF1AKMT3;DNMT3B;EHMT1;NSUN3;PRMT7;AMT;GCSH;NSUN4;DNMT1;MRM2;NTMT1;PRMT5;FTSJ3;METTL3;COQ3;NSUN2
prerank,serine-type peptidase activity (GO:0008236),0.4447517697477375,1.342706014561019,0.037815126050420166,0.5297353900556704,1.0,16/96,13.51%,PLAU;ST14;RHBDF2;KLK1;KLK6;PRSS8;F11;GZMM;TPP1;PREP;MASP1;PARL;KLK3;FURIN;CLPP;MASP2
prerank,ADP binding (GO:0043531),0.5296451718799491,1.3422285725099674,0.11346633416458853,0.5262448526430973,1.0,5/25,9.54%,MYO9B;ABCG1;ERN1;LONP1;PGK1
prerank,leucine zipper domain binding (GO:0043522),0.6410837928263853,1.3411506788225525,0.1377840909090909,0.5249859899580548,1.0,2/10,9.15%,MRTFA;DDIT3
prerank,E-box binding (GO:0070888),0.4991534428217887,1.340556785547377,0.10059880239520957,0.5222447798642454,1.0,4/34,5.31%,MITF;BHLHE41;PPARG;BHLHE40
prerank,active ion transmembrane transporter activity (GO:0022853),-0.3603022807317502,-1.3392947556630805,0.058394160583941604,0.348868037565266,1.0,15/37,15.60%,SLCO2B1;SLCO1B1;COX6A1;SLC16A7;COX8A;UQCRC1;COX5A;SLCO3A1;SLCO4C1;UQCRFS1;SLCO4A1;COX15;COX4I1;NDUFA4;SLCO1C1
prerank,sialyltransferase activity (GO:0008373),-0.4351316976837869,-1.3391746768317143,0.10909090909090909,0.34113504806359735,1.0,4/20,3.71%,ST3GAL6;ST3GAL5;ST8SIA4;ST6GAL2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5287902151478616,1.3391134596967869,0.1111111111111111,0.5223122184865049,1.0,6/25,8.75%,MICAL2;CYP27B1;MICAL1;CH25H;POR;MTRR
prerank,BMP binding (GO:0036122),-0.5108373723023129,-1.3369114192936125,0.14383561643835616,0.3365753628667331,1.0,3/11,24.63%,NBL1;GREM1;ENG
prerank,DNA replication origin binding (GO:0003688),0.5386102558204061,1.3368749954857249,0.12579415501905972,0.5252038453241052,1.0,12/23,26.22%,ORC3;GRWD1;MCM2;MCM7;DHX9;MCM8;HSPD1;KAT7;MCM6;MCM3;POLA1;MCM5
prerank,protein tyrosine kinase binding (GO:1990782),0.4563956927158395,1.3342378841369789,0.06430868167202572,0.529358743333383,1.0,23/71,18.30%,SIRPA;ITGAX;BLNK;TRIM6;ALKAL2;SQSTM1;TJP2;NEDD9;PTPN2;LRP4;GAS6;PIK3R2;TREM2;SOCS5;RNF41;NCK1;CPNE3;ANGPT2;CBL;CRK;ELMO2;DUSP3;PTPN1
prerank,phospholipase binding (GO:0043274),0.597612978267242,1.332054777389873,0.12859097127222982,0.5315917826279597,1.0,6/13,13.32%,BLNK;PDPK1;SYK;ARHGAP6;BTK;FYN
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6170255486506102,1.3317811241897206,0.13370473537604458,0.5276583394822488,1.0,4/12,4.15%,STAP1;BLNK;GAB2;TRAT1
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.5281141849449733,-1.3315896915236551,0.15331010452961671,0.3383328882595952,1.0,6/10,26.25%,KAT2B;CDKN2C;CDKN2D;CDKN1A;CDKN1B;HEXIM2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5618847436774846,1.3299716994807593,0.12121212121212122,0.5292261503801109,1.0,2/17,0.55%,ABCA1;ABCG1
prerank,ATPase regulator activity (GO:0060590),0.49635024640048464,1.3288523751874688,0.09399773499433749,0.5284860583614239,1.0,19/38,28.32%,FNIP2;TOR1AIP2;DNAJB6;SIL1;BAG3;DNAJC10;FNIP1;ATP1B3;DNAJC1;PFN1;DNAJC15;BRSK2;GRPEL2;DNAJA1;ATP5IF1;TOR1AIP1;BAG5;BAG2;HSPBP1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6034393373605846,1.3267315102547035,0.1361031518624642,0.531197927854466,1.0,5/11,12.34%,PRMT3;CARM1;PRMT6;PRMT7;PRMT2
prerank,lipoprotein particle binding (GO:0071813),0.5452564476126825,1.3265688695818418,0.12953367875647667,0.5271411368056907,1.0,6/20,13.91%,COLEC12;LPL;APOA2;TREM2;HSPD1;MSR1
prerank,nuclear localization sequence binding (GO:0008139),0.5564139662805506,1.3262269970180578,0.13003901170351106,0.5236246589230645,1.0,6/18,11.94%,IPO5;KPNA4;BRAP;TNPO1;TNPO2;KPNA6
prerank,protein kinase activator activity (GO:0030295),0.4586914928028169,1.3258802914951229,0.07845303867403315,0.5203582855046975,1.0,19/60,20.03%,FGF13;IQGAP1;ERCC6;ALS2;CAB39;STK3;NCKAP1L;GAS6;PAK2;DBF4;GPRC5B;CALM2;IRGM;MAP2K2;MARK2;TAOK1;EPO;STK11;RICTOR
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5160848015313085,1.3243704299134837,0.12622549019607843,0.5209920126690499,1.0,11/29,19.92%,SLC26A1;SLC46A1;SLC38A7;SLC26A4;SLC25A18;SLC13A5;SLC19A1;SLC25A21;SLC25A14;SLC25A13;SLC1A5
prerank,translation elongation factor activity (GO:0003746),0.5827230638094117,1.3241985898331388,0.13844086021505375,0.5170724389926354,1.0,8/14,22.71%,GTPBP2;EEF2;EEF1A1;GFM2;EIF5AL1;EIF5A;EEF1A2;TSFM
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.49459610875618837,1.3240880507436723,0.1053864168618267,0.5130918888932916,1.0,12/34,20.03%,IQGAP1;ALS2;CAB39;STK3;CCNB1;CCNT2;DBF4;CALM2;IRGM;MAP2K2;TAOK1;RICTOR
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6055672151528692,1.3239150230442969,0.14542936288088643,0.5093608459571853,1.0,3/12,7.82%,GALNS;GNS;ARSA
prerank,ATP binding (GO:0005524),0.417153152391899,1.3236752305375385,0.010030090270812437,0.5058648926212295,1.0,89/266,24.64%,MYO9B;PEAK1;ABCA1;ABCG1;ERCC6;P2RX4;MYO1F;AARS1;CDK6;SPHK1;MAP4K5;GCK;CARS1;ABCD4;IGHMBP2;EIF4G1;MAP4K3;ERN2;DYRK2;PFKL;PI4K2A;STK3;ABCD2;NEK6;HSPA4;SIK1;PTPA;ERN1;TLK1;PDXK;LONP1;PAPOLA;MTHFS;SRPK1;HSPA9;CAD;PGK1;ATP7A;DAPK1;AK6;SRPK2;CDK11B;ATP1A1;ATP1A3;MLKL;BTK;DHX9;MARK4;TRIP13;STK38L;MINK1;TARS1;PNKP;GUK1;STK38;LATS1;EIF2B2;MAP3K20;SARS2;PRKAG1;PFKP;PRAG1;TGFBR1;MARK2;MKNK1;RRM1;TAOK1;HNRNPU;BLM;PDK3;OLA1;STK11;HSPA2;ATP7B;CLPX;PRPS2;BRSK2;KIFC1;NVL;MTPAP;HSP90AB1;ATP1A2;MCM6;RAD51;HSPA13;ABCF2;TOP1;ABL1;MYO18A
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.5788060757309774,1.3227015052952762,0.13430851063829788,0.5048573667969116,1.0,2/15,10.16%,SLC26A1;SLC26A4
prerank,GTPase inhibitor activity (GO:0005095),0.5934237865697236,1.320425178380223,0.14919354838709678,0.5077285079382934,1.0,3/13,4.50%,IQGAP1;IPO5;CPEB2
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5108915177126463,-1.319158336630839,0.16271186440677965,0.35046542259393776,1.0,4/11,18.06%,ATP8A2;ABCA3;ABCB4;ATP11C
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.6320205557348715,1.3173471179127407,0.14723032069970846,0.5139083092285137,1.0,4/10,12.62%,CYBA;NCF4;CYBB;NCF2
prerank,phosphatidylinositol binding (GO:0035091),0.44036569421000393,1.3157903374200217,0.0667361835245047,0.5148176241610485,1.0,25/91,18.40%,MYO1E;SNX24;EEA1;SNX8;ESYT1;WDFY1;SNX10;APPL2;WDR45;WDFY3;HIP1R;PITPNC1;SESTD1;NUMA1;SNX4;SNX27;MREG;PLEKHF2;SNX31;RUBCN;PLEKHN1;HIP1;SNX17;DENND1B;FES
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.5078869191027273,1.3155298616116062,0.14336492890995262,0.5117504950705111,1.0,8/28,15.12%,TRAF2;TRAF3;TRAP1;TNFSF9;BID;TMBIM1;TNF;BABAM2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.6172707457525648,1.3079366213849348,0.1671388101983003,0.531284206967944,1.0,8/10,30.27%,SMYD2;PRDM9;SETMAR;ASH1L;NSD1;SETD3;NSD3;SETD2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6154610903335568,1.3046415366771305,0.1391035548686244,0.5379200527833349,1.0,2/10,1.35%,B4GALT5;B4GALT7
prerank,protein phosphatase regulator activity (GO:0019888),0.4609658144978896,1.303558414980376,0.09182530795072788,0.537202093385475,1.0,20/53,25.27%,LGALS3;MGAT5;PPP2R5C;PTPA;CABIN1;PPME1;RCAN1;BOD1L1;PPP2R1A;PPP2R2D;ANKLE2;CALM2;SAG;PPP4R2;SHOC2;PPP1R9B;SET;B3GAT3;PPP1R15B;CALM3
prerank,retinoic acid binding (GO:0001972),-0.4848459325125247,-1.3033813902904414,0.175,0.36783676765891427,1.0,9/12,34.63%,RARA;CYP26B1;CYP26C1;NR2F2;UGT1A1;UGT1A8;UGT1A6;UGT1A7;UGT1A4
prerank,snoRNA binding (GO:0030515),0.5018601909073456,1.3026045254678211,0.1330049261083744,0.5363639718370611,1.0,17/30,32.79%,TSR1;NUDT5;DDX21;RRP9;GAR1;DKC1;SNU13;WDR3;BYSL;XRCC5;NOP14;BMS1;PRKDC;DHX37;NOP58;TBL3;NOP56
prerank,gated channel activity (GO:0022836),0.5745508573273288,1.300591477229523,0.13975576662143827,0.5388913103776202,1.0,2/14,2.93%,PACC1;PIEZO1
prerank,frizzled binding (GO:0005109),0.4862367736972299,1.3000521973580088,0.12293144208037825,0.536488077983126,1.0,8/34,17.53%,SDCBP;BAMBI;MYOC;LRP6;FZD1;ZNRF3;NDP;SFRP1
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5634743720702425,1.2994678740596495,0.1539456662354463,0.5303738338330406,1.0,4/16,7.33%,TTYH2;ANO9;ANO8;ANO6
prerank,intracellular chloride channel activity (GO:0061778),0.5634743720702425,1.2994678740596495,0.1539456662354463,0.5303738338330406,1.0,4/16,7.33%,TTYH2;ANO9;ANO8;ANO6
prerank,protein phosphatase 2A binding (GO:0051721),0.5264300297900169,1.2979618857306898,0.12690355329949238,0.531117506042715,1.0,6/23,8.63%,MFHAS1;ADCY8;SPHK1;PTPA;PPME1;BOD1L1
prerank,histone deacetylase activity (GO:0004407),0.5396892668572747,1.2970913340056849,0.1553784860557769,0.5299843613926835,1.0,8/19,20.75%,HDAC4;HDAC9;SUDS3;MIER2;SIRT3;HDAC1;HDAC3;SIRT2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.5146275699578958,1.297071149862283,0.14762516046213095,0.5261951482554083,1.0,8/23,17.03%,SH3PXD2B;ATP13A2;WDR45;HIP1R;SESTD1;MAPKAP1;HIP1;KIF16B
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5513391963030465,1.294657328603562,0.1472972972972973,0.5304347875663886,1.0,7/15,20.58%,PIK3CB;PI4K2A;PI4KA;PI4K2B;PIK3C2A;PIKFYVE;PIK3CA
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.6199553272990709,1.2934325700157994,0.16200294550810015,0.5305000028303115,1.0,1/10,0.08%,APOBEC1
prerank,nucleosomal DNA binding (GO:0031492),0.5262107918231392,1.2931682041309238,0.14376590330788805,0.5275258633263049,1.0,13/21,33.83%,SMARCB1;HNRNPC;SMARCD2;GATAD2B;HDAC1;SMARCA4;H3-3A;SMARCC1;SMARCC2;HDAC2;SMARCE1;RCC1;MTA2
prerank,P-type ion transporter activity (GO:0015662),0.5899922084654607,1.287551202969512,0.17207334273624825,0.5405682300802477,1.0,5/12,20.61%,ATP2B1;ATP7A;ATP2A2;ATP7B;ATP6V1E1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.49123490289962657,-1.287190354065385,0.1717171717171717,0.38619893187269166,1.0,7/12,14.93%,PDE3B;PDE7B;PDE4D;PDE8B;PDE7A;PDE4B;PDE2A
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5806730659431757,1.283140459624558,0.17294281729428174,0.5506442283792999,1.0,2/12,3.49%,ITGA5;VEGFA
prerank,SH2 domain binding (GO:0042169),0.48476178697420763,1.2830090833391026,0.15151515151515152,0.5472693862186472,1.0,8/31,11.20%,SH3PXD2B;BLNK;DAG1;SQSTM1;INPPL1;LILRB1;LAT2;RUFY1
prerank,1-phosphatidylinositol binding (GO:0005545),0.5656364628323773,1.2824448509078032,0.15159574468085107,0.5451745043197385,1.0,5/15,9.79%,EEA1;WDFY1;SNX10;WDFY3;SESTD1
prerank,lysine N-methyltransferase activity (GO:0016278),0.5281323814300992,1.2801524556401882,0.15891472868217055,0.5486587153782145,1.0,8/20,23.86%,KMT5A;ETFBKMT;SMYD2;EEF1AKMT3;EHMT1;EEF2KMT;SETD3;SETD4
prerank,endodeoxyribonuclease activity (GO:0004520),0.5258476115705139,1.2794457079627795,0.14863102998696218,0.5470984050790344,1.0,7/20,18.61%,ZRANB3;ERCC1;RAD50;MBD4;ERCC4;SETMAR;DCLRE1C
prerank,cytokine receptor binding (GO:0005126),0.4280753560476979,1.2784518765937618,0.0976890756302521,0.5461736253827232,1.0,16/83,13.83%,CSF1;CD300LF;SDCBP;VEGFA;IL12RB1;ADAM17;IL27;TGFBRAP1;SPRED2;SYK;KITLG;TNFSF9;JAK1;IL6;SOCS2;IL2
prerank,GTPase regulator activity (GO:0030695),0.4036464289832908,1.276002006064242,0.03636363636363636,0.5500149854546682,1.0,62/212,20.84%,ARHGAP25;ABR;MYO9B;RGS1;ARHGAP24;ARHGAP10;IQGAP1;ASAP1;SIRPA;TBC1D22A;SIPA1L2;GNAQ;NRP1;RASGRP3;IPO5;ALS2;TBC1D2;RALGAPA2;RIN2;CPEB2;RGS3;GDI1;RANBP1;NCKAP1L;RGPD1;ARHGAP19;JUN;LLGL2;GMIP;RASA1;TBC1D10A;ELMOD3;ARHGAP17;NPRL3;TBC1D12;TBC1D16;ELMOD2;LLGL1;CDC42SE1;BNIP2;LARS1;ARFGAP3;NF1;ARFGEF1;ADAP1;HTR2B;FLCN;CHN2;ARHGAP9;RAB3GAP1;RAB3GAP2;ARHGAP22;KRIT1;RGS11;ERRFI1;TBC1D20;ARL2BP;ITGB1BP1;TAGAP;ARHGAP30;RALBP1;RUNDC1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.4547222219293475,1.2757547203506594,0.1324354657687991,0.5470959305781193,1.0,23/49,27.49%,TNIP1;OPTN;SQSTM1;IKBKE;ZRANB3;AGAP3;VCP;ABRAXAS1;TNIP2;TNFAIP3;UIMC1;BABAM2;TNIP3;MINDY2;SHARPIN;WDR81;BRCC3;UBQLN1;PSMD4;UBQLN2;ABRAXAS2;ZBTB1;RAD23A
prerank,carboxypeptidase activity (GO:0004180),0.47315139639763026,1.2751677207083076,0.1755813953488372,0.5453932481663237,1.0,9/35,16.39%,CPVL;CTSZ;CTSA;AGBL5;CPD;AGTPBP1;BLMH;SCPEP1;MINDY2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5080592552454462,-1.2719471585743498,0.17465753424657535,0.4043053039341316,1.0,6/10,18.62%,DPP10;DPP6;DPP4;FAP;DPP3;PRCP
prerank,double-stranded RNA binding (GO:0003725),0.43316863404573464,1.2700291946589788,0.125531914893617,0.5573470082564655,1.0,22/70,19.52%,RFTN1;ADARB1;EIF4A1;AGO2;SLC3A2;ZNF346;MSN;LRRFIP1;VIM;DHX33;ZFR;DHX9;AGO3;HSPD1;ACTN1;AGO4;SUPV3L1;TFRC;ADAR;TLR7;SIDT1;HNRNPU
prerank,glucuronosyltransferase activity (GO:0015020),0.5226813509288235,1.2696930024207003,0.17904509283819628,0.5548203035226057,1.0,2/19,2.56%,LARGE1;B4GAT1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.606393901237129,1.26952158905021,0.1794871794871795,0.5517621519424427,1.0,4/10,12.59%,CACNA1A;CACNA1D;CACNB3;CACNB1
prerank,lipase activator activity (GO:0060229),0.6074443151594501,1.2694137916725965,0.17664233576642335,0.548587008066753,1.0,5/10,13.32%,PDPK1;ARHGAP6;BTK;APOH;FYN
prerank,cadherin binding (GO:0045296),0.3999870035808458,1.26661376271442,0.02,0.5536784361179099,1.0,112/315,23.50%,TRPC4;CTNNB1;IQGAP1;ASAP1;P2RX4;TLN1;NIBAN2;PKM;MACF1;UBAP2;SLC3A2;PAK6;TBC1D2;FMNL2;CAPG;TJP2;LRRFIP1;CHMP4B;PTPRM;EIF4G2;FLNA;EFHD2;STK24;MRTFB;LASP1;LDHA;RANBP1;LARP1;ALDOA;CC2D1A;ATIC;PPME1;SCYL1;SND1;EEF2;PI4KA;NDRG1;SH3GL1;PUF60;CRKL;PKP2;HNRNPK;BAIAP2;PKN2;PAK2;TBC1D10A;VAPB;ENO1;NCK1;CSNK1D;BAG3;RAB1A;PRDX1;EEF1D;JUP;DHX29;USO1;STX5;EHD4;RARS1;LYPLA2;CBL;FLNB;PKP4;PROM1;RPS26;HCFC1;GIPC1;S100A11;GOLGA3;SH3GLB2;BAIAP2L1;PDXDC1;STK38;YKT6;PCBP1;CAST;CORO1B;MAPRE1;VASP;PFN1;PFKP;ZC3H15;PTPN1;GOLGA2;UNC45A;MARK2;TAGLN2;CDH1;GAPVD1;USP8;OLA1;AFDN;CDH18;CDH24;CDC42EP1;ZC3HAV1;RPS2;CAPZB;EIF2A;CLINT1;SNX1;HDLBP;PARVA;TES;NUDC;RACK1;SCRIB;OLFM4;GIGYF2;PTPN11;HSP90AB1
prerank,nuclear import signal receptor activity (GO:0061608),0.5574636784620093,1.2646714848642138,0.184,0.5560148391970237,1.0,6/15,17.96%,IPO5;KPNA4;TNPO1;TNPO2;KPNA6;KPNA3
prerank,miRNA binding (GO:0035198),0.47899487448705647,1.264498459407669,0.16389548693586697,0.5530137586816223,1.0,10/30,22.28%,AGO2;ZNF346;DDX21;ZC3H7B;AGO3;HNRNPA2B1;AGO4;PUM1;ZC3H12A;PUM2
prerank,mannosyltransferase activity (GO:0000030),-0.3990943429333574,-1.263247973830089,0.15948275862068967,0.4122966848353941,1.0,5/21,7.13%,TMTC2;TMTC3;TMTC1;POMT2;PIGV
prerank,Notch binding (GO:0005112),0.5154157567526744,1.2630634651966546,0.16645326504481434,0.5539650154273337,1.0,11/22,24.86%,ADAM17;JAG1;DLK2;DLL4;KCTD10;SNW1;NOTCH4;SNED1;HIF1AN;TCIM;CUL3
prerank,ATPase binding (GO:0051117),0.4326572996081504,1.2614201145433859,0.13714902807775378,0.5555737855133336,1.0,17/71,14.99%,ABCA1;TCIRG1;ANK1;ATP6V0A1;CHMP4A;TOR1AIP2;ATP6V1G1;SNX10;ATXN3;CAV1;DNAJC10;CLPP;ZNHIT6;ATP1B3;ATP6V0A4;PIH1D1;SNU13
prerank,phosphatase binding (GO:0019902),0.414831619676551,1.2593740159931233,0.09593326381647549,0.5586625129179108,1.0,20/105,12.85%,LGALS3;CTNNB1;IQGAP1;ANK1;SIRPA;CD22;TRAF2;IKBKE;TRAF3;PPME1;VCP;PIK3R2;PPP3R1;GTF2F1;SYTL2;MVP;JUP;JAK1;KCNN4;PPP1R3F
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.53124663942817,1.2587950346394778,0.1997264021887825,0.55684811688893,1.0,4/17,10.41%,AK8;AK4;AK3;AK5
prerank,insulin-like growth factor receptor binding (GO:0005159),0.582913679219112,1.258284013170609,0.1773049645390071,0.5550125910661409,1.0,4/12,16.79%,IGF1;YWHAG;SOCS2;GNAS
prerank,clathrin adaptor activity (GO:0035615),0.5464497535162253,1.2544354142789105,0.2106703146374829,0.5637472613284599,1.0,8/15,27.27%,DAB2;HIP1R;AP1M1;HIP1;AP1G1;STON1;LDLRAP1;AP2B1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.5019378737738069,1.2522243288177013,0.17183462532299743,0.5667483168652087,1.0,5/24,10.41%,AK8;ITPKB;AK4;AK3;AK5
prerank,CoA-ligase activity (GO:0016405),0.5574543664991566,1.2510326184611298,0.21241379310344827,0.5671141195920505,1.0,5/14,16.28%,SLC27A5;ACSBG2;ACSL1;AACS;ACSBG1
prerank,snRNA binding (GO:0017069),0.4536635071614732,1.2504427143518975,0.16743119266055045,0.5654365477548291,1.0,15/42,22.80%,SNRNP35;DDX21;SF3B3;DDX39B;CCNT2;GEMIN5;SNU13;EIF5A;SNRPB2;RBM22;SART3;HNRNPU;SNRPD3;TOE1;LSM8
prerank,actin binding (GO:0003779),0.40133818175332514,1.2499170355552298,0.06477732793522267,0.5637669181870157,1.0,20/170,4.81%,GAS2L3;MYO9B;LCP1;MICAL2;MYO1F;MRTFA;ABL2;MACF1;COTL1;KCNMA1;ADCY8;SPATA32;MSRB1;DAG1;MICAL1;MTSS1;CORO7;TLNRD1;SYNE1;CAP1
prerank,glycine binding (GO:0016594),-0.48514625809241574,-1.2476733345172235,0.21299638989169675,0.4315982501877955,1.0,5/11,9.18%,GLRA3;GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,endonuclease activity (GO:0004519),0.4415757092176172,1.2444335615835933,0.14908256880733944,0.576968445644169,1.0,15/49,19.57%,AGO2;PIWIL2;ERN2;ZRANB3;ERN1;SND1;ZC3H12B;MBD4;RNASEL;ERCC4;AGO3;SETMAR;PNKP;ZC3H12C;ZC3H12A
prerank,microtubule minus-end binding (GO:0051011),0.5544440777345256,1.242688270478106,0.23097826086956522,0.5789594642786384,1.0,3/13,10.36%,MACF1;TUBGCP4;NUMA1
prerank,rRNA binding (GO:0019843),0.4526299329398156,1.2419891581434108,0.16998827667057445,0.5779609303799976,1.0,13/42,17.88%,DDX21;RCC1L;RPL12;TST;PPAN;MDM2;FASTKD2;MRPL18;MRPL11;FASTKD5;MRPS7;CIRBP;RPS13
prerank,diacylglycerol kinase activity (GO:0004143),0.5779868294800354,1.2379092168116177,0.20634920634920634,0.5872368320415485,1.0,3/11,8.80%,DGKZ;DGKH;DGKD
prerank,voltage-gated potassium channel activity (GO:0005249),-0.2920871420346155,-1.2340666664439044,0.09523809523809523,0.44645028289519945,1.0,17/80,9.68%,KCNQ5;KCND2;KCNJ3;KCNB2;KCND1;HCN1;KCNH7;KCNA6;KCNN2;KCNB1;KCNC2;KCNQ3;KCND3;KCNA1;KCNK2;KCNK1;KCNH1
prerank,ribosomal large subunit binding (GO:0043023),0.5766007744453223,1.2332154024960706,0.2426367461430575,0.598181035689181,1.0,3/11,7.88%,EIF6;CPEB2;DHX33
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.46380259403268864,-1.232609887458659,0.20075757575757575,0.44055842772205284,1.0,2/13,6.36%,SREBF2;IDI1
prerank,carboxy-lyase activity (GO:0016831),0.4868308132967614,1.2323445744900032,0.20363164721141375,0.5974144421231552,1.0,4/23,9.48%,UMPS;AZIN1;PCK2;ACOD1
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.4202295504667599,-1.230018346912735,0.19540229885057472,0.4364996793082163,1.0,5/16,11.54%,ALOX5;BCO2;ADI1;ETHE1;HAAO
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.4552823612424296,1.2299659252813633,0.17087155963302753,0.6013507378622092,1.0,10/40,15.11%,DNMT3A;PEMT;AS3MT;GNMT;DNMT3B;PRMT7;METTL2A;METTL2B;METTL8;DNMT1
prerank,adenyl ribonucleotide binding (GO:0032559),0.3863508597302595,1.229683444507057,0.04909819639278557,0.5989271704243769,1.0,92/291,24.64%,MYO9B;PEAK1;ABCA1;ABCG1;ERCC6;P2RX4;MYO1F;AARS1;CDK6;SPHK1;MAP4K5;GCK;CARS1;ABCD4;IGHMBP2;EIF4G1;MAP4K3;ERN2;DYRK2;PFKL;PI4K2A;STK3;ABCD2;NEK6;HSPA4;SIK1;PTPA;ERN1;TLK1;PDXK;LONP1;PAPOLA;MTHFS;SRPK1;HSPA9;CAD;PGK1;ATP7A;DAPK1;AK6;SRPK2;CDK11B;ATP1A1;ATP1A3;MLKL;BTK;DHX9;MARK4;TRIP13;STK38L;APRT;MINK1;SLC19A1;TARS1;PNKP;GUK1;STK38;LATS1;EIF2B2;MAP3K20;SARS2;PRKAG1;PFKP;PRAG1;TGFBR1;MARK2;MKNK1;RRM1;TAOK1;HNRNPU;BLM;PDK3;OLA1;STK11;HSPA2;ATP7B;CLPX;PRPS2;BRSK2;KIFC1;NVL;PDE4A;MTPAP;HSP90AB1;ATP1A2;MCM6;RAD51;HSPA13;ABCF2;TOP1;ABL1;MYO18A
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.38432042437592084,1.22876741223942,0.032,0.5984433670498589,1.0,142/431,24.64%,MYO9B;PEAK1;ABCA1;ABCG1;ERCC6;P2RX4;MYO1F;RRAGD;TSR1;AARS1;RAP2A;CDK6;MFHAS1;ARF3;SPHK1;MAP4K5;GCK;CARS1;ABCD4;IGHMBP2;EIF4G1;REM1;MAP4K3;ERN2;DYRK2;PFKL;PI4K2A;STK3;ABCD2;NEK6;HSPA4;RHOQ;RAB32;ARL11;SIK1;GEM;PTPA;ERN1;TLK1;ARL1;RAB5A;RHOD;GTPBP4;PDXK;LONP1;PAPOLA;MTHFS;DRG1;DNM2;ADSS1;ARL8B;ARL8A;SRPK1;HSPA9;NRAS;KRAS;CAD;PGK1;ATP7A;DAPK1;GNL3;RAB7A;EEF1A1;RHOG;AK6;RAB9A;SRPK2;CDK11B;RHOA;ATP1A1;ATP1A3;MLKL;BTK;DHX9;MARK4;TRIP13;RHOF;GTPBP10;STK38L;RAB22A;MINK1;ARHGEF5;TARS1;PNKP;RABL3;GUK1;STK38;RIT1;RHOU;RAP2B;LATS1;TUBE1;TUBB6;RASL12;EIF2B2;MAP3K20;SARS2;PRKAG1;TUBB;PFKP;PRAG1;TGFBR1;NOA1;RHOT2;TUBA1C;MARK2;MKNK1;RRM1;TAOK1;HNRNPU;BLM;PDK3;OLA1;STK11;HSPA2;ARF6;ATP7B;RHEBL1;CLPX;PRPS2;BRSK2;KIFC1;ANXA6;NVL;CDC42;MTPAP;TUBB1;RRAGC;PSMA6;ADSS2;RRAD;HSP90AB1;ATP1A2;MCM6;RAD51;HSPA13;ABCF2;TOP1;RAB31;RALB;ABL1;MYO18A
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.5634907970376062,1.2286887192577063,0.24753867791842477,0.5953594753200336,1.0,4/10,16.17%,RENBP;FUOM;GFUS;DSEL
prerank,sulfotransferase activity (GO:0008146),0.46837744552883376,1.2269555699570742,0.19463869463869463,0.5973621465158343,1.0,10/33,22.56%,CHST11;HS6ST1;SULT6B1;TPST1;SULT2B1;CHST12;CHST3;HS3ST2;CHST1;CHST2
prerank,adenylate cyclase binding (GO:0008179),-0.49661464024313695,-1.2252999524431238,0.20408163265306123,0.43749250396106476,1.0,5/10,7.97%,AKAP6;ADCY2;CAP2;AKAP12;ADCY5
prerank,pentosyltransferase activity (GO:0016763),0.4593698170762832,1.2240186193624847,0.1902497027348395,0.6030530570194556,1.0,15/36,22.59%,LARGE1;UMPS;PARP4;TNKS2;SIRT5;QTRT1;TIPARP;ART4;PARP2;SIRT3;PPAT;SIRT4;ZC3HAV1;SIRT2;PARP1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.5700311379119785,1.2231150383902682,0.24118476727785615,0.6024343368512907,1.0,1/11,0.33%,TRPC4
prerank,endopeptidase activity (GO:0004175),0.3889626610507627,1.2225250747082672,0.05511022044088176,0.6011006863723114,1.0,58/257,19.70%,PLAU;ADAM33;CTSB;MMP12;CTSZ;RHBDF2;ADAMTS13;NAPSA;USP12;KLK1;KLK6;MALT1;PSMA1;ADAMTS10;ADAM17;F11;USP5;DDI2;PSMA8;PSEN2;MBTPS2;AFG3L2;USP9X;GZMM;TPP1;PREP;PITRM1;MASP1;TPP2;ADAMTSL5;PARL;PSMA5;KLK3;CAPN7;USP2;FURIN;CLPP;CASP9;USP47;USP36;MMP28;MASP2;USP35;USP40;MMP19;MMP17;PSMB10;CASP7;USP14;TASP1;F9;USP13;SFRP1;ADAMTS2;CTSL;USP16;NLN;USP8
prerank,magnesium ion binding (GO:0000287),0.4002850264634362,1.2223818089401919,0.12207527975584945,0.598268740211646,1.0,34/135,18.97%,CERK;ABL2;DCTPP1;RAP2A;SPHK1;NUDT5;ERN2;DYRK2;PI4K2A;STK3;NEK6;DXO;SIK1;GEM;CLYBL;ERN1;PDXK;PAPOLA;SRPK1;SRPK2;MTHFD2;ADPRS;STK38L;GEN1;HMGCL;XYLT2;STK38;AASDHPPT;FIGNL1;LATS1;MAP3K20;MAPK12;MARK2;PGM1
prerank,protein serine/threonine kinase activity (GO:0004674),0.3834214687305585,1.2214229161559964,0.042,0.5979936290918614,1.0,90/335,20.24%,FAM20C;CDK14;PRKCH;IRAK2;SGK1;CDK6;CDK5;PTK2B;PRKCD;CDK8;SGK3;SGK2;MAP4K5;PAK6;PDPK1;SQSTM1;MAP4K3;ERN2;IKBKE;DYRK2;PRKCB;PLK2;STK24;STK3;NEK6;SIK1;ERN1;TLK1;BRD4;TAOK3;LIMK1;MAP3K12;SYK;SRPK1;STKLD1;DAPK1;CDK16;STK32A;PKN2;PAK2;MAP3K8;TGFBR2;CSNK2A2;CSNK1D;SRPK2;CDK11B;CPNE3;CDK13;TESK1;MAK;PLK3;CLK4;TP53RK;RPS6KC1;RAF1;RIPK3;MAPKAPK3;MARK4;MAPKAPK2;GAK;MAPK7;RPS6KA2;ILK;MAP3K1;RIOK3;CHEK2;STK38L;MINK1;FASTK;TBK1;CSNK1G1;STK38;MAP3K9;LATS1;CDK4;MAP3K20;MAPK12;MAPK3;IRAK4;MAPK15;TGFBR1;PIKFYVE;MARK2;MKNK1;DYRK1B;TAOK1;PDK3;STK11;SMG1;MAPK6
prerank,RNA polymerase II complex binding (GO:0000993),0.453027569346198,1.2189874640123548,0.21585365853658536,0.6023421210170824,1.0,12/32,19.52%,AGO2;ZNF326;BRD4;SMYD2;ELOF1;SCAF1;WDR43;DHX9;RPRD1A;RECQL5;PCIF1;HNRNPU
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5689328666878481,1.216322084774405,0.2184065934065934,0.607447846032515,1.0,2/12,7.84%,TENT5C;PAPOLA
prerank,phospholipase C activity (GO:0004629),-0.3645091490571337,-1.2142504987060652,0.1787709497206704,0.45003993642214624,1.0,6/25,8.27%,PLCL1;CCR5;PLCB1;PLCH1;CHRM3;CCR1
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3892721185083328,1.2132595339554073,0.10070493454179255,0.6134769656384745,1.0,37/173,16.25%,MITF;ATF3;TGIF1;SOX30;TBX18;PPARD;LRRFIP1;NFX1;IRF8;BHLHE41;PPARG;NFIL3;BHLHE40;CC2D1A;ETV6;MNT;SKI;BCL6;KLF12;JUN;ZBTB2;NFKB1;NR3C1;ZBTB34;ELK3;ENO1;ZKSCAN3;ZNF148;ZGPAT;ZNF177;NFATC3;ZEB2;FOXP4;YY1;ZFP57;ZBTB4;ZBTB17
prerank,chloride channel regulator activity (GO:0017081),0.5366944847396564,1.2129037282484183,0.23424657534246576,0.6112887064669486,1.0,2/14,2.18%,SGK1;SGK3
prerank,growth factor receptor binding (GO:0070851),0.40738571923347083,1.2116919802044284,0.13229166666666667,0.611780637021355,1.0,20/95,16.40%,CD300LF;ITGA5;SDCBP;PDGFA;FGF2;GRB2;VEGFA;IL12RB1;ADAM17;ERN1;FGF20;ATXN2;IL6;SNX4;FYN;FGF7;IL2;FGF18;HIP1;CNOT9
prerank,calcium channel regulator activity (GO:0005246),0.444187995433001,1.2093903107928252,0.19908466819221968,0.6154050131073215,1.0,10/37,17.85%,SGK1;SGK3;REM1;GEM;PHPT1;CACNB3;PRKG1;SRI;CALM2;FKBP1B
prerank,voltage-gated anion channel activity (GO:0008308),0.5313581210773899,1.2088948790947385,0.24128686327077747,0.6137065643874084,1.0,7/15,26.07%,VDAC2;ANO6;GPR89A;GPR89B;CLCN4;CLCN6;CLCN2
prerank,GTPase binding (GO:0051020),0.38467593423322166,1.206031279167306,0.09687184661957618,0.61923032155169,1.0,59/195,20.56%,MYO5A;MYO9B;LCP1;IQGAP1;ABCA1;RRAGD;DMXL2;EPRS1;GOLGA4;OPTN;RUSC2;ALS2;FGD6;FLNA;AKAP13;RIC1;SPHK2;RANBP1;RGP1;CYFIP1;RABGGTB;GCC2;NDRG1;CAV1;PAK2;HPS6;RASA1;RNF41;ENO1;DOCK7;RANBP9;EXOC2;BECN1;RAPGEF6;RAF1;GGA2;GNB1;MAPKAP1;FGD5;SIKE1;ATP6AP1;AP1G1;ARHGEF2;EXOC4;RAB3GAP1;RAB3GAP2;ATG16L1;TRIP11;RILP;TBC1D20;ABI2;STOML2;LAMTOR1;PARD6A;AFDN;TRIOBP;USP33;YBX3;RALBP1
prerank,kinase binding (GO:0019900),0.37768324321430874,1.2058989663599076,0.024,0.6164982905065163,1.0,112/435,18.79%,BCAR3;LYST;CSPG4;CTNNB1;IQGAP1;HIF1A;BCL2L1;KIF13B;FGR;SASH1;STAP1;LAT;BLNK;PTPRC;PRKCD;GRB2;TRAF2;TRIM6;TSKS;GYS1;HSPB1;SQSTM1;PTPN23;MSN;SMCR8;PFKL;FLNA;CAB39;NEK6;CEBPA;SIK1;PTPN2;TPCN2;CCNB1;WDR45;HDAC7;HTT;RHOD;MAP3K12;SKI;EEF2;DCTN1;TRAP1;SPRED2;CAV1;IRF5;NISCH;DGKD;ATF5;NR3C1;PAK2;MVP;EEF1A1;JTB;RHOG;ADIPOR1;EIF4ENIF1;LIMS1;EXOC2;BECN1;RHOA;GPRC5B;TPRKB;TICAM1;ATP1A4;RPS6;TNIP2;LLGL1;CASP9;CEP250;FAM83D;MAP2K3;ILK;MAP3K1;SLC12A4;CHEK2;MAPKAP1;RHOF;PIH1D1;CDK5RAP1;SPRED3;CDC25B;DLG4;SIKE1;FBXW5;PIP5K1A;SUFU;FAM83H;ZBTB4;CDC25A;CNOT9;TEX14;TFRC;CRK;UFL1;FBXO7;LATS1;QARS1;CALM2;DOK7;IRGM;PRKAG1;MAPRE1;DUSP3;IRAK4;RAD9A;PTPN1;PPP1R12A;ERRFI1;GOLGA2;HSF1;ITGB2
prerank,DNA-binding transcription factor binding (GO:0140297),0.38709953067276337,1.2058258194252052,0.09201213346814964,0.6135079651093203,1.0,61/189,25.49%,CTNNB1;BCL2;NFE2L2;MEF2D;PPARD;NOC2L;HSPB1;BHLHE41;PPARG;NEK6;CRTC1;HDAC4;SIK1;BHLHE40;ID2;HDAC9;HDAC7;SKI;EGR2;JUN;DDIT3;SRF;TLE5;WWP2;MIER2;LYAR;BBS10;DHX9;EIF4E;SP1;HCFC1;ATN1;HDAC1;LMO2;RERE;USF2;ZBTB17;PURA;PRRX1;PIAS4;DACT1;BBS2;LDB2;LDB1;DGKQ;CRTC3;BEX1;MTDH;TBP;DMAP1;CREM;MTA3;CREBBP;KDM1A;GSK3B;PIAS1;EP300;RBL1;SPI1;CXXC5;SCX
prerank,nuclear receptor coactivator activity (GO:0030374),0.43141334031976053,1.2055560936978826,0.1881298992161254,0.6111701073820184,1.0,22/52,27.40%,ZMIZ1;FGF2;ZMIZ2;PRKCB;CCAR1;TMF1;MED17;CARM1;CNOT6;ACTN1;PPARGC1B;CNOT9;MED1;BRD8;SLC30A9;KDM1A;MED13;ACTN4;PPRC1;DCAF6;MED12;WDR77
prerank,exoribonuclease activity (GO:0004532),0.5612159895701796,1.2026875301222892,0.254957507082153,0.616480661290153,1.0,6/12,20.78%,EXOSC9;CNOT6;EXOSC10;EXOSC5;ZC3H12A;EXOSC4
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.5754177088463053,1.2003962623598543,0.24964739069111425,0.6202960402390415,1.0,8/10,27.20%,OTUD4;ATXN3;TNFAIP3;STAMBPL1;STAMBP;YOD1;OTUD5;DESI2
prerank,RNA polymerase binding (GO:0070063),0.5012585281855525,1.19708914643664,0.24338624338624337,0.6268132647951961,1.0,6/18,12.69%,PABPN1;BRCA1;PHRF1;PKN2;CCNT2;DHX9
prerank,carboxylic acid binding (GO:0031406),-0.3224741298058659,-1.1966194317245473,0.16891891891891891,0.47461726032392754,1.0,14/38,17.55%,GRM7;GLRA3;GRIN3A;GRIN2B;GLUD1;GRIN1;EPDR1;GLRA2;PADI4;SESN3;GLRA1;NOS1;SESN1;CASTOR1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4073116080802926,1.1965754914918583,0.17702845100105374,0.6251460774968872,1.0,39/83,28.45%,TANK;OTULIN;USP12;JOSD1;OTUD4;USP5;ATXN3;BAP1;USP9X;PSMD14;USP53;USP2;TNFAIP3;USP47;USP36;USP35;USP40;MYSM1;USP14;USP13;STAMBPL1;STAMBP;USP21;USP16;ZC3H12A;USP8;BRCC3;USP33;PAN2;USP30;YOD1;USP48;USP19;OTUD5;USP18;USP28;DESI2;USP50;USP11
prerank,ankyrin binding (GO:0030506),0.4925511049534481,1.1956551444378873,0.24773022049286642,0.6246979633078417,1.0,3/19,12.09%,PTPRC;CACNA1D;SLC8A1
prerank,cGMP binding (GO:0030553),-0.44255021826094065,-1.1955444397556108,0.24749163879598662,0.4687797623728464,1.0,3/11,14.93%,RAPGEF2;PDE10A;PDE2A
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.44918910930382044,1.1914037610637647,0.2249705535924617,0.6344138167189965,1.0,15/35,22.34%,MMP12;AGO2;UBTF;SMARCB1;NR3C1;TBPL1;PIH1D1;HDAC1;ZBTB17;KLF10;TAF1C;RUVBL2;POU2F1;TBP;SMARCA4
prerank,actin monomer binding (GO:0003785),0.4858191694682884,1.1898285737325016,0.2582697201017812,0.6359250934801449,1.0,3/22,3.95%,MRTFA;ABL2;MTSS1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4963436902188589,1.1894224914522749,0.24808184143222506,0.6339621569784453,1.0,5/21,15.46%,FGF2;NPTN;FGF20;FGF7;FGF18
prerank,voltage-gated ion channel activity (GO:0005244),0.5257740665320366,1.1893382854048806,0.26450742240215924,0.6311021516028054,1.0,5/14,10.60%,KCNA3;VDAC2;ANO6;GPR89A;GPR89B
prerank,cation:chloride symporter activity (GO:0015377),-0.46672538849996326,-1.188347354687791,0.26480836236933797,0.4744978618316075,1.0,5/10,20.50%,SLC12A2;SLC12A9;SLC6A1;SLC12A8;SLC12A6
prerank,phospholipid transfer activity (GO:0120014),0.4880182399766566,1.18823188794987,0.2512690355329949,0.631478752161219,1.0,5/21,10.16%,GLTP;PRELID2;TRIAP1;PITPNC1;OSBPL2
prerank,serine-type endopeptidase activity (GO:0004252),0.3992986962078782,1.1877544847082606,0.2023681377825619,0.6297965192884081,1.0,12/80,13.51%,PLAU;RHBDF2;KLK1;KLK6;F11;GZMM;MASP1;PARL;KLK3;FURIN;CLPP;MASP2
prerank,filamin binding (GO:0031005),0.5553153915626989,1.1840787163152513,0.26822157434402333,0.6377173381847334,1.0,1/11,0.26%,FBLIM1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.5059482578049562,1.1826856659804366,0.2703751617076326,0.6388825282475974,1.0,11/17,32.78%,ACSBG2;ACOT9;ACOT6;ACOT1;ACAA2;ACOT13;ACOT4;ACOT7;PPT1;ACOT8;PLA2G6
prerank,transforming growth factor beta receptor binding (GO:0005160),0.49366857472968834,1.18240286512547,0.2581081081081081,0.6365701949347933,1.0,6/18,20.66%,SMAD7;BAMBI;TGFBRAP1;TGFBR2;TGFBR1;TGFB1
prerank,deubiquitinase activity (GO:0101005),0.4008150766801213,1.1809801284184114,0.19198312236286919,0.637821169597926,1.0,40/88,28.45%,TANK;OTULIN;USP12;JOSD1;OTUD4;USP5;ATXN3;BAP1;USP9X;PSMD14;USP53;USP2;TNFAIP3;USP47;USP36;USP35;USP40;MYSM1;USP14;MINDY2;USP13;STAMBPL1;STAMBP;USP21;USP16;ZC3H12A;USP8;BRCC3;USP33;PAN2;USP30;YOD1;USP48;USP19;OTUD5;USP18;USP28;DESI2;USP50;USP11
prerank,sulfate transmembrane transporter activity (GO:0015116),0.5341730016135595,1.180093498374428,0.25616438356164384,0.6375135281512306,1.0,3/14,10.16%,SLC26A1;SLC26A11;SLC26A4
prerank,ion gated channel activity (GO:0022839),0.47171864352387805,1.1783202857547899,0.2648845686512758,0.639682414484274,1.0,4/24,7.33%,TTYH2;ANO9;ANO8;ANO6
prerank,receptor ligand activity (GO:0048018),0.3748208063425353,1.1774513153253896,0.116,0.6393262295969421,1.0,31/245,16.23%,LGALS3;GPNMB;IGF1;CSF1;PDGFA;FGF2;CCL4;BMP8B;GDF6;NPPA;POMC;VEGFA;DEFB130A;LRPAP1;JAG1;CRH;FGF20;GAS6;VIP;KITLG;IL6;FAM3C;FGF7;DAND5;IL2;OSGIN2;GNRH1;TNF;FGF18;NPPC;BMP5
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",-0.4589865061241275,-1.1772716607347777,0.2490974729241877,0.4891472188759893,1.0,4/11,21.73%,PADI2;PADI4;DDAH2;ARG2
prerank,phospholipase activator activity (GO:0016004),0.5534576227958118,1.1767448087825005,0.28733997155049784,0.6384492765591537,1.0,6/10,24.21%,PDPK1;ARHGAP6;BTK;FYN;CCL3;STX4
prerank,5'-nucleotidase activity (GO:0008253),0.5385250482262127,1.1760258303039444,0.2821576763485477,0.6377825654654342,1.0,2/13,6.47%,NT5C3B;NT5DC2
prerank,acylglycerol lipase activity (GO:0047372),0.5447588388959936,1.17514875612704,0.27753934191702434,0.637510291327108,1.0,2/11,2.14%,ABHD12;MGLL
prerank,cysteine-type peptidase activity (GO:0008234),0.40071665184133776,1.1746557966235824,0.21748400852878466,0.6358575999068006,1.0,25/73,20.24%,CTSB;CTSZ;OTULIN;USP12;MALT1;ATG4D;USP5;USP9X;ATG4A;USP2;CASP9;USP47;USP36;USP35;BLMH;USP40;CASP7;USP14;USP13;SFRP1;CTSL;USP21;USP16;USP8;USP33
prerank,NAD+ binding (GO:0070403),-0.4479708361271244,-1.1742521762139457,0.24647887323943662,0.48700208059836086,1.0,3/12,3.41%,HPGD;CRYL1;GLUD1
prerank,protein kinase binding (GO:0019901),0.36683333130336826,1.17294006461781,0.057,0.6379929279603669,1.0,122/480,18.99%,LYST;CSPG4;NELL2;IQGAP1;HIF1A;SIRPA;BCL2L1;PLEK;KIF13B;FGR;SASH1;STAP1;LAT;BLNK;PTPRC;NELL1;TNIP1;PRKCD;GRB2;TRAF2;TRIM6;DUSP9;TSKS;GYS1;HSPB1;SQSTM1;TJP2;PTPN23;SOX9;MSN;SMCR8;PRKCB;NEK6;NEDD9;SIK1;PTPN2;TPCN2;CCNB1;WDR45;HDAC9;HDAC7;RHOD;MAP3K12;SKI;EEF2;DCTN1;SPAG9;TRAP1;SPRED2;CAV1;IRF5;NISCH;TREM2;PKP2;NR3C1;PAK2;MVP;EEF1A1;JTB;RHOG;ADIPOR1;LIMS1;EXOC2;BECN1;RHOA;GPRC5B;TPRKB;TICAM1;YWHAG;MAPKAPK3;RPS6;TNIP2;LLGL1;MAPKAPK2;CASP9;CEP250;FAM83D;MAP2K3;MAPK7;ILK;TPR;MAP3K1;SLC12A4;TRIB2;CHEK2;MAPKAP1;RHOF;PIH1D1;CDK5RAP1;SPRED3;CDC25B;SIKE1;FBXW5;SUFU;FAM83H;ZBTB4;CDC25A;STK38;TEX14;TFRC;CRK;PIN1;UFL1;FBXO7;LATS1;QARS1;CALM2;DOK7;IRGM;PRKAG1;MAPRE1;DUSP3;IRAK4;RAD9A;PTPN1;PPP1R12A;ERRFI1;DACT1;GOLGA2;HSF1;ITGB2;MAPK8IP3
prerank,ferrous iron binding (GO:0008198),0.4775819005936908,1.1718752142455566,0.28316326530612246,0.6384754717063064,1.0,9/21,22.12%,FTL;ALKBH1;EGLN1;CDO1;FTO;EGLN3;PHYH;HIF1AN;ALKBH3
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5182386050123163,1.1711058203786593,0.274310595065312,0.6378880935999452,1.0,3/14,10.41%,AK8;AK4;AK5
prerank,myosin V binding (GO:0031489),-0.4091812991088163,-1.169298061327547,0.2749003984063745,0.48928647996298563,1.0,3/15,6.85%,RAB6B;RAB3A;RAB27B
prerank,metallopeptidase activity (GO:0008237),0.38573984444695375,1.1692496341309506,0.19690721649484536,0.6403647270033924,1.0,18/113,14.64%,ADAM33;ANPEP;MMP12;ADAM8;ADAMTS13;BMP1;ADAMTS10;ADAM17;MBTPS2;AFG3L2;PITRM1;ADAMTSL5;ADAM15;PSMD14;MMP28;MYSM1;MMP19;MMP17
prerank,transition metal ion binding (GO:0046914),0.36577829730413963,1.169024838265079,0.077,0.6381674696846864,1.0,100/397,22.87%,FAM20C;LITAF;ADAM33;P2RX4;ANPEP;EEA1;LARGE1;KMT2A;ABL2;MGAT5;MMP12;EPRS1;SORD;B4GALT7;ADAM8;ADAMTS13;MSRB1;AOC2;ATP13A2;FTL;WDFY1;CHD3;DYRK2;KDM3A;PPARG;HDAC4;SEC24A;ZDHHC15;SIRT5;RABGGTB;TRIM28;RNF2;TET3;RIOX1;SKI;PCK2;PDXK;PAPOLA;FBXL19;ATAD3A;GYG1;PITRM1;CAD;ATP7A;QPCT;TIMP2;LIMS1;MDM2;NAPEPLD;BAZ1B;SIRT3;APIP;DUSP12;TMEM163;MYT1;MELTF;HPF1;GALNT3;MNAT1;HMGCL;CLIP1;B4GALT1;ARHGEF2;TARS1;XYLT2;DPF3;ATOX1;KDM2A;XPNPEP1;S100B;PIAS4;RASSF1;ALKBH8;LOXL3;PTPN1;BIRC2;TIMP1;USP16;BLM;SEC24D;RCHY1;PHF2;USP33;ATP7B;RNF7;SIRT2;KMT2B;TK1;HIF1AN;NSD1;THAP1;RXRA;CYP2R1;BMI1;MOXD1;MT2A;CALR;TES;MTPAP;TIMM9
prerank,store-operated calcium channel activity (GO:0015279),0.5552572400436124,1.1688498178911078,0.29219858156028367,0.6357316496119034,1.0,3/10,15.65%,TRPC4;ORAI3;ORAI1
prerank,acetylation-dependent protein binding (GO:0140033),0.48445361929391345,1.1683186254966917,0.2853470437017995,0.6316075603280897,1.0,4/20,9.60%,KMT2A;BRD4;THAP7;CARM1
prerank,lysine-acetylated histone binding (GO:0070577),0.48445361929391345,1.1683186254966917,0.2853470437017995,0.6316075603280897,1.0,4/20,9.60%,KMT2A;BRD4;THAP7;CARM1
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5330775052200838,1.1680681471659697,0.28492392807745504,0.629595242411672,1.0,6/12,24.95%,XDH;ISCA1;CIAPIN1;SDHB;CISD1;FDX1
prerank,protein homodimerization activity (GO:0042803),0.36400567048027377,1.1672681142903774,0.033,0.6292386938344319,1.0,145/590,21.87%,MYO9B;LPL;BCL2;ABCG1;BCL2L1;ATG7;ATF3;MYOM3;EEA1;CSF1;RABEP1;TBC1D22A;APOE;KMT2A;PLEK;ZHX2;IRAK2;EPRS1;XDH;PDGFA;ADCY8;MGLL;TYRP1;TRIM6;APOA2;PON1;TBX18;ALS2;TPD52;NUDT5;MCL1;HSPB1;VEGFA;PSAP;LRRFIP1;CHMP4B;CHMP4A;FLNA;ABCD2;BHLHE41;CADM1;SYNE1;HMOX1;CEBPA;GLB1;GLA;BHLHE40;CST7;APPL2;PTPA;NECTIN3;BAX;ERN1;KLHL7;SLC8B1;ATIC;GTF2A2;MAP3K12;PDXK;SLC11A1;LRP6;FZD4;PDCD6IP;GYG1;DGKD;RBPMS;QTRT1;ALDH3A2;CAT;DDIT3;ST6GAL1;MASP1;NECTIN1;NRF1;FXR2;HIP1R;SRF;LILRB1;VPS4B;ST3GAL2;VAPB;ENO1;TPST1;PPCS;XPA;JUP;SERPINF2;PRDM9;PRMT2;TMEM192;TPM4;SETMAR;TPR;SP1;CHEK2;ZBTB7B;ACTN1;GEN1;S100A11;SUPV3L1;HIP1;BST2;TERT;KYNU;USF2;ZBTB4;RABL3;CNOT9;TFRC;MAP3K9;S100A16;NDP;XPNPEP1;SARS1;S100B;MIGA2;ODC1;PIP4K2A;SPPL3;JAML;GRHL1;HOOK1;EFEMP2;TERF1;BCL2L2;HOGA1;MMUT;LDB1;BLM;RCHY1;SMIM1;FGFR2;MFSD1;SLC39A13;GCA;GDNF;PDGFB;HIF1AN;GLIPR2;SNX1;THAP1;IRAK1;CYP2R1;ZBTB16;PRPS2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.3736731907274905,1.1659577962494323,0.125250501002004,0.6302546595120364,1.0,67/248,19.37%,MYO1E;RRAGD;TSR1;RAP2A;GNAQ;ATP2B1;GNA13;GPN2;CHD3;ABCD2;IRGC;RHOQ;RAB32;RAB8B;GEM;KIF1A;ARL1;RAB5A;AGAP3;TBC1D24;RHOD;VCP;GTPBP4;EEF2;DRG1;DNM2;ARL8B;ARL8A;KLC1;NRAS;KRAS;RAB7A;EEF1A1;VPS4B;RHOG;RAB9A;RAB5C;GFM2;RAB1A;RHOA;GNA11;DHX29;RAB20;SAR1A;DHX9;GNA12;GNB1;EFL1;RHOF;GTPBP10;RAB22A;TOR3A;RABL3;RIT1;RHOU;RAP2B;PIN1;GNAS;RASL12;IRGM;TOR1B;RUVBL2;MYO19;RHOT2;MTG1;VWA8;MMUT
prerank,flavin adenine dinucleotide binding (GO:0050660),0.41153114305194816,1.165637191740627,0.23915461624026696,0.6284202182523649,1.0,19/53,23.26%,MICAL2;XDH;MICAL1;CYB5R1;POR;MTRR;CYBB;ACADL;MTHFR;AIFM2;ACOX3;GFER;GSR;CYB5R3;SQOR;NOX4;GCDH;KDM1A;MTO1
prerank,nucleotidase activity (GO:0008252),0.5152998776762591,1.1653571909197848,0.28112449799196787,0.626342533650558,1.0,6/15,31.83%,NT5C3B;NT5DC2;BPNT2;NT5C2;ACP3;NT5C
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.40238616126933613,-1.163689985538651,0.27238805970149255,0.4926064726849601,1.0,4/15,10.29%,P2RY12;GPR34;P2RY14;P2RY13
prerank,hexosaminidase activity (GO:0015929),0.5310613400946307,1.1636207681008763,0.32916666666666666,0.628534480141248,1.0,3/12,9.67%,HEXA;HEXB;OGA
prerank,protein kinase C activity (GO:0004697),0.5091670467171517,1.1634565672198218,0.3012379642365887,0.626212898276067,1.0,3/14,4.20%,PRKCH;PRKCD;PRKCB
prerank,neuropeptide receptor activity (GO:0008188),-0.3296713636840646,-1.1610354319510638,0.28125,0.4902125403207989,1.0,11/29,28.74%,SORCS1;GPR37;SORCS2;TACR3;GRPR;NPSR1;SSTR2;NMUR2;SORCS3;NTSR1;GAL
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.28352307012246536,-1.160497250831894,0.14814814814814814,0.4840035724663006,1.0,11/60,6.65%,CSF1R;EPHA4;EPHA5;EPHA6;NTRK3;KIT;BMPR1B;NTRK2;EPHB1;ERBB4;EGFR
prerank,sodium channel regulator activity (GO:0017080),0.4316357675643038,1.1603536375309287,0.2828638497652582,0.6322895006837328,1.0,8/37,13.57%,FGF13;SGK1;SGK3;SGK2;PRSS8;PKP2;FXYD4;SCN1B
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4186160444017955,1.1582824053453067,0.2580275229357798,0.6353908536814588,1.0,10/46,14.02%,LARGE1;MGAT5;B4GAT1;HEXA;PIGQ;GCNT2;HEXB;OGT;GCNT1;EXTL2
prerank,3'-5' DNA helicase activity (GO:0043138),0.4928414197151277,1.157011094621064,0.2756232686980609,0.6362127878773062,1.0,10/16,27.73%,MCM2;ASCC3;MCM7;NAV2;DHX9;RECQL5;BLM;MCM6;MCM5;HELQ
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5126246727717055,1.1567739788384073,0.2901907356948229,0.6342662239931551,1.0,4/13,22.14%,SLX4;DNASE1L1;GEN1;ZGRF1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.35778592687581434,-1.156334259521313,0.24528301886792453,0.484181540268258,1.0,6/22,14.03%,SCN1A;SCN8A;HCN1;CACNA1I;SCN2A;SCN7A
prerank,chloride channel inhibitor activity (GO:0019869),-0.4618785416137339,-1.1551116936056187,0.29310344827586204,0.4793702200954616,1.0,3/10,10.38%,WNK1;STX1A;WNK3
prerank,zinc ion binding (GO:0008270),0.36391752196107424,1.1537922264964215,0.12212212212212212,0.6400826493951266,1.0,72/293,22.45%,LITAF;ADAM33;P2RX4;ANPEP;EEA1;KMT2A;MMP12;EPRS1;SORD;ADAM8;ADAMTS13;MSRB1;ATP13A2;WDFY1;CHD3;PPARG;HDAC4;SEC24A;ZDHHC15;SIRT5;RABGGTB;TRIM28;RNF2;TET3;SKI;PDXK;FBXL19;ATAD3A;PITRM1;CAD;QPCT;TIMP2;LIMS1;MDM2;NAPEPLD;BAZ1B;SIRT3;APIP;DUSP12;TMEM163;MYT1;HPF1;MNAT1;CLIP1;ARHGEF2;TARS1;DPF3;KDM2A;S100B;PIAS4;RASSF1;ALKBH8;PTPN1;BIRC2;TIMP1;USP16;BLM;SEC24D;RCHY1;PHF2;USP33;SIRT2;KMT2B;TK1;HIF1AN;NSD1;THAP1;RXRA;BMI1;MT2A;CALR;TES
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.28881601055362277,-1.153143662572532,0.18666666666666668,0.47571124811270593,1.0,21/57,18.91%,COX6A1;COX8A;CYB561A3;NDUFS3;NDUFV3;NDUFB9;UQCRC1;NDUFS4;COX5A;NDUFS5;UQCRFS1;NDUFB7;NDUFA10;NDUFB10;COX15;COX4I1;NDUFA4;NDUFS2;CYB561D2;COX6B1;NDUFA5
prerank,mRNA 3'-UTR binding (GO:0003730),0.3895104555797804,1.1528098854718907,0.2620837808807734,0.6401655166167588,1.0,38/79,30.87%,PABPC5;CPEB4;CPEB2;LARP4;LARP1;CELF1;HNRNPC;FXR2;GEMIN5;EXOSC9;CPEB1;HNRNPA2B1;CCT5;PABPC4;PUM1;CPEB3;PABPC1;CIRBP;HNRNPU;ZC3H12A;YBX3;EXOSC4;RNF20;PUM2;PCBP4;SECISBP2L;RPS7;LARP4B;TARDBP;ILF3;DHX36;FMR1;RC3H1;RBMS2;DAZAP1;RSL1D1;FXR1;DDX5
prerank,vitamin D receptor binding (GO:0042809),0.5131314053751616,1.151994784031686,0.3054054054054054,0.6398925632700742,1.0,7/14,26.28%,MED17;TAF7;SNW1;MED1;RXRA;MED13;MED12
prerank,endopeptidase regulator activity (GO:0061135),0.4195125805511542,1.1507706432229927,0.26713124274099886,0.6408301798945992,1.0,12/40,20.59%,RENBP;A2M;CST7;PROS1;TFPI;PSMD14;SERPINF2;CSTB;USP14;CAST;APH1A;SERPIND1
prerank,actinin binding (GO:0042805),0.4718251779412621,1.1502549432516622,0.2943396226415094,0.6397517509117303,1.0,6/21,14.07%,CACNA1D;DAG1;PPARG;MAGI1;NFKB1;PROM1
prerank,tRNA methyltransferase activity (GO:0008175),0.49336376754256805,1.1485660048504955,0.3035230352303523,0.6419723664290624,1.0,8/16,23.27%,METTL2A;METTL2B;TRMT13;TRMT5;ALKBH8;TRMT12;LCMT2;THUMPD2
prerank,tau-protein kinase activity (GO:0050321),0.4716867066174146,1.147598887894347,0.2892998678996037,0.6420166451667819,1.0,9/20,26.12%,CDK5;MARK4;FYN;MARK2;TAOK1;ROCK1;BRSK2;GSK3B;TTBK2
prerank,I-SMAD binding (GO:0070411),0.5138199866559029,1.1472302013381404,0.29619181946403383,0.6404786720252661,1.0,5/13,20.95%,CTNNB1;SMAD7;TGFBR1;TGFB1I1;SMAD1
prerank,calcium-dependent phospholipid binding (GO:0005544),0.40421076299949377,1.1462718528575633,0.2650334075723831,0.6404544509883044,1.0,8/49,11.69%,MCTP1;ANXA5;ANXA4;FER1L5;ESYT1;ANXA3;CPNE3;SYT8
prerank,chemokine activity (GO:0008009),0.43481252883314214,1.1457481216212522,0.27672955974842767,0.6393173205813765,1.0,4/31,9.76%,CCL4;CCL13;CCL28;CCL14
prerank,NADP binding (GO:0050661),-0.3217483740159969,-1.143699360318321,0.25308641975308643,0.4855055539073037,1.0,15/32,25.69%,ME3;CRYZL1;DPYD;QDPR;DHCR7;NDOR1;NOS1;CRYZ;CBR3;NOX1;LBR;HSD11B1;HMGCR;GRHPR;GMDS
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.4191471187943034,1.1417772023046362,0.3075060532687651,0.6480931618459433,1.0,13/33,25.32%,LLPH;AGO2;ZNF326;SMYD2;ELOF1;WDR43;DHX9;RPRD1A;RECQL5;HNRNPU;TBP;UVSSA;SUPT4H1
prerank,GTPase activator activity (GO:0005096),0.3591059388279758,1.1414737480513806,0.1374122367101304,0.6463762243608016,1.0,82/313,19.15%,ARHGAP25;ABR;MYO9B;RGS1;ARHGAP24;ARHGAP10;IQGAP1;ASAP1;TBC1D22A;SIPA1L2;CYTH1;DOCK2;GNAQ;NRP1;RASGRP3;PCP2;ALS2;FGD6;TBC1D2;RALGAPA2;RIN2;SMCR8;DENND4C;AKAP13;SERGEF;RIC1;RGS3;ARFGEF2;RASGEF1B;RANBP1;HPS1;NCKAP1L;RGP1;RGPD1;ARHGEF11;RCC1L;ARHGAP19;JUN;LLGL2;DNMBP;GMIP;RASA1;TBC1D10A;ELMOD3;ARHGAP17;DENND4B;NPRL3;EEF1D;TBC1D12;RAPGEF6;TBC1D16;ELMOD2;LLGL1;FNIP1;BNIP2;CYTH4;LARS1;ARFGAP3;NF1;RCBTB2;DOCK11;FGD5;ARHGEF5;ARFGEF1;ADAP1;HTR2B;ARHGEF2;FLCN;VAV1;CHN2;RGL2;ARHGAP9;RAB3GAP1;RAB3GAP2;EIF2B2;ARHGAP22;DENND1B;RGS11;ERRFI1;FARP1;TBC1D20;LAMTOR3
prerank,omega peptidase activity (GO:0008242),0.3860605582796605,1.1400429457861898,0.27148846960167716,0.6477489782404969,1.0,39/89,28.45%,TANK;OTULIN;USP12;JOSD1;OTUD4;USP5;ATXN3;BAP1;USP9X;PSMD14;USP53;USP2;TNFAIP3;USP47;USP36;USP35;USP40;MYSM1;USP14;USP13;STAMBPL1;STAMBP;USP21;USP16;ZC3H12A;USP8;BRCC3;USP33;PAN2;USP30;YOD1;USP48;USP19;OTUD5;USP18;USP28;DESI2;USP50;USP11
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.36800548755187934,1.1390911389638534,0.19416498993963782,0.6479346198042556,1.0,58/181,26.23%,MDFIC;CTNNB1;HIF1A;NFE2L2;ANXA4;PPARD;HSPB1;BHLHE41;PPARG;TAF4B;HDAC4;BHLHE40;SMARCB1;ID2;EGR2;JUN;WWP2;MIER2;TACC2;BBS10;JUP;DHX9;SP1;ATN1;HDAC1;SNW1;LMO2;RERE;PRRX1;PIAS4;MED1;DACT1;BBS2;HDAC3;LDB2;LDB1;BEX1;MTDH;TBP;DMAP1;HIF1AN;RXRA;MTA3;CREBBP;SMARCA4;KDM1A;PSMA6;ACTN4;GSK3B;PIAS1;EP300;DNAJA1;RBL1;SPI1;RNF25;PARP9;FAF1;TAF6
prerank,cysteine-type endopeptidase activity (GO:0004197),0.38655626676833366,1.1360418911371621,0.2648936170212766,0.6539156209492577,1.0,23/78,20.72%,CTSB;CAPN15;CTSZ;USP12;MALT1;CAPN1;USP5;USP9X;USP2;CASP9;USP47;USP36;USP35;USP40;CASP7;USP14;USP13;SFRP1;CTSL;USP16;USP8;USP33;GPAA1
prerank,protein tyrosine kinase activity (GO:0004713),0.3744894409645871,1.1357353455214059,0.2396694214876033,0.6521787737958439,1.0,18/108,13.32%,FLT1;PEAK1;ABL2;FGR;TEC;PTK2B;AXL;DYRK2;SCYL1;SYK;YES1;IGF1R;WEE1;PKDCC;JAK1;BAZ1B;BTK;FYN
prerank,signal sequence binding (GO:0005048),0.42864767184922004,1.1347196349122746,0.30177514792899407,0.6525244241899051,1.0,15/35,28.03%,IPO5;KPNA4;CAT;BRAP;TNPO1;TNPO2;KPNA6;BABAM2;KPNA3;SEC61A1;KDELR1;KDELR2;IPO4;AP2B1;KPNA2
prerank,ribosomal small subunit binding (GO:0043024),0.4804613467108956,1.1311598588904597,0.3227931488801054,0.6600874887171972,1.0,4/17,11.90%,EIF1;CPEB2;LARP1;DHX29
prerank,histone acetyltransferase binding (GO:0035035),0.4512826761342614,1.1298382307401844,0.3174193548387097,0.6611879383444943,1.0,4/21,10.68%,HIF1A;ECD;TAF7;KANSL1L
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3602608945601458,1.1280575512015298,0.19539078156312625,0.6634401963139438,1.0,48/254,18.73%,LITAF;MITF;HIF1A;ATF3;NFIC;MAFF;ELF4;SOX30;RUNX1;FOXJ1;SOX9;E2F3;CEBPA;KLF6;PRDM15;MEF2B;EGR2;JUN;IRF5;ATF5;DDIT3;NFKB1;NRF1;SRF;NR3C1;SP7;ELK3;MYBL2;CEBPG;NPAS4;GMEB1;MDM2;ELK4;FOXJ3;MTF1;ETV4;SMARCD2;SP1;NFATC3;MEIS3;YY1;ZBTB17;KLF10;PRRX1;UBP1;GRHL1;RXRB;REL
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.42421292134580113,1.126560436790123,0.31137724550898205,0.6652503141810963,1.0,10/34,17.03%,MYO10;IQGAP1;GAB2;ARAP2;HIP1R;OGT;BTK;MAPKAP1;ARHGAP9;KIF16B
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.3261085023323865,-1.1263862820057848,0.22905027932960895,0.512809821087573,1.0,17/29,26.25%,RPTOR;KAT2B;PKIG;CIT;PRKAR2A;PRKAR2B;CDKN2C;CDKN2D;SPRED1;SPRY2;CDKN1A;SFN;PRKAR1B;CDKN1B;INKA1;INKA2;HEXIM2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.47341447152480925,1.125727868822371,0.3293333333333333,0.6650216413516146,1.0,9/18,28.04%,WDR91;PIK3R5;PIK3R2;SOCS5;SOCS2;WDR81;SOCS6;SOCS4;SOCS7
prerank,vinculin binding (GO:0017166),0.5142808864698493,1.1244871286246334,0.3619718309859155,0.6661445634382196,1.0,4/11,14.84%,TLN1;DAG1;SORBS3;ACTN1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5313099885323211,1.122734224109462,0.3249258160237389,0.6683975146381534,1.0,3/10,18.67%,ANKRD13B;DNAJC2;ANKRD13A
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.4630826224550009,1.1222440064571622,0.32620320855614976,0.6671373767488803,1.0,5/20,10.41%,AK8;TJP2;AK4;AK3;AK6
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4563637346024701,1.1218104226756327,0.32575757575757575,0.6658984279412845,1.0,7/22,21.57%,DUSP9;CDKN3;DUSP15;DUSP12;DUSP3;DUSP23;DUSP6
prerank,amino acid binding (GO:0016597),-0.32003975974533905,-1.1209858291060106,0.2654320987654321,0.5163517102892295,1.0,12/31,19.01%,GRM7;GLRA3;GRIN3A;GRIN2B;GRIN1;GLRA2;AGXT;PADI4;GLRA1;NOS1;CASTOR1;DDAH2
prerank,carbohydrate kinase activity (GO:0019200),0.5182563320814584,1.1200925656611593,0.34306569343065696,0.6679921492539697,1.0,5/11,23.93%,NAGK;GALK2;HK3;HK1;XYLB
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5210966399147927,1.1193520784492679,0.34392265193370164,0.6675784022016736,1.0,4/11,20.88%,PPP1R14B;PPP1R14A;PPP1R8;PPP1R14C
prerank,pyrophosphatase activity (GO:0016462),0.3948323586094945,1.1184718506038647,0.31214528944381387,0.6676558302761519,1.0,12/50,16.23%,DCTPP1;NUDT5;NUDT6;DXO;NUDT9;ITPA;DHX29;DHX9;ENTPD6;BNIP2;NUDT22;DCP2
prerank,ubiquitin-specific protease binding (GO:1990381),0.4717091776785403,1.1171630162095352,0.35695876288659795,0.6688570546705949,1.0,9/19,27.49%,DERL3;VCP;DERL1;SART3;LCOR;SUMO1;SYVN1;PTEN;RAD23A
prerank,retinoid binding (GO:0005501),-0.34829829250124267,-1.114288555127376,0.2722772277227723,0.5217900285884981,1.0,14/22,35.14%,PTGDS;RARA;CYP26B1;ABCA4;CYP26C1;NR2F2;CRABP2;CRABP1;UGT1A1;UGT1A8;UGT1A6;UGT1A7;UGT1A4;ALDH1A2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.35546179954532464,1.112393186196277,0.24469160768452983,0.6791392876430317,1.0,32/188,14.62%,ATF3;NFE2L2;NFYA;ARID5B;TBX18;TFEB;RUNX1;FOXJ1;CHD3;BASP1;RBBP5;PPARG;CEBPA;HDAC4;NKX2-1;CREB3L2;EGR2;BRCA1;JUN;ATF5;DDIT3;NFKB1;CARM1;TAF7;GABPB1;GABPB2;PRDM9;CREBZF;DHX9;HNRNPL;SP1;TNF
prerank,nuclease activity (GO:0004518),0.39413724072965783,1.1092507490420276,0.33674630261660976,0.6851937660826115,1.0,23/52,27.60%,ERN2;RNASEH2A;RNASE12;SND1;RNASEH1;ISG20L2;RNASE7;DNASE1L1;DFFB;RNASEL;RNASE3;SETMAR;DDX1;PNKP;ZC3H12A;XRN2;REXO5;AEN;REXO1;PLSCR1;MAP1S;RNASE1;REXO4
prerank,nuclear receptor binding (GO:0016922),0.363097710762585,1.1078010414286268,0.29568788501026694,0.6865718195963235,1.0,36/111,24.63%,CTNNB1;HIF1A;JMJD1C;KDM3A;PRKCB;TRIP12;RNF6;TMF1;MED17;RNF14;TAF7;TACC2;JUP;PRMT2;PPARGC1B;SNW1;GTF2H1;LATS1;MMS19;MED1;PRPF6;BRD8;TGFB1I1;LCOR;NSD1;RXRA;CALR;SMARCA4;KDM1A;ASXL1;DAXX;WBP2;MED13;ACTN4;EP300;GAS2L1
prerank,G protein-coupled receptor activity (GO:0004930),-0.23799308879878112,-1.1068125360523051,0.0,0.5288408907338694,1.0,76/239,27.89%,P2RY12;CX3CR1;GRM1;ADGRL3;GABBR1;CYSLTR1;GPR34;ADGRB3;GRM5;GRM3;ADGRG6;GPR149;TAPT1;GPR37;GPR173;P2RY14;ELOVL4;CALCRL;GRM8;GPR22;PAX8;P2RY13;ADGRE1;RXFP1;NTSR2;F2R;PDGFRL;ADRB1;ADGRB2;ADRA2A;ADGRL1;DRD2;C5AR2;GPR85;ADGRL4;OPN3;GPR45;ADGRV1;ADGRG1;ADGRG2;GPR75;GPR26;CRHR1;LGR5;VIPR1;GPR61;GPR101;TSHR;GRPR;F2RL2;OPRD1;NPFFR2;S1PR2;ADCYAP1R1;GPR88;MC5R;TRHR;HCAR2;SSTR2;NMUR2;BDKRB2;NPY;GPR171;GPR174;LTB4R;LPAR4;ADGRA1;CXCR5;LPAR2;FFAR4;TM2D1;VIPR2;GPR35;CXCR6;RXFP2;FPR3
prerank,disordered domain specific binding (GO:0097718),0.4463659899925166,1.1067662558447218,0.3427471116816431,0.6869966055130694,1.0,10/23,25.27%,FN1;DFFB;NUMA1;MDM2;FYN;CALM2;BCL2L2;HSPA2;HSP90AB1;CALM3
prerank,small GTPase binding (GO:0031267),0.35264850956584315,1.10096168117393,0.28484848484848485,0.7016461801896617,1.0,49/170,20.56%,MYO5A;MYO9B;IQGAP1;ABCA1;DMXL2;GOLGA4;OPTN;RUSC2;ALS2;FGD6;FLNA;AKAP13;RIC1;SPHK2;RANBP1;RGP1;CYFIP1;RABGGTB;GCC2;NDRG1;CAV1;PAK2;HPS6;RNF41;DOCK7;RANBP9;EXOC2;RAPGEF6;RAF1;GGA2;MAPKAP1;FGD5;SIKE1;ATP6AP1;AP1G1;ARHGEF2;EXOC4;RAB3GAP1;RAB3GAP2;TRIP11;RILP;TBC1D20;ABI2;PARD6A;AFDN;TRIOBP;USP33;YBX3;RALBP1
prerank,NF-kappaB binding (GO:0051059),0.44537544069816987,1.1006658041324868,0.35555555555555557,0.6999172841462931,1.0,14/24,31.11%,ANXA4;TAF4B;HDAC1;HDAC3;MTDH;HIF1AN;PSMA6;GSK3B;EP300;RNF25;FAF1;CDK5RAP3;HDAC2;NPM1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.430314094768713,1.1002140397515883,0.3527272727272727,0.6984564351921804,1.0,10/30,20.56%,SLC11A1;SLC39A7;ATP7A;SLC39A11;SLC39A6;SLC25A37;SLC39A3;SLC39A13;ATP7B;TMEM165
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3754614565105869,1.1000991402921236,0.34582441113490364,0.6961949622686422,1.0,25/71,23.46%,PTPRA;EYA4;PTPRC;PTPN23;PTPRM;HACD2;PTPN2;CDKN3;PTPN21;DUSP15;PTPN18;UBASH3B;DUSP11;CDC25B;CDC25A;MTMR6;DUSP3;PALD1;PTPN1;PTPN6;PTP4A2;DUSP23;PTPN12;PTPN11;PTPRN2
prerank,CoA hydrolase activity (GO:0016289),0.4794931988801434,1.1000062497482725,0.3412698412698413,0.6939131938315677,1.0,5/16,17.40%,ACSBG2;ACOT9;ACOT6;ACOT1;ACAA2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.42080787488770344,1.0995250882265344,0.35799522673031026,0.6927682095474036,1.0,14/33,23.59%,NOCT;ERI3;USB1;EXOSC9;CNOT6;EXOSC10;DCP2;EXOSC5;ERI2;EXOSC4;XRN2;PAN2;TOE1;XRN1
prerank,telomerase RNA binding (GO:0070034),0.4436749956303529,1.0964406492279144,0.35402906208718626,0.6988722363259835,1.0,12/22,27.38%,HNRNPC;EXOSC10;GAR1;DKC1;TERT;DCP2;HNRNPU;SNRPD3;XRN1;TEP1;TENT4B;DHX36
prerank,metalloendopeptidase activity (GO:0004222),0.3733287532284525,1.0962482971189678,0.3035143769968051,0.6968707872391312,1.0,12/76,14.64%,ADAM33;MMP12;ADAMTS13;ADAMTS10;ADAM17;MBTPS2;AFG3L2;PITRM1;ADAMTSL5;MMP28;MMP19;MMP17
prerank,N-acyltransferase activity (GO:0016410),0.4217518541440283,1.0937950774960932,0.34394124847001223,0.701449612512095,1.0,8/32,15.26%,SAT1;PLAAT3;CERS6;GNPNAT1;NAT8;GLYAT;NAT10;NAA80
prerank,U6 snRNA binding (GO:0017070),0.48720290970062263,1.0919767125637292,0.3650137741046832,0.7038558041198014,1.0,10/14,37.13%,DDX39B;EIF5A;RBM22;SART3;LSM8;LSM4;PRPF4;PRPF8;TUT1;LSM7
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.504709425938675,1.090888902059529,0.3709449929478138,0.7042779644697802,1.0,8/12,28.36%,JMJD1C;KDM3A;KDM4D;PHF2;KDM3B;KDM1A;HR;KDM4B
prerank,proton transmembrane transporter activity (GO:0015078),0.40608264566997637,1.0892859301816664,0.3513203214695752,0.7063059219872208,1.0,11/39,20.70%,SLC9A1;ATP6V1B2;SLC46A1;COX6A2;COX5B;COX10;COX7A2L;ATP6V1F;CLCN4;CTNS;UQCRH
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.43936750539292324,1.0871828231857643,0.36046511627906974,0.7096298818647979,1.0,8/22,19.57%,OPTN;SQSTM1;IKBKE;ZRANB3;TNFAIP3;UIMC1;MINDY2;WDR81
prerank,water transmembrane transporter activity (GO:0005372),0.5053149075647123,1.0869180686621438,0.38549075391180654,0.707889001002887,1.0,1/11,5.18%,PDPN
prerank,ubiquitin protein ligase binding (GO:0031625),0.34349598325358954,1.0857097252160204,0.2733668341708543,0.708907973464191,1.0,76/254,25.32%,BCL2;HIF1A;PSMD1;MFHAS1;TRAF2;TANK;SQSTM1;IKBKE;FBXW7;TRAF3;NEK6;SMAD7;TNFRSF1B;ATXN3;TRIM28;UBA52;VCP;CCT2;SKI;EGR2;UBE2L6;BRCA1;FZD4;JUN;HSPA9;MDM2;BECN1;USP2;JAK1;MAP1LC3B;CUL2;ELOB;HSPD1;SHPRH;TRIB2;CHEK2;ATP6V0C;UBE2L3;RPS27A;UBC;SLF2;EIF4E2;FBXO7;USP13;PIAS4;TUBB;WFS1;PACRG;DERL1;CUL1;ABI2;TRIOBP;CUL4A;RNF20;SUMO1;SUMO2;UBE2J1;CALR;XRCC5;RNF34;DAXX;FOXO1;HM13;HSP90AB1;GABARAP;GSK3B;YOD1;AMBRA1;ERLIN2;RALB;SCAMP3;DNAJA1;CUL3;RPL23;PSMA3;CBS
prerank,transcription coregulator binding (GO:0001221),0.3859678003010435,1.0854934818651545,0.3655793025871766,0.7069592154487349,1.0,16/50,22.97%,CTNNB1;PPARD;NEK6;PHF1;MTF2;THAP7;EED;EHMT1;CCNT2;TERT;LMO2;ZBTB17;HDAC3;LCOR;ZBTB16;PER3
prerank,protease binding (GO:0002020),0.361308969427699,1.0845864696159009,0.3495850622406639,0.7069779880461449,1.0,28/99,22.04%,BCL2;FN1;A2M;DERL3;PSAP;ECM1;VCP;TWNK;TIMP2;ITGA3;SERPINF2;BFAR;FURIN;CSTB;TNFAIP3;CRADD;RIOK3;TNF;UBC;SRI;SERPINE1;DERL1;SART3;TIMP1;NOL3;LCOR;SUMO1;SYVN1
prerank,growth factor activity (GO:0008083),0.36878220571369585,1.0844000585458933,0.3429796355841372,0.7050880568873743,1.0,11/74,15.46%,CSF1;PDGFA;FGF2;VEGFA;JAG1;FGF20;IL6;FGF7;IL2;OSGIN2;FGF18
prerank,methylated histone binding (GO:0035064),0.37970967676812417,1.083683303735056,0.37445414847161573,0.704822983994089,1.0,18/62,20.22%,CXXC1;ING4;RBBP5;NCAPG2;BPTF;PHF1;MTF2;THAP7;TTLL12;TAF7;CBX2;MSL3;L3MBTL2;WDR5;PHF13;MPHOSPH8;GLYR1;PHF2
prerank,gap junction channel activity (GO:0005243),0.43951948803271734,1.0825650017294337,0.3765432098765432,0.7055457709192714,1.0,3/22,12.48%,PANX1;GJB2;GJC2
prerank,GDP binding (GO:0019003),0.37855043581004555,1.0815453565090412,0.3333333333333333,0.706020533588999,1.0,15/63,17.09%,RRAGD;RAP2A;RAB8B;GEM;RAB5A;ARL8B;NRAS;KRAS;RAB7A;RAB9A;RAB5C;RAB22A;RIT1;RAP2B;RASL12
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3995445632044866,1.0784581701119917,0.38156359393232203,0.7119247886203177,1.0,6/38,12.30%,A2M;SERPINA10;SERPINE2;TFPI;SERPINF2;FURIN
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.44787527673443084,1.0756242660793631,0.3778337531486146,0.7171852476745706,1.0,13/20,31.47%,COPS2;SENP5;USP9X;USP47;USP21;UFSP2;YOD1;SENP1;OTUD5;DESI2;USP50;SENP3;OTUB1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.36730629995879616,1.0753234827390477,0.3456659619450317,0.7155981701631796,1.0,20/75,24.50%,SORD;DHRS3;MDH1B;RDH12;LDHA;AKR1A1;AKR1B10;DHRS11;HSD17B8;CBR1;KDSR;GFUS;RDH10;GLYR1;DHDH;HIBADH;PHGDH;PGD;KCNAB1;H6PD
prerank,GTPase activity (GO:0003924),0.34606016071859086,1.074263893733301,0.3329979879275654,0.7159193892744242,1.0,48/192,17.43%,RRAGD;TSR1;RAP2A;GNAQ;GNA13;GPN2;IRGC;RHOQ;RAB32;RAB8B;GEM;ARL1;RAB5A;AGAP3;TBC1D24;RHOD;GTPBP4;EEF2;DRG1;DNM2;ARL8B;ARL8A;NRAS;KRAS;RAB7A;EEF1A1;RHOG;RAB9A;RAB5C;GFM2;RAB1A;RHOA;GNA11;RAB20;SAR1A;GNA12;GNB1;EFL1;RHOF;GTPBP10;RAB22A;RABL3;RIT1;RHOU;RAP2B;GNAS;RASL12;IRGM
prerank,calcium channel activity (GO:0005262),0.3639055172549135,1.0742387163467284,0.3545258620689655,0.7136065638289556,1.0,14/84,15.65%,CACNA1A;TRPC4;P2RX4;CACNA1D;SLC24A4;TPCN2;PANX1;TRPM7;CACNB3;CACNB1;ORAI3;PKD1L2;GRIN3B;ORAI1
prerank,bHLH transcription factor binding (GO:0043425),0.44849259594966717,1.0722764243379157,0.4,0.7164158524660961,1.0,8/19,25.49%,BHLHE41;BHLHE40;SP1;LMO2;USF2;CREBBP;KDM1A;SCX
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3479450672581008,-1.0718659846731133,0.35772357723577236,0.594461873830881,1.0,4/19,5.28%,RYR3;GRIN2B;GRIN2A;GRIN1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.4611958343026421,1.070803865782194,0.3876177658142665,0.7157330447160253,1.0,3/16,4.02%,PTPRA;PTPRC;PTPRM
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.4611958343026421,1.070803865782194,0.3876177658142665,0.7157330447160253,1.0,3/16,4.02%,PTPRA;PTPRC;PTPRM
prerank,fatty acid synthase activity (GO:0004312),-0.43344021249566256,-1.0699094736630954,0.39672131147540984,0.5911372151380617,1.0,2/10,7.73%,ELOVL6;ELOVL4
prerank,thyroid hormone receptor binding (GO:0046966),0.41283008404832905,1.0692139646920165,0.3814064362336114,0.7176617664540159,1.0,12/28,26.28%,JMJD1C;TRIP12;MED17;TAF7;PRMT2;GTF2H1;MED1;BRD8;NSD1;MED13;GAS2L1;MED12
prerank,SH3 domain binding (GO:0017124),0.36918056518461423,1.0673186429483341,0.375,0.7203698967015287,1.0,24/62,24.61%,SH3BP2;GRB2;WIPF1;MICAL1;CYBA;DNM2;ADAM15;RUFY1;EVL;CASP9;CBL;ESPN;CRK;VASP;RAD9A;MAPK15;ABI2;SYNJ1;REPS1;RUFY2;PTPN12;AFAP1;SYNJ2;ABL1
prerank,poly(U) RNA binding (GO:0008266),0.4327464535918347,1.0652923157742842,0.3875,0.7234348180572674,1.0,6/20,16.44%,PABPC5;PATL1;HNRNPC;ATXN1;PABPC4;PABPC1
prerank,acetyltransferase activity (GO:0016407),0.40944201913264827,1.0649612277682872,0.4002389486260454,0.7219676280739774,1.0,14/31,25.53%,SAT1;SPHK1;PAFAH2;GNPNAT1;NAT8;NAA16;NAT10;NAA80;NAA15;CREBBP;NAA50;EP300;ELP3;KAT8
prerank,nuclear export signal receptor activity (GO:0005049),0.5012607729146953,1.063454282217143,0.4139402560455192,0.7235712680629736,1.0,5/11,21.54%,XPO7;EIF4ENIF1;NUP42;XPO6;XPO1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.4240853258928095,1.062606966962255,0.4138817480719794,0.7235245284538638,1.0,13/25,26.32%,PARP4;TNKS2;SIRT5;TIPARP;ART4;PARP2;SIRT3;SIRT4;ZC3HAV1;SIRT2;PARP1;PARP9;PARP16
prerank,methylation-dependent protein binding (GO:0140034),0.3740031526710426,1.0625093751998924,0.40522875816993464,0.7214308356777747,1.0,16/57,20.22%,CXXC1;ING4;RBBP5;NCAPG2;BPTF;PHF1;MTF2;THAP7;CBX2;MSL3;L3MBTL2;WDR5;PHF13;MPHOSPH8;GLYR1;PHF2
prerank,calcium:sodium antiporter activity (GO:0005432),0.5076667160191675,1.0616638323911312,0.4108983799705449,0.72142757667088,1.0,4/10,12.09%,SLC3A2;SLC24A4;SLC8B1;SLC8A1
prerank,5'-3' exonuclease activity (GO:0008409),0.47432146069373543,1.0614582103221522,0.4048582995951417,0.719656101714191,1.0,7/14,23.59%,DXO;DCLRE1A;DCP2;TRIR;DCLRE1C;XRN2;XRN1
prerank,G protein-coupled receptor binding (GO:0001664),0.34584561186612606,1.0603122854736802,0.37063655030800824,0.720342031329405,1.0,26/132,20.74%,SDCBP;GNAQ;NPPA;POMC;GNA13;FLNA;BAMBI;ARHGEF11;MYOC;HOMER2;LRP6;PDCD6IP;FZD1;NPB;GPRC5B;C1QBP;GNA11;ZNRF3;GNA12;GNAS;NDP;SFRP1;PACRG;HOMER1;USP33;SAG
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.36486354161883555,1.0603067409229756,0.39658848614072495,0.7180411633201125,1.0,23/69,25.53%,SPHK1;SOAT1;PLAAT3;CERS6;ZDHHC18;ZDHHC15;SOAT2;LPGAT1;GLYAT;LPCAT3;ZDHHC1;NAA16;SCP2;ZDHHC6;NAA15;DGAT1;DGAT2L6;CREBBP;MCAT;CERS5;EP300;ELP3;KAT8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.37201581846273674,1.0591119372503301,0.39349775784753366,0.7187863555105319,1.0,16/54,20.75%,HDAC4;SIRT5;GLS2;GLS;HDAC9;SUDS3;ASAH1;PIGL;MIER2;AMDHD2;KLK3;HDAC1;SIRT4;AGA;HDAC3;SIRT2
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4659376345279464,1.0584955146002446,0.40298507462686567,0.718046762842103,1.0,2/14,4.60%,CAPN15;CAPN1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3901210065707917,1.0531037260288292,0.4134969325153374,0.7301988016225985,1.0,10/33,19.52%,AGO2;ZNF326;SMYD2;ELOF1;WDR43;DHX9;RPRD1A;MAF1;RECQL5;HNRNPU
prerank,mannose binding (GO:0005537),0.48485288042996844,1.052261292778374,0.4142857142857143,0.7303124973972852,1.0,5/12,32.80%,MBL2;LMAN2L;LMAN1;CLEC4D;LMAN2
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.2934941781706568,-1.0510426275485587,0.34868421052631576,0.6256349515595682,1.0,13/31,25.93%,HCN1;SLC12A2;KCNK10;SLC12A9;KCNA1;KCNK1;ABCC9;SLC12A8;KCNK5;SLC12A6;KCNK4;KCNK7;KCNG1
prerank,histone demethylase activity (GO:0032452),0.4130532635284701,1.0497218983341463,0.4054388133498146,0.7346211250676916,1.0,13/27,28.59%,JMJD1C;KDM3A;RIOX1;FBXL19;KDM4D;RIOX2;KDM2A;PHF2;KDM3B;KDM1A;HR;KDM4B;KDM5C
prerank,metal ion transmembrane transporter activity (GO:0046873),0.40756072543718697,1.0484279939835162,0.41041162227602906,0.7355738485235913,1.0,5/27,7.80%,SLC23A1;ATP2B1;SLC11A1;MAGT1;CNNM2
prerank,hydro-lyase activity (GO:0016836),0.3816438552105626,1.0480603505805786,0.4050632911392405,0.734222410663628,1.0,8/41,12.68%,ECHDC3;HACD2;PCBD2;TBXAS1;ENO2;TGDS;ENO1;APIP
prerank,poly-pyrimidine tract binding (GO:0008187),0.41571340691160796,1.0476862289721298,0.41469489414694893,0.7329271337905335,1.0,12/23,30.68%,PABPC5;PATL1;HNRNPC;ATXN1;PABPC4;PABPC1;HNRNPU;PTBP1;FMR1;RBMS2;DAZAP1;SSB
prerank,poly-purine tract binding (GO:0070717),0.4065365563803114,1.0460188231791723,0.42909987669543775,0.7349183036351439,1.0,10/27,19.52%,PABPC5;LARP4;PATL1;RBPMS;PPIE;ATXN1;PABPC4;DDX1;PABPC1;HNRNPU
prerank,chemokine binding (GO:0019956),-0.2936619337851888,-1.0454013586527833,0.3657142857142857,0.6301459649742979,1.0,3/30,2.53%,CX3CR1;CCR5;CCR2
prerank,FAD binding (GO:0071949),0.4115706578896421,1.0431160618719182,0.41875,0.7400609100725125,1.0,5/24,10.60%,MICAL2;MICAL1;CYB5R1;MTRR;MTHFR
prerank,syntaxin binding (GO:0019905),0.36619275004418145,1.0421488913433195,0.42350332594235035,0.7403648922235896,1.0,16/61,19.25%,CACNA1A;ABCA1;NAPA;VPS18;PTPN2;STX6;DAPK1;VAMP2;SYT8;SYPL1;CPLX2;VAMP3;GOLGA2;VPS54;STX7;VPS11
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4780641678223997,1.0412489395706492,0.4331864904552129,0.7406010892515352,1.0,6/11,23.95%,NAA20;NAA16;NAA80;NAA15;NAA40;NAA50
prerank,transcription corepressor binding (GO:0001222),0.4057606737934544,1.0401746101357825,0.42021924482338613,0.7410985958377737,1.0,10/27,22.97%,NEK6;PHF1;MTF2;THAP7;EED;EHMT1;HDAC3;LCOR;ZBTB16;PER3
prerank,amyloid-beta binding (GO:0001540),0.3513996007604729,1.0400889325596756,0.4291845493562232,0.739066978378307,1.0,10/79,10.07%,CACNA1A;APBB2;LRP1;APOE;GSAP;LRPAP1;FZD4;TREM2;LILRB3;LILRB1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3874199889520003,1.0395959293126011,0.4190012180267966,0.7381639899902768,1.0,9/38,13.61%,STAP1;LAT;BLNK;GAB2;TRAT1;CARD10;SPAG9;NCK1;SH2B1
prerank,single-stranded DNA binding (GO:0003697),0.3431938587077577,1.036025167653282,0.4394904458598726,0.745331314354642,1.0,37/93,28.53%,RAD51B;IGHMBP2;MCM2;POLR2H;MCM7;ERCC1;LONP1;TWNK;ERCC4;RAD51AP1;DHX9;SETMAR;MCM8;HSPD1;POLR2D;PURA;FUBP1;PCBP1;HNRNPU;BLM;WBP11;PMS2;MCM6;RAD51;TOP1;MCM3;POLA1;MCM5;PCBP2;NUP35;FUBP3;DHX36;RAD23A;WDR48;REXO4;TDP2;SMC6
prerank,alpha-actinin binding (GO:0051393),0.40943782116213495,1.0353882932959542,0.43253467843631777,0.744593910280995,1.0,5/24,12.65%,CACNA1D;DAG1;PPARG;MAGI1;PALLD
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3609986991851423,1.0352885383916626,0.44130434782608696,0.7425394455682085,1.0,5/60,3.57%,FLT1;NRP2;IGF2R;NRP1;AXL
prerank,alpha-tubulin binding (GO:0043014),0.3951682864779628,1.0342238479388142,0.4385342789598109,0.7429759195892844,1.0,11/31,24.25%,EML4;ARL8B;ARL8A;INO80;FYN;EFHC1;PACRG;TAOK1;EFHC2;TBCE;TRAPPC14
prerank,microtubule plus-end binding (GO:0051010),0.42360838722755767,1.034101754412153,0.42038216560509556,0.7410551607128063,1.0,7/20,17.58%,CLIP2;DCTN1;DST;NUMA1;FBXW11;CLIP1;MAPRE1
prerank,sequence-specific DNA binding (GO:0043565),0.3240422305027588,1.0333566567232513,0.387,0.7408463236793147,1.0,106/590,20.15%,CXXC1;BCL2;HIF1A;ATF3;NFE2L2;KMT2A;NFIC;MMP12;MAFF;TGIF1;MEF2D;SNAPC1;ELF4;CUX1;POU3F1;HOXA4;SOX30;TBX18;TFEB;PPARD;ELF2;SHOX2;SOX9;E2F3;IRF8;BHLHE41;PPARG;SAFB2;HES7;HDAC4;BHLHE40;KLF6;NCL;MAFG;BPTF;CSRNP1;TET3;MEF2B;LONP1;EGR2;BCL6;FBXL19;KLF12;JUN;IRF5;ZBTB2;ACD;ATF5;SRF;NR3C1;ELK3;MYBL2;ZNF296;UPF3A;ZKSCAN3;CEBPG;GMEB1;ZNF148;ELK4;XPA;CHTOP;DMRTA2;GMEB2;PRDM9;SIRT3;FOXJ3;MTF1;SP9;ETV4;SP1;ZGPAT;MYBBP1A;ZBTB7B;ZNF177;NFATC3;MEIS3;FOXR2;ZEB2;YY1;ZFP41;TERT;USF2;ZBTB4;BCL11B;KLF13;KLF10;MAFB;KDM2A;UBP1;ZBTB12;FOXN2;GRHL1;JUNB;ZBTB43;RXRB;HSF1;TERF1;SAFB;ZBTB45;HNRNPU;BARX2;XBP1;SMG1;POLRMT;MBNL2;POU2F1
prerank,RNA stem-loop binding (GO:0035613),0.4787003486162528,1.030864464944787,0.4581005586592179,0.7451004238851829,1.0,7/12,29.12%,EPRS1;DHX9;CPEB3;ZC3H12A;CSDE1;FMR1;RC3H1
prerank,wide pore channel activity (GO:0022829),0.4162488675741167,1.0300398364744237,0.4444444444444444,0.7449808250220343,1.0,3/23,12.48%,PANX1;GJB2;GJC2
prerank,thioesterase binding (GO:0031996),0.48152171204874983,1.0292304188461292,0.4444444444444444,0.7447167320864078,1.0,2/11,4.80%,TRAF2;TRAF3
prerank,adrenergic receptor binding (GO:0031690),-0.3375958161779987,-1.0291606787049319,0.3991769547325103,0.6577140090317098,1.0,6/16,14.37%,RAPGEF2;APLP1;PDE4D;UCHL1;ADRB1;ADRA2A
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3247478651535792,1.0281248931554658,0.4391959798994975,0.7451961967710286,1.0,82/269,26.40%,BCL2;HIF1A;PSMD1;MFHAS1;TRAF2;TANK;SQSTM1;IKBKE;FBXW7;TRAF3;NEK6;SMAD7;TNFRSF1B;CCNB1;ATXN3;TRIM28;UBA52;VCP;CCT2;SKI;EGR2;UBE2L6;BRCA1;FZD4;JUN;HSPA9;MDM2;BECN1;USP2;JAK1;MAP1LC3B;CUL2;ELOB;HSPD1;SHPRH;TRIB2;CHEK2;ATP6V0C;UBE2L3;RPS27A;UBC;SLF2;EIF4E2;FBXO7;USP13;PIAS4;TUBB;WFS1;UBE2C;PACRG;DERL1;CUL1;ABI2;TRIOBP;CUL4A;RNF20;SUMO1;SUMO2;UBE2J1;CALR;XRCC5;RNF34;DAXX;FOXO1;HM13;HSP90AB1;GABARAP;GSK3B;YOD1;AMBRA1;ERLIN2;RALB;SCAMP3;DNAJA1;CUL3;RPL23;PSMA3;CBS;PARP9;FAF1;PRDX6;PCBP2
prerank,hexose transmembrane transporter activity (GO:0015149),0.4725974907880752,1.02784643936947,0.4618585298196949,0.7436399362613849,1.0,6/12,29.83%,SLC2A1;SLC5A3;SLC2A6;SLC2A8;MFSD4A;SLC2A3
prerank,kinase activity (GO:0016301),0.33501708549340353,1.0275628573134532,0.44282744282744285,0.7421888567595809,1.0,34/109,26.27%,DGKZ;CERK;ITPKB;PIK3CB;CDK5;SPHK1;GK;CHKB;SPHK2;PDXK;PI4KA;DGKH;DGKD;PGK1;PKN2;COQ8B;COASY;PIK3C2A;MAPK15;TAOK1;DGKQ;NADK;PIK3CA;CHKA;IRAK1;CCL3;ITPKC;STK39;GSK3B;ABL1;LYN;ADPGK;CDC7;AGK
prerank,calcium-release channel activity (GO:0015278),0.43040249186104956,1.0270591970216434,0.4453125,0.7412754894253365,1.0,3/17,7.43%,MCOLN2;TPCN2;MCOLN3
prerank,"DNA binding, bending (GO:0008301)",-0.37302152996548726,-1.0266687066406899,0.3898916967509025,0.654841994020002,1.0,7/14,30.69%,TOP2A;HMGA2;LEF1;HMGB3;FOXD1;HMGB2;HMGB1
prerank,titin binding (GO:0031432),-0.37700649795796404,-1.0265324677169931,0.4218181818181818,0.6470530153384055,1.0,2/13,5.90%,CAPN3;MYBPC1
prerank,cytokine activity (GO:0005125),0.33222248450867986,1.0251899889555416,0.4560327198364008,0.7437773096882264,1.0,23/131,23.98%,CSF1;FGF2;CCL4;BMP8B;GDF6;VEGFA;CCL13;CCL28;CCL14;KITLG;IL6;FAM3C;IL2;TNF;BMP5;NDP;EPO;TIMP1;TGFB1;CCL3;CKLF;IL7;IL34
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.46230588524663063,1.0232232463990265,0.45643153526970953,0.7464605539485676,1.0,6/13,20.58%,PIK3CB;PIP5K1A;PIP4K2A;PIK3C2A;PIKFYVE;PIK3CA
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.28301596191109074,-1.0166330447168734,0.4171779141104294,0.6537812244958803,1.0,11/34,18.91%,NDUFS3;NDUFV3;NDUFB9;NDUFS4;NDUFS5;NDUFB7;NDUFA10;NDUFB10;NDUFA4;NDUFS2;NDUFA5
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.28301596191109074,-1.0166330447168734,0.4171779141104294,0.6537812244958803,1.0,11/34,18.91%,NDUFS3;NDUFV3;NDUFB9;NDUFS4;NDUFS5;NDUFB7;NDUFA10;NDUFB10;NDUFA4;NDUFS2;NDUFA5
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3179446318324161,1.013765307277881,0.463,0.7678578919351876,1.0,107/597,20.13%,ATF3;NFE2L2;NFYA;NFIC;ORC3;ARID5B;MAFF;TGIF1;MEF2D;ELF4;CUX1;POU3F1;HOXA4;SOX30;TBX18;TFEB;PPARD;GRWD1;RUNX1;MCM2;FOXJ1;ELF2;SHOX2;SOX9;CHD3;BASP1;E2F3;RBBP5;IRF8;BHLHE41;PPARG;MCM7;HES7;CEBPA;HDAC4;BHLHE40;KLF6;MAFG;NKX2-1;MEF2B;CREB3L2;EGR2;BCL6;DHX33;BRCA1;KLF12;JUN;IRF5;ZBTB2;ATF5;DDIT3;NFKB1;CARM1;MBD4;TAF7;SRF;NR3C1;ELK3;MYBL2;ZNF296;CEBPG;GABPB1;GABPB2;GMEB1;ELK4;XPA;DMRTA2;GMEB2;PRDM9;CREBZF;DHX9;HNRNPL;FOXJ3;MTF1;SP9;ETV4;MCM8;HSPD1;SP1;ZBTB7B;TNF;ZNF177;NFATC3;MEIS3;FOXR2;YY1;ZFP41;USF2;BCL11B;KLF13;KAT7;KLF10;UBP1;ZBTB12;FOXN2;GRHL1;JUNB;ZBTB43;RXRB;HSF1;ZBTB45;ZNF568;HNRNPU;BARX2;XBP1;ARID4A;MBNL2
prerank,protein kinase regulator activity (GO:0019887),0.33514509602300674,1.009132906506762,0.48798328108672934,0.7771823116852241,1.0,24/95,23.20%,FGF13;CCNY;CCNL1;SMCR8;CAB39;CCNC;NCKAP1L;CCNB1;TAOK3;CCNL2;CCNT2;SPRY4;NCK1;GPRC5B;KIDINS220;QARS1;PRKAG1;MARK2;EPO;STK11;CCND1;PARVA;CCNH;DAXX
prerank,3'-5' exonuclease activity (GO:0008408),0.36608152853420606,1.0088280111558177,0.4574944071588367,0.7755910701246065,1.0,16/45,22.68%,NOCT;RAD50;ERI3;USB1;EXOSC9;CNOT6;EXOSC10;EXOSC5;ERI2;RAD9A;TRIR;EXOSC4;XRN2;PAN2;TATDN1;TOE1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.42294299530463186,1.0069848008705924,0.4912751677852349,0.7779097757906213,1.0,4/18,12.36%,AKR1B10;ALDH3A2;ALDH3B1;HSD17B12
prerank,transcription cis-regulatory region binding (GO:0000976),0.3173573639672746,1.005991105203717,0.495,0.7782439861418105,1.0,97/406,25.49%,HIF1A;ATF3;NFE2L2;NFYA;MMP12;ARID5B;MEF2D;FOXN3;CUX1;TBX18;TFEB;RUNX1;AGO2;FOXJ1;SOX9;CHD3;NFX1;BASP1;E2F3;RBBP5;PPARG;NFIL3;CEBPA;HDAC4;CIC;NKX2-1;ETV6;MNT;LONP1;CREB3L2;EGR2;GBX1;ASCL4;BRCA1;JUN;STOX1;ATF5;DDIT3;NFKB1;CARM1;TAF7;NR3C1;ELK3;ENO1;NPAS4;GABPB1;GABPB2;TIPARP;PRDM9;CREBZF;HNRNPL;MTF1;SP1;ZBTB7B;TCF24;TNF;ZNF177;YY1;ZFP41;ZFP57;HDAC1;ZBTB4;ZBTB17;PURA;KLF10;FOXN2;GRHL1;ZBTB43;RXRB;HSF1;ZNF568;BARX2;XBP1;ARID4A;POLRMT;SATB2;XRN2;ATF1;TBP;CREM;RXRA;XRCC5;KMT2D;MTERF3;PER3;TFCP2;ACTN4;TCF7;MXI1;RFXANK;TEAD1;CDK5RAP2;EGR1;RBL1;SPI1;STAT6;SCX
prerank,aspartic-type endopeptidase activity (GO:0004190),0.46350699626968167,1.0049985597165079,0.4794520547945205,0.778471134111055,1.0,6/12,28.41%,NAPSA;DDI2;SPPL3;HM13;SPPL2A;CTSE
prerank,Hsp90 protein binding (GO:0051879),0.37955093354794706,1.004434060675284,0.468384074941452,0.7775759003494138,1.0,8/33,24.39%,HIF1A;ERN1;NR3C1;PACRG;UNC45A;HSF1;PTGES3;USP19
prerank,MHC class II protein complex binding (GO:0023026),0.4652645986404648,1.0034068699780136,0.4618705035971223,0.7778297942402576,1.0,1/11,0.91%,PKM
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.32714940611037796,1.0025117895149038,0.5087179487179487,0.7778737794930422,1.0,40/147,19.75%,ABR;CYTH1;DOCK2;PCP2;ALS2;FGD6;RIN2;SMCR8;DENND4C;AKAP13;SERGEF;RIC1;ARFGEF2;RASGEF1B;HPS1;RGP1;ARHGEF11;RCC1L;DNMBP;DENND4B;EEF1D;RAPGEF6;FNIP1;CYTH4;RCBTB2;DOCK11;FGD5;ARHGEF5;ARFGEF1;ARHGEF2;VAV1;RGL2;RAB3GAP1;RAB3GAP2;EIF2B2;DENND1B;FARP1;LAMTOR3;GAPVD1;LAMTOR1
prerank,steroid hydroxylase activity (GO:0008395),-0.34475831445966004,-1.002098650473576,0.46124031007751937,0.679392748954412,1.0,3/16,5.82%,CYP27A1;CYP7B1;CYP39A1
prerank,neuropeptide hormone activity (GO:0005184),0.40538698969381265,1.0018728755631936,0.4872773536895674,0.7772852784177426,1.0,4/22,14.18%,NPPA;CRH;VIP;AGRP
prerank,GTP binding (GO:0005525),0.3217421691333317,1.0017990796924143,0.49798387096774194,0.7752607841762654,1.0,43/172,18.64%,RRAGD;TSR1;RAP2A;MFHAS1;ARF3;REM1;RHOQ;RAB32;ARL11;GEM;ARL1;RAB5A;RHOD;GTPBP4;DRG1;DNM2;ADSS1;ARL8B;ARL8A;NRAS;KRAS;GNL3;RAB7A;EEF1A1;RHOG;RAB9A;RHOA;RHOF;GTPBP10;RAB22A;ARHGEF5;RABL3;RIT1;RHOU;RAP2B;TUBE1;TUBB6;RASL12;EIF2B2;TUBB;NOA1;RHOT2;TUBA1C
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.382322868036052,1.0011219407439291,0.4803337306317044,0.7745768410919034,1.0,13/34,22.68%,NOCT;ERI3;USB1;EXOSC9;CNOT6;EXOSC10;EXOSC5;ERI2;PAN3;EXOSC4;XRN2;PAN2;TOE1
prerank,alkali metal ion binding (GO:0031420),0.44689495914873756,1.0006825532113437,0.46879334257975036,0.7734616908197539,1.0,4/13,12.14%,HDAC4;PDXK;DRG1;ATP1A1
prerank,N-methyltransferase activity (GO:0008170),0.406550802347828,0.9974619901784963,0.4609271523178808,0.7791517767496339,1.0,9/20,26.51%,PEMT;GNMT;METTL15;DIMT1;RNMT;TRMT1L;SETD3;ZCCHC4;FDXACB1
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.30231672679993166,-0.9972580300648667,0.43147208121827413,0.682663291112919,1.0,12/23,25.87%,CCR5;PLCB1;PLCH1;CHRM3;CCR1;CCL5;PLCG2;F2RL2;PLCE1;PLCD1;BDKRB2;PLCB3
prerank,mRNA 5'-UTR binding (GO:0048027),0.4080799833556915,0.9967917436430049,0.4841463414634146,0.7785821957142068,1.0,13/24,32.88%,LARP1;NCL;GNL3;CCT5;RPS13;RPS7;SYNCRIP;DHX36;FMR1;SHMT1;RSL1D1;SHMT2;DDX3X
prerank,acid-thiol ligase activity (GO:0016878),0.4415082633851892,0.9962614187111111,0.4703448275862069,0.7776553553214405,1.0,3/13,15.21%,SLC27A5;ACSL1;AACS
prerank,phosphatidic acid binding (GO:0070300),0.4194670891566158,0.9952691408666559,0.4930643127364439,0.7777243163382562,1.0,6/19,15.52%,ATP13A2;PITPNC1;SESTD1;RAPGEF6;MAPKAP1;PLEKHN1
prerank,protein tyrosine kinase activator activity (GO:0030296),0.4116679776610429,0.9952237554827781,0.4889466840052016,0.7756732654878677,1.0,4/19,9.97%,ERCC6;ALKAL2;GAS6;PAK2
prerank,guanyl ribonucleotide binding (GO:0032561),0.318913861131575,0.9947679829353572,0.513595166163142,0.7746074732427949,1.0,47/196,18.64%,RRAGD;TSR1;RAP2A;MFHAS1;ARF3;REM1;RHOQ;RAB32;RAB8B;ARL11;GEM;ARL1;RAB5A;RHOD;GTPBP4;DRG1;DNM2;ADSS1;ARL8B;ARL8A;NRAS;KRAS;GNL3;RAB7A;EEF1A1;RHOG;RAB9A;RAB5C;RHOA;RHOF;CNGB1;GTPBP10;RAB22A;ARHGEF5;SLC19A1;RABL3;RIT1;RHOU;RAP2B;TUBE1;TUBB6;RASL12;EIF2B2;TUBB;NOA1;RHOT2;TUBA1C
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.46920112681005527,0.9926903577137951,0.5,0.7772721269036204,1.0,6/11,32.36%,UBE4A;UBE4B;ANAPC11;UBOX5;UBE2K;RBX1
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.2513150953055639,-0.9917661772165068,0.45263157894736844,0.6871157385475573,1.0,23/49,27.97%,PLCXD3;PTPRJ;PPP1CA;SMPDL3B;SAMHD1;SMPDL3A;PXYLP1;ENPP6;PPP1CB;PTPRO;SACM1L;PTPN22;PDXP;HDHD2;EPHX2;APEX1;GDPD1;SMPD1;DUSP5;MPPED2;SBF1;DUSP8;DUSP28
prerank,chloride channel activity (GO:0005254),0.3493121718013841,0.9872621021503757,0.5148514851485149,0.7880053875959504,1.0,6/59,7.33%,PACC1;TTYH2;CLCN7;ANO9;CLIC4;ANO6
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.34146843074692534,-0.9855934182140154,0.497907949790795,0.6938758096538317,1.0,8/16,22.88%,MACROD2;ADPRH;MACROD1;TDG;NEIL1;BST1;NTHL1;NEIL3
prerank,GABA receptor binding (GO:0050811),0.45131848521091444,0.9855419472667667,0.5150645624103299,0.7898590970855954,1.0,2/11,5.24%,TRAK1;ARFGEF2
prerank,insulin-like growth factor I binding (GO:0031994),-0.3466044504709002,-0.9846306264595784,0.4568345323741007,0.6882646557484169,1.0,9/13,33.62%,IGFBP5;ITGB4;IGFBP4;IGFBP3;LRP2;ITGA6;IGFBP6;INSR;IGFBP2
prerank,microtubule binding (GO:0008017),0.31148527554738076,0.9831364233957188,0.5589123867069486,0.7933643604087792,1.0,35/222,13.60%,FMN1;FGF13;GAS2L3;KIF13B;MACF1;MAP10;UXT;CDK5;CLIP2;TUBGCP4;HAUS8;EML4;CFAP157;KIF1A;STARD9;DCTN1;DST;NDRG1;DRG1;DNM2;CRIPT;REEP3;ABRAXAS1;KIF21B;RAE1;RMDN2;NUMA1;VAPB;HOOK3;MAP1LC3B;PEX14;MARK4;FAM83D;CEP57L1;FBXW11
prerank,mRNA methyltransferase activity (GO:0008174),0.4508917351481438,0.9807293805095874,0.520949720670391,0.7967726393351469,1.0,6/12,24.06%,TRMT10C;METTL8;RNMT;PCIF1;METTL3;NSUN2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4586960245991691,0.9803695358874599,0.49859154929577465,0.7932745117271869,1.0,7/11,28.32%,SIL1;BAG3;PFN1;GRPEL2;BAG5;BAG2;HSPBP1
prerank,adenyl nucleotide binding (GO:0030554),0.4586960245991691,0.9803695358874599,0.49859154929577465,0.7932745117271869,1.0,7/11,28.32%,SIL1;BAG3;PFN1;GRPEL2;BAG5;BAG2;HSPBP1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.3807299891883217,-0.9767225120773256,0.487012987012987,0.6989691479173193,1.0,1/11,2.04%,RYR3
prerank,RNA methyltransferase activity (GO:0008173),0.4126144196291072,0.9760433652201126,0.505249343832021,0.8012557575438252,1.0,9/19,23.09%,METTL8;TRMT13;MRM2;TRMT5;TGS1;TRMT12;LCMT2;FTSJ3;METTL3
prerank,telomeric DNA binding (GO:0042162),0.3647639312221588,0.9756584895554405,0.5171597633136095,0.7998856707973627,1.0,15/32,27.92%,NCL;RAD50;ACD;UPF3A;HNRNPA2B1;TERT;PURA;TERF1;BLM;SMG1;XRCC5;KDM1A;TERF2IP;UPF2;TERF2
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4563253990105947,0.9756584596496517,0.5029498525073747,0.7977179589523834,1.0,5/10,23.95%,NAA20;NAA16;NAA80;NAA15;NAA50
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.43690737259569323,0.9744768916422359,0.5169606512890095,0.7982546004418651,1.0,2/13,16.23%,BMP8B;BMP5
prerank,low-density lipoprotein particle binding (GO:0030169),0.4198205342285151,0.9740112170982753,0.5183673469387755,0.7972087147534098,1.0,5/16,21.37%,COLEC12;TREM2;MSR1;SCARF1;STAB2
prerank,heme binding (GO:0020037),0.3353828095789607,0.9739027616658563,0.5217391304347826,0.7953617448523481,1.0,20/65,29.29%,CYP19A1;HMOX1;CYB5R4;TBXAS1;CAT;CYBB;CYP1B1;PTGIS;FLVCR1;FLVCR2;HEBP1;CYB561D1;CYP2R1;NOX4;CYCS;CBS;PXDNL;SDHC;BACH1;PXDN
prerank,enoyl-CoA hydratase activity (GO:0004300),0.4628161077846625,0.9720334842626414,0.5292397660818714,0.797571780911065,1.0,1/10,4.05%,ECHDC3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.38640216853821935,0.9719234215114275,0.5207547169811321,0.7956985954965113,1.0,8/25,17.03%,PLEK;GAB2;PLEKHA1;HIP1R;SESTD1;MAPKAP1;HIP1;KIF16B
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.3438807939342046,0.9717342479046733,0.534521158129176,0.7940159289931449,1.0,9/48,14.55%,CALHM6;ASIC3;PIEZO1;ATP6V1B2;SLC46A1;TRPM7;ATP6V1F;SLC12A4;GRIN3B
prerank,metal ion binding (GO:0046872),0.30420055169578636,0.9699189442205924,0.603,0.7962441585682621,1.0,77/477,17.45%,LPL;LCP1;LRP1;MAN1C1;IQGAP1;ASPH;POSTN;APOE;MCTP1;CERK;ABL2;DCTPP1;ANXA5;MMP12;RAP2A;ADAM8;ANXA4;RASGRP3;FER1L5;ADAMTS13;PON1;SPHK1;TPD52;ESYT1;NUDT5;CRACR2A;ERN2;DYRK2;PI4K2A;EFHD2;CAPN1;STK3;NEK6;DXO;SIK1;GEM;CLYBL;ANXA3;ERN1;PDXK;ANXA7;ARSA;PAPOLA;SRPK1;PPP3R1;GJB2;MASP1;SRPK2;SYT8;PIR;SLC8A1;ATP2A2;MTHFD2;ADPRS;TPM4;BNIP2;CPNE6;STK38L;GALNT3;NUDT22;GEN1;HMGCL;S100A11;CALU;NOTCH4;XYLT2;STK38;SRI;AASDHPPT;F9;FIGNL1;LATS1;S100A16;MAP3K20;CALM2;S100B;MAPK12
prerank,motor activity (GO:0003774),0.3373843090741638,0.9698759647687192,0.5398907103825137,0.794204469480781,1.0,6/60,9.30%,MYO1E;KIF13B;KIF1A;STARD9;KIF21B;KLC1
prerank,DNA binding (GO:0003677),0.3011824396034143,0.969452789478499,0.646,0.7930336285033752,1.0,189/694,27.60%,DNMT3A;BCL2;C1D;ERCC6;HIF1A;NFE2L2;NFYA;MMP12;PARP4;ARID5B;MAFF;SNAPC1;RAD51B;CUX1;POU3F1;SPHK1;VDR;PPARD;IGHMBP2;MCM2;FOXJ1;SOX9;LRRFIP1;CHD3;E2F3;PPARG;POLR2H;SAFB2;MCM7;APLP2;HES7;TAF4B;CEBPA;HDAC4;HMGN1;POGK;SMARCB1;BPTF;ERCC1;CSRNP1;TRIM28;RAD50;PHF1;NKX2-1;DNASE2;LONP1;EGR2;TWNK;BCL6;MTF2;BRCA1;KLF12;JUN;IRF5;JRK;ATF5;DDIT3;DNASE1L1;MBD4;SP7;DDB2;DDB1;SNAPC4;ZKSCAN3;CEBPG;LYAR;ZDHHC1;DCLRE1A;AIFM2;ZNF148;ELK4;KIN;ERCC4;XPA;INO80;ZNF638;RAD51AP1;AIM2;PRDM9;CREBZF;SIRT3;DHX9;FOXJ3;MTF1;MSL3;SETMAR;PMS1;MCM8;HSPD1;SP1;ZGPAT;MYBBP1A;HUWE1;CENPX;POLE;SYCP2;DNMT1;POLR2D;MEIS3;SUPV3L1;ZEB2;ZMYM4;YY1;RFC1;TERT;USF2;ZBTB4;PNKP;PURA;FUBP1;PCBP1;MAFB;YAF2;CNBP;ERCC2;GRHL1;JUNB;HP1BP3;DCLRE1C;HSF1;TERF1;SAFB;CENPS;LIN9;HNRNPU;ZC3H12A;BLM;BARX2;XBP1;ARID4A;POLRMT;POU2F1;GLYR1;GTF3C4;WBP11;CREM;THAP1;RXRA;ARID3A;GZF1;ZBTB16;PMS2;CREBBP;CALR;XRCC5;SMARCA4;KMT2D;HIC2;BCLAF3;TFCP2;FOXO1;XRN1;ZMYM6;MCM6;SURF6;RAD51;EP300;TOP1;TEAD1;ZNF292;ZMYM3;ABL1;MCM3;CSRNP2;EGR1;MYRF;CXXC5;CAMTA2;SCX;POLA1;NR5A1;MCM5;TAF6;DEDD2;PCBP2;GTF2A1;IRF3;CENPB;NUP35;FUBP3;TARDBP;PRKDC;NFYB;ILF3;DHX36;MAP1S;RAD23A;WDR48;REXO4
prerank,inward rectifier potassium channel activity (GO:0005242),-0.29943316733004666,-0.9693821035343392,0.45023696682464454,0.7087017643776073,1.0,11/24,27.80%,KCNJ3;KCNN2;KCNK1;ABCC9;KCNJ13;KCNN3;KCNH2;KCNJ12;KCNN1;KCNK6;KCNJ15
prerank,tubulin binding (GO:0015631),0.3058544603523313,0.9692234010078223,0.5981963927855711,0.7914557331588886,1.0,83/296,24.72%,FMN1;FGF13;GAS2L3;KIF13B;MAP10;UXT;CDK5;CLIP2;TUBGCP4;DAG1;HAUS8;AGBL5;EML4;CFAP157;KIF1A;ALDOA;HTT;STARD9;GIT1;DCTN1;DST;NDRG1;DRG1;BRCA1;DNM2;ARL8B;ARL8A;CRIPT;REEP3;ATF5;ABRAXAS1;KIF21B;TTLL12;RAE1;RMDN2;NUMA1;IFT74;VAPB;AGTPBP1;HOOK3;INO80;MAP1LC3B;PEX14;MARK4;FAM83D;CEP57L1;FYN;TPR;CCT5;EFHC1;CLIP1;ARHGEF2;CEP295NL;TBCA;CEP44;KIF16B;KRIT1;HOOK1;PACRG;GOLGA2;TERF1;TAOK1;PRUNE1;ALMS1;IRAG2;GPAA1;KIF1B;TOGARAM2;CCDC170;KIFC1;CAMSAP1;CEP57;EFHC2;EML3;CCDC69;GABARAP;TBCE;KIF3A;CEP295;TRAPPC14;MDM1;GAS2L1;CDK5RAP2
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.37869011444284667,0.9681423740422919,0.5469135802469136,0.7916916056833846,1.0,8/28,19.04%,AGO2;RNASEH2A;PRORP;RNASEH1;AGO3;RPP38;POP1;EDC3
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.45482208840326627,0.9667649955662935,0.5179856115107914,0.7927457154989597,1.0,1/11,1.24%,SASH1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.41720895805805047,0.9659329289927869,0.5286885245901639,0.7925696335908364,1.0,7/15,28.04%,PIK3R5;PIK3R2;SOCS5;SOCS2;SOCS6;SOCS4;SOCS7
prerank,phosphoric diester hydrolase activity (GO:0008081),0.36124200977563425,0.965711135359613,0.5454545454545454,0.791017343572489,1.0,5/35,5.53%,PLD3;PLCB4;GDPD3;PLCB2;SMPD4
prerank,lipid phosphatase activity (GO:0042577),0.4266912232830973,0.9648522239171354,0.5423023578363384,0.7910256084815945,1.0,3/14,9.89%,PLPP6;PLPP3;PLPP7
prerank,WW domain binding (GO:0050699),0.3787187461497226,0.9604727994400225,0.53125,0.7986316730382982,1.0,3/26,13.07%,LITAF;PMEPA1;TCEAL5
prerank,BMP receptor binding (GO:0070700),0.436917561108323,0.9548402940939107,0.5498614958448753,0.8089259416585689,1.0,2/12,16.23%,BMP8B;BMP5
prerank,calcium channel inhibitor activity (GO:0019855),0.4505113809949782,0.9530803856476352,0.5305832147937412,0.8105954005638947,1.0,3/11,17.85%,PHPT1;CALM2;FKBP1B
prerank,N-acetyltransferase activity (GO:0008080),0.40014653514429344,0.9524474992235323,0.5311688311688312,0.8099723895818158,1.0,8/19,24.10%,SAT1;GNPNAT1;NAT8;NAT10;NAA80;AANAT;NAA50;EP300
prerank,nucleotidyltransferase activity (GO:0016779),0.39993122423181793,0.9515923555115525,0.5405742821473158,0.8098097388937959,1.0,8/19,27.76%,NUDT5;YRDC;REV1;TERT;MOCS3;MTPAP;TENT4B;PAPSS1
prerank,glutamate receptor binding (GO:0035254),0.40990961908173673,0.9510692253251873,0.5545087483176312,0.8088862201712382,1.0,6/17,19.35%,SQSTM1;HOMER2;DLG4;HIP1;GNAS;HOMER1
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3693360889154517,-0.9505174056695197,0.53,0.7446591380133867,1.0,2/11,11.15%,ITCH;PF4
prerank,ATPase activator activity (GO:0001671),0.3959843784408971,0.9501720600981507,0.5381727158948686,0.8087478529626101,1.0,8/20,27.33%,TOR1AIP2;DNAJB6;DNAJC10;ATP1B3;DNAJC1;DNAJC15;DNAJA1;TOR1AIP1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3160004377286757,-0.9501410975518353,0.5022421524663677,0.7375015929797463,1.0,8/18,29.41%,ACVR2B;BMPR1B;LTBP1;LTBP4;TGFBR3;ENG;AMHR2;ACVR2A
prerank,poly(A) binding (GO:0008143),0.3859977276304912,0.9488649798366118,0.5384615384615384,0.8097030962799194,1.0,8/21,19.52%,PABPC5;LARP4;RBPMS;PPIE;PABPC4;DDX1;PABPC1;HNRNPU
prerank,retinoic acid receptor binding (GO:0042974),0.3992634338034664,0.9479359884663234,0.5398457583547558,0.809640486054796,1.0,8/17,23.49%,VDR;PPARG;PRMT2;SNW1;MED1;NSD1;ASXL1;ACTN4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.30138840640141984,0.9471980273597828,0.643,0.8091858219611083,1.0,54/232,22.60%,MYLIP;NSMCE2;NEURL2;TRIM6;TRIM43;NHLRC1;NFX1;SIAH2;RNF128;VPS18;TRIP12;UBR4;RNF180;RNF6;RNF2;UBE3C;EGR2;DTX3;RNF149;RNF121;DTX4;RNF14;UBE3B;RNF41;BRAP;WWP2;RNF167;MDM2;RNF145;UBR2;BFAR;ZNRF3;CBL;SHPRH;HUWE1;RNF185;MKRN2;UFL1;TRIM72;NHLRC3;PIAS4;HECTD1;RNF19A;VPS11;BIRC2;RCHY1;RNF111;NEDD4;RNF7;RNFT1;TRIM7;SYVN1;CDC42;RNF19B
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.35590546413372376,0.9453488938284066,0.5608899297423887,0.8110842880380073,1.0,9/35,19.92%,AARS1;QTRT1;ALKBH1;GATB;TRMT13;TRMT5;FTO;TRMT12;LCMT2
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.44085824336766,0.9447140753453634,0.5438335809806835,0.8103322922933018,1.0,4/11,20.53%,SLC25A25;SLC35B3;SLC19A1;SLC17A9
prerank,peptide hormone receptor binding (GO:0051428),0.4419106600192919,0.9444310232139524,0.5537790697674418,0.8088790807228082,1.0,4/11,30.07%,VIP;GNRH1;PSMC5;ADCYAP1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3359445390704584,0.943449689420687,0.5736782902137233,0.8089564197737109,1.0,13/51,21.08%,ANKH;SLC16A10;SLC25A3;SLC7A8;SLCO5A1;SLC46A2;SLCO2A1;SLC35D2;CLCN4;SLC4A4;SLC25A14;SLC5A6;SLC16A2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4329399111624879,0.9429329392417409,0.5542521994134897,0.8079976261134668,1.0,4/12,20.53%,SLC25A25;SLC35B3;SLC19A1;SLC17A9
prerank,single-stranded RNA binding (GO:0003727),0.3422806744956353,0.9358215184266606,0.5941860465116279,0.8206843127154574,1.0,12/43,19.52%,PUS1;AGO2;LONP1;ZFR;DHX9;AGO3;EXOSC10;POLR2D;AGO4;CNBP;TLR7;HNRNPU
prerank,symporter activity (GO:0015293),0.4462873494883488,0.9322593376767236,0.5599435825105783,0.8260130373041126,1.0,3/10,19.24%,SLC46A2;SLC4A4;SLC5A6
prerank,voltage-gated calcium channel activity (GO:0005245),0.344714786375374,0.9316815160432638,0.5685814771395076,0.8251672650733732,1.0,3/37,5.58%,CACNA1A;CACNA1D;TPCN2
prerank,endopeptidase activator activity (GO:0061133),-0.3781023310228847,-0.9311016940070258,0.50814332247557,0.7725921987618404,1.0,6/10,25.07%,VSIR;APH1B;ADRM1;PSME1;PSME2;PSENEN
prerank,cell adhesion mediator activity (GO:0098631),0.368137561325724,0.9309994661782494,0.5664596273291925,0.8244159511749213,1.0,5/24,12.65%,SIRPA;NPTN;NINJ1;IGSF9;PALLD
prerank,glucose transmembrane transporter activity (GO:0005355),0.3962117005398628,0.9301822077674025,0.5757575757575758,0.8241685651705005,1.0,4/17,18.83%,SLC2A1;SLC5A3;SLC2A6;SLC2A8
prerank,endopeptidase inhibitor activity (GO:0004866),0.31606701570715334,0.9300979484858631,0.627831715210356,0.8223082217614055,1.0,19/82,22.50%,RENBP;A2M;SERPINA10;CST7;PROS1;SERPINE2;TFPI;TIMP2;SERPINF2;FURIN;CSTB;BST2;USP14;CAST;SERPINE1;TIMP1;SERPIND1;ROCK1;BIRC6
prerank,potassium channel regulator activity (GO:0015459),0.3319534000805378,0.929488668545213,0.5957683741648107,0.821576967588639,1.0,7/49,10.48%,SGK1;SGK3;SGK2;LRRC52;FLNA;RASA1;SLC5A3
prerank,protein phosphatase activator activity (GO:0072542),0.4206438654863951,0.9279384920216619,0.5605006954102921,0.8226963666992196,1.0,8/13,31.74%,PPP2R5C;PTPA;CALM2;B3GAT3;CALM3;PPP2R5D;PPP2R5A;PPP2R5E
prerank,voltage-gated chloride channel activity (GO:0005247),0.44732690172415257,0.9272882143785525,0.5883211678832116,0.8219157387962119,1.0,4/10,26.07%,ANO6;CLCN4;CLCN6;CLCN2
prerank,copper ion binding (GO:0005507),0.3371065903724965,0.9264730978076103,0.6064441887226697,0.821539143879349,1.0,9/42,21.97%,P2RX4;AOC2;ATP13A2;ATP7A;ATOX1;LOXL3;ATP7B;RNF7;MOXD1
prerank,tau protein binding (GO:0048156),0.3368397166068313,0.9250979923207818,0.6291618828932262,0.8222980293162284,1.0,14/40,24.10%,APOE;CDK5;DCTN1;MARK4;FYN;PIN1;S100B;MARK2;TAOK1;ROCK1;BRSK2;HSP90AB1;GSK3B;EP300
prerank,ubiquitin-protein transferase activity (GO:0004842),0.29074627797700336,0.9250580980925462,0.725,0.820383349785638,1.0,81/346,22.60%,MYLIP;CNOT4;TRAF2;NEURL2;TRIM6;TRIM43;NHLRC1;MALT1;NFX1;SIAH2;RNF128;VPS18;TRIP12;UBR4;TRAF3;RNF180;RNF6;TRIM28;RNF2;UBE2Q1;UBE3C;TTC3;KLHL13;UBE2L6;DTX3;BRCA1;RNF149;RNF121;DTX4;RMND5B;RNF14;UBE2R2;UBE3B;RNF41;DDB2;BRAP;WWP2;RNF167;MDM2;RNF145;UBR2;BFAR;CUL2;ZNRF3;TNFAIP3;CBL;FBXW11;FBXL6;SHPRH;HUWE1;KCTD10;UBE2L3;RNF185;MKRN2;SHARPIN;OBI1;FBXO7;TRIM72;NHLRC3;HECTD1;UBE2H;UBE2C;RNF19A;CUL1;VPS11;BIRC2;RCHY1;CUL4A;RNF111;NEDD4;RNF7;RNF20;RNFT1;FBXW2;TRIM7;SYVN1;RNF214;UBE2J1;CDC42;BIRC6;RNF19B
prerank,ubiquitin protein ligase activity (GO:0061630),0.2937952692986038,0.9234105024082623,0.6986986986986987,0.821668639549498,1.0,76/228,30.24%,MYLIP;NEURL2;TRIM6;TRIM43;NHLRC1;NFX1;SIAH2;RNF128;VPS18;TRIP12;UBR4;RNF180;RNF6;RNF2;UBE3C;DTX3;RNF149;RNF121;DTX4;RNF14;UBE3B;RNF41;BRAP;WWP2;RNF167;MDM2;RNF145;UBR2;BFAR;ZNRF3;UBE4A;CBL;SHPRH;HUWE1;RNF185;MKRN2;UBE4B;TRIM72;NHLRC3;HECTD1;RNF19A;VPS11;BIRC2;RCHY1;RNF111;NEDD4;RNF7;RNFT1;TRIM7;SYVN1;CDC42;RNF19B;RNF34;DTX2;CUL3;PELI2;RNF215;RNF25;CBLL1;PDZRN3;ZNRF2;ANAPC11;RNF216;RNF13;LRSAM1;TRIM71;RC3H1;MEX3C;UBOX5;TRIM3;ARIH2;RNF43;TRIM35;TRIM37;UBE2K;TOPORS
prerank,kinase inhibitor activity (GO:0019210),0.3464470338087899,0.922013921283458,0.6042654028436019,0.8224853090042954,1.0,5/33,10.98%,SMCR8;TAOK3;LRP6;SPRY4;NCK1
prerank,cytochrome-c oxidase activity (GO:0004129),0.41041579287605373,0.9215129479724788,0.5743243243243243,0.8214822037806235,1.0,4/15,9.78%,COX6A2;COX5B;COX10;COX7A2L
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.35393358116036483,0.9208714416068398,0.5980746089049338,0.8208710580325025,1.0,12/32,22.12%,TET3;RIOX1;ALKBH1;EGLN1;TMLHE;RIOX2;KDM2A;FTO;EGLN3;PHYH;HIF1AN;ALKBH3
prerank,exonuclease activity (GO:0004527),0.330711597566862,0.9191254502387273,0.6101123595505618,0.8223371286359161,1.0,23/46,33.10%,DXO;RAD50;ISG20L2;EXOSC9;CNOT6;EXOSC10;EXOSC5;RAD9A;TRIR;DCLRE1C;ZC3H12A;EXOSC4;XRN2;REXO5;AEN;REXO1;REXO4;POLG;MRE11;EXOSC3;ENPP1;CNOT7;EXD1
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.30515700750478114,0.9161587085532646,0.658307210031348,0.8262943554099939,1.0,18/91,18.04%,SH3PXD2B;SLC9A1;SDCBP;ATP13A2;CAPG;KCNJ2;WDR45;SYTL2;HIP1R;SESTD1;OSBPL2;SNX18;MAPKAP1;FLII;HIP1;KIF16B;PFN1;KRIT1
prerank,DNA polymerase binding (GO:0070182),0.3841021700720445,0.9156414706297873,0.6173677069199457,0.8252941540037763,1.0,7/18,23.94%,LONP1;ACD;NAT10;SMARCA4;PTGES3;HSP90AB1;RAD51
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.4341453381148291,0.9144757911889901,0.5914454277286135,0.8256202323689797,1.0,3/10,23.20%,ANKRD13B;ANKRD13A;DAXX
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.3631506786959585,-0.9121357548667477,0.538961038961039,0.8078528447923846,1.0,3/10,8.36%,PKIG;PRKAR2A;PRKAR2B
prerank,nucleotide diphosphatase activity (GO:0004551),-0.3370010775640222,-0.909744762894331,0.58203125,0.8045089525546002,1.0,4/14,18.49%,FHIT;NUDT4;NUDT12;NUDT11
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.37267630287045483,0.9084639172485913,0.6116751269035533,0.8350433603722425,1.0,2/22,5.73%,APOE;LRPAP1
prerank,AMP binding (GO:0016208),0.43097242948474923,0.9068070683944839,0.6166902404526167,0.8363071526112971,1.0,4/11,18.00%,PFKL;APRT;PRKAG1;PFKP
prerank,ligand-gated cation channel activity (GO:0099094),0.30788767753947033,0.9060270121992424,0.6545454545454545,0.8357308732176315,1.0,6/75,4.13%,P2RX4;CHRNB2;PTK2B;ASIC3;KCNJ2;CCDC51
prerank,platelet-derived growth factor binding (GO:0048407),0.4177765455338241,0.904967665556484,0.59366391184573,0.8358452649029048,1.0,4/11,25.05%,PDGFA;COL4A1;PDGFB;PDGFRA
prerank,single-stranded DNA helicase activity (GO:0017116),0.37472717078470186,0.902998030809432,0.6301546391752577,0.8375033456418063,1.0,8/19,27.73%,MCM2;MCM7;DHX9;RFC2;MCM6;RAD51;MCM5;HELQ
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.35487803708053844,-0.9014724123405584,0.5637583892617449,0.8143090659812744,1.0,3/10,11.70%,CASP2;CASP6;CASP3
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.34445636261727924,-0.9005166481424658,0.5796610169491525,0.8081842243882544,1.0,3/11,11.70%,CASP2;CASP6;CASP3
prerank,myosin II binding (GO:0045159),0.4251913321602299,0.899117086015757,0.606508875739645,0.8428600863811071,1.0,5/10,22.48%,LLGL2;LLGL1;MYL4;TRIOBP;GSN
prerank,PDZ domain binding (GO:0030165),0.3122119358755307,0.8982425833276039,0.6484458735262594,0.8424635860493228,1.0,10/61,10.63%,GNG12;ATP2B1;CADM1;ADAM17;PLEKHA1;FZD4;FZD1;CRIPT;LLGL2;TBC1D10A
prerank,mitogen-activated protein kinase binding (GO:0051019),0.34829978755572566,0.8957953541609209,0.6308243727598566,0.8447902177753028,1.0,6/29,13.67%,TNIP1;DUSP9;MAPKAPK3;MAPKAPK2;MAPK7;TPR
prerank,hexosyltransferase activity (GO:0016758),0.2938026894530648,0.8946783807094972,0.6773858921161826,0.8449812598991467,1.0,21/101,20.58%,B4GALT5;LARGE1;B4GALT7;B4GAT1;HEXA;GCNT2;B3GALNT2;PIGZ;HEXB;GYG1;GBA2;OGT;GCNT1;B4GALT1;B3GLCT;POFUT1;GBE1;B3GALT4;DPY19L1;CSGALNACT2;POGLUT2
prerank,neurexin family protein binding (GO:0042043),-0.36656571167960766,-0.8922393987542092,0.5672131147540984,0.8185772209993095,1.0,2/10,1.17%,NLGN1;CPE
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2680131267434323,-0.8916277433547578,0.678391959798995,0.8117206709845127,1.0,4/26,8.46%,CPE;AGBL4;AGBL3;FOLH1
prerank,amino acid:sodium symporter activity (GO:0005283),0.41631804362509195,0.8910170751998574,0.6204481792717087,0.8497571691691437,1.0,1/11,0.83%,SLC38A1
prerank,NAD binding (GO:0051287),0.3514534010995016,0.8907943570462041,0.6443037974683544,0.8481546105708581,1.0,11/26,27.82%,SORD;NUDT6;SIRT5;HSD17B8;SIRT3;ZC3HAV1;SIRT2;ALDH2;NNT;PARP9;ALDH1A1
prerank,pre-mRNA binding (GO:0036002),-0.2629509647499067,-0.8904424969360107,0.6524064171122995,0.8062458574521674,1.0,8/28,16.79%,CELF2;RBM7;RNPC3;RBM41;SLU7;CELF5;CELF4;SNRPC
prerank,ephrin receptor binding (GO:0046875),0.3540648289954751,0.887101232673871,0.6199494949494949,0.8529689816640338,1.0,10/21,30.09%,GRB2;FYN;CBL;EFNA1;CRK;PTPN1;ABL1;LYN;ANKS1B;PIK3CG
prerank,anion transmembrane transporter activity (GO:0008509),0.40920542324147746,0.8859794518181942,0.622286541244573,0.8530410871603863,1.0,6/12,27.34%,SLC26A11;SLC4A2;SLC19A1;MFSD10;ABCC5;ABCG2
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.33630777418170915,0.8859591074388956,0.6431137724550898,0.8511153525547783,1.0,13/33,31.99%,SIAH2;RNF180;RNF14;DCUN1D4;RNF185;DCUN1D2;RNF19A;RNF19B;DCUN1D3;UBA2;ARIH2;AUP1;ZMYM2
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.3901414388586142,0.8834915701225364,0.6282225237449118,0.853610354484647,1.0,6/14,24.98%,MTMR12;MTMR14;MTMR6;MTMR10;SYNJ1;PTEN
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.2772449366854375,0.8833431919897027,0.907,0.8518965722194972,1.0,113/731,18.83%,LITAF;MITF;DNMT3A;HIF1A;ATF3;NFE2L2;NFYA;NFIC;MAFF;TGIF1;MUC1;MEF2D;FOXN3;ELF4;POU3F1;HOXA4;SOX30;TBX18;VDR;TFEB;PPARD;RUNX1;FOXJ1;SOX9;LRRFIP1;E2F3;IRF8;BHLHE41;PPARG;NFIL3;HES7;CEBPA;HDAC4;BHLHE40;ZNF160;KLF6;MAFG;BPTF;CC2D1A;NKX2-1;PRDM15;MNT;SKI;MEF2B;CCAR1;EGR2;BCL6;KLF12;JUN;IRF5;ZBTB2;DDIT3;ZFHX2;NFKB1;NFE2L1;NRF1;SRF;NR3C1;ZBTB34;SP7;ELK3;MYBL2;ZNF296;ZKSCAN3;CEBPG;NPAS4;ZNF569;GMEB1;ZNF148;ELK4;TIPARP;DMRTA2;GMEB2;ZSCAN12;DHX9;FOXJ3;MGA;MYT1;MTF1;SP9;ETV4;SP1;ZGPAT;ZBTB7B;ZNF83;ZBTB40;NFATC3;MEIS3;ZEB2;FOXP4;YY1;HDAC1;USF2;ZBTB4;ZBTB17;BCL11B;KLF13;KLF10;ZSCAN20;MAFB;PRRX1;UBP1;SARS1;ZBTB12;FOXN2;GRHL1;RUVBL2;JUNB;RXRB;ZKSCAN1;REL;HSF1;SAFB
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.398716404009069,0.8812262143741183,0.6404341926729986,0.8537526178433951,1.0,7/14,27.20%,ATXN3;USP9X;MINDY2;USP13;YOD1;OTUD5;DESI2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.37845320135816607,0.8803705250914317,0.6375661375661376,0.8533550454279246,1.0,6/16,19.92%,SLC38A7;SLC25A18;SLC13A5;SLC25A14;SLC25A13;SLC1A5
prerank,acetylcholine receptor activity (GO:0015464),0.3586355561214765,0.8789722241722892,0.6409937888198758,0.853930492357112,1.0,1/22,1.57%,CHRNB2
prerank,phosphatase activity (GO:0016791),0.29754842927417324,0.8704562910616727,0.7141327623126338,0.8667572641427603,1.0,17/73,21.27%,PLPP6;PON1;PLPP3;NOCT;ENOPH1;DUSP15;NANP;DUSP12;DUSP11;BPNT2;PHOSPHO2;LPIN3;DUSP3;PRUNE1;PLPP5;PTPMT1;DUSP23
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.40286653519501253,0.8700273868472543,0.6643550624133149,0.8655038417619152,1.0,7/12,26.45%,TBPL1;HDAC1;RUVBL2;POU2F1;TBP;H3-3A;GTF2A1
prerank,ribonuclease P activity (GO:0004526),0.4058963947401173,0.8681473742313004,0.6398305084745762,0.8667214399331076,1.0,3/11,18.42%,PRORP;RPP38;POP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.41408340028137736,0.8665181146487907,0.6418338108882522,0.8655295429128699,1.0,1/10,2.67%,DUSP9
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.41408340028137736,0.8665181146487907,0.6418338108882522,0.8655295429128699,1.0,1/10,2.67%,DUSP9
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.2714414595684745,0.8654759466037261,0.937,0.8653005989704091,1.0,111/730,18.83%,LITAF;MITF;DNMT3A;HIF1A;ATF3;NFE2L2;NFYA;NFIC;MAFF;TGIF1;MUC1;MEF2D;ELF4;POU3F1;HOXA4;SOX30;TBX18;VDR;TFEB;PPARD;RUNX1;FOXJ1;SOX9;LRRFIP1;E2F3;IRF8;BHLHE41;PPARG;NFIL3;HES7;CEBPA;HDAC4;BHLHE40;ZNF160;KLF6;MAFG;BPTF;CC2D1A;NKX2-1;PRDM15;MNT;SKI;MEF2B;CREB3L2;CCAR1;EGR2;BCL6;KLF12;JUN;IRF5;ZBTB2;DDIT3;ZFHX2;NFKB1;NFE2L1;NRF1;SRF;NR3C1;ZBTB34;SP7;ELK3;MYBL2;ZNF296;ZKSCAN3;CEBPG;NPAS4;ZNF569;GMEB1;ZNF148;ELK4;DMRTA2;GMEB2;ZSCAN12;DHX9;FOXJ3;MGA;MYT1;MTF1;SP9;ETV4;SP1;ZGPAT;ZBTB7B;ZNF83;ZBTB40;NFATC3;MEIS3;ZEB2;FOXP4;YY1;HDAC1;USF2;ZBTB4;ZBTB17;BCL11B;KLF13;KLF10;ZSCAN20;MAFB;PRRX1;UBP1;SARS1;ZBTB12;GRHL1;RUVBL2;JUNB;RXRB;ZKSCAN1;REL;HSF1;SAFB
prerank,single-stranded telomeric DNA binding (GO:0043047),0.4047365653044458,0.8651927048917085,0.6647727272727273,0.8637988720858842,1.0,5/11,27.92%,RAD50;HNRNPA2B1;TERF1;TERF2IP;TERF2
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.355865943452442,0.864868015090315,0.6742712294043093,0.8624715277643278,1.0,1/21,1.57%,CHRNB2
prerank,fibroblast growth factor binding (GO:0017134),0.35130416821129135,0.8635127195855891,0.6461731493099122,0.862924575693566,1.0,11/21,31.92%,FGFRL1;FGFBP3;FGFR2;GLG1;RPS2;RPS19;CEP57;FGFR3;FGFR4;ITGAV;ITGB3
prerank,FMN binding (GO:0010181),0.40795402594586505,0.862675814112124,0.6596045197740112,0.8623426258356495,1.0,2/11,8.75%,POR;MTRR
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.31365131787211836,0.8615757853379654,0.6978335233751425,0.8623168619835848,1.0,6/42,10.31%,CCNY;CCNL1;CCNC;CCNB1;CCNL2;CCNT2
prerank,calcium activated cation channel activity (GO:0005227),0.3678865488037576,0.8607393084630574,0.6569536423841059,0.8618892895352062,1.0,3/17,12.42%,KCNMA1;ANO6;KCNN4
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.1962135506930232,-0.859187376240412,0.8611111111111112,0.8648728422840075,1.0,27/73,27.89%,CX3CR1;CYSLTR1;SORCS1;GPR37;CALCRL;SORCS2;RXFP1;F2R;EDNRB;INPP5K;CRHR1;LGR5;VIPR1;TSHR;GRPR;NPSR1;OPRD1;S1PR2;ADCYAP1R1;MC5R;BDKRB2;LTB4R;VIPR2;CCKBR;SORCS3;RXFP2;FPR3
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2678873914733057,0.8546149037489906,0.964,0.870001784414131,1.0,126/830,18.83%,LITAF;MITF;DNMT3A;HIF1A;ATF3;NFE2L2;NFYA;NFIC;MAFF;TGIF1;MUC1;MEF2D;ELF4;CUX1;POU3F1;HOXA4;SOX30;TBX18;VDR;TFEB;PPARD;RUNX1;FOXJ1;SOX9;LRRFIP1;NFX1;E2F3;IRF8;BHLHE41;PPARG;NFIL3;HES7;CEBPA;HDAC4;BHLHE40;ZNF160;KLF6;CIC;MAFG;BPTF;CC2D1A;NKX2-1;PRDM15;ETV6;MNT;SKI;MEF2B;CCAR1;EGR2;BCL6;GBX1;ASCL4;KLF12;JUN;IRF5;STOX1;ZBTB2;ATF5;DDIT3;ZFHX2;NFKB1;NFE2L1;NRF1;SRF;NR3C1;ZBTB34;SP7;ELK3;MYBL2;ZNF296;ENO1;ZKSCAN3;CEBPG;NPAS4;ZNF569;GMEB1;ZNF148;ELK4;DMRTA2;GMEB2;ZSCAN12;DHX9;FOXJ3;MGA;MYT1;MTF1;SP9;ETV4;SP1;ZGPAT;TBPL1;ZBTB7B;ZNF83;TCF24;ZBTB40;ZNF177;NFATC3;MEIS3;ZEB2;FOXP4;YY1;ZFP41;ZFP57;HDAC1;USF2;ZBTB4;ZBTB17;BCL11B;KLF13;PURA;KLF10;ZSCAN20;MAFB;PRRX1;UBP1;SARS1;ZBTB12;GRHL1;RUVBL2;JUNB;ZBTB43;RXRB;ZKSCAN1;REL;HSF1;SAFB
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.3050257255009118,-0.8505752244116553,0.6431095406360424,0.8747436493929461,1.0,8/14,31.58%,KCNJ3;KCND3;KCNH2;KCNQ1;KCNIP2;KCNE3;KCNE4;KCNJ5
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.3960161264040255,0.850233368287111,0.6714082503556188,0.8752728996371041,1.0,3/10,20.58%,PIK3CB;PIK3C2A;PIK3CA
prerank,microtubule motor activity (GO:0003777),-0.21460375159124118,-0.8488829869934714,0.7029702970297029,0.8693927151790389,1.0,22/51,24.47%,DYNC1I1;KIFC3;KIF26B;KIF11;KIF6;DNAH8;KIF15;KIF3C;CENPE;KIF24;KIF4A;KIF5A;KIF17;KIF9;KIF14;KIF13A;KIF23;KIF2C;KIFC2;KIF18B;KIF19;KIF27
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.3044595998140588,-0.8475883065805603,0.676,0.863583138173302,1.0,4/14,17.61%,BAD;RPS27L;ATP2A3;CTSH
prerank,MHC class I protein binding (GO:0042288),0.3719357800494361,0.8459829036683643,0.6616643929058663,0.8803869122047493,1.0,5/13,22.36%,TAPBP;LILRB1;TUBB;DERL1;ATP5F1B
prerank,phosphatase activator activity (GO:0019211),0.3719473589343014,0.8457744865615835,0.665359477124183,0.8787748967977407,1.0,8/14,31.74%,PPP2R5C;GTF2F1;CALM2;B3GAT3;CALM3;PPP2R5D;PPP2R5A;PPP2R5E
prerank,peptidase activator activity (GO:0016504),0.3462064823701977,0.8446271784489087,0.6959798994974874,0.878775537574127,1.0,8/22,23.35%,TANK;VCP;CAV1;PSMD14;APH1A;CLPX;PSME4;CASP8AP2
prerank,histone deacetylase binding (GO:0042826),0.2815748242998524,0.8443870570297897,0.7518479408658922,0.877229522025931,1.0,21/88,21.58%,MEF2D;BHLHE41;HDAC4;GMNN;HDAC9;MEF2B;SUDS3;THAP7;PKN2;MIER2;KCTD21;SP1;HDAC1;RAD9A;DACT1;HDAC3;SATB2;CCND1;LCOR;SIRT2;MTA3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.31586583482571673,-0.8435415297253958,0.6341463414634146,0.8631726533277503,1.0,4/12,17.61%,BAD;RPS27L;ATP2A3;CTSH
prerank,calcium ion binding (GO:0005509),0.26620924972155646,0.8433609575565738,0.894,0.87690631543818,1.0,20/323,4.60%,LPL;LCP1;LRP1;MAN1C1;IQGAP1;ASPH;MCTP1;ANXA5;MMP12;ADAM8;ANXA4;RASGRP3;FER1L5;ADAMTS13;PON1;TPD52;ESYT1;CRACR2A;EFHD2;CAPN1
prerank,methyl-CpG binding (GO:0008327),0.3437885332185013,0.8428868043342299,0.6871165644171779,0.8756910254974978,1.0,10/22,31.17%,TET3;CHTOP;ZBTB4;PRMT5;CXXC5;WDR77;ERH;MBD1;LRWD1;PRMT1
prerank,glutathione transferase activity (GO:0004364),0.3371054703234699,0.8427086228177415,0.6878901373283396,0.8740473643195836,1.0,2/23,3.56%,GSTA2;PTGES
prerank,LRR domain binding (GO:0030275),0.37561716124668987,0.8404860426255317,0.6952908587257618,0.8757100943921192,1.0,2/14,9.15%,MRTFA;DDIT3
prerank,H4 histone acetyltransferase activity (GO:0010485),0.39472076303895687,0.838893888034684,0.6710144927536232,0.8762105306767763,1.0,6/10,25.53%,MSL3;HAT1;NAA40;NAA50;EP300;KAT8
prerank,double-stranded DNA binding (GO:0003690),0.26350301850671626,0.8373601494731242,0.941,0.8766803688050271,1.0,85/531,20.13%,ATF3;NFIC;MAFF;TGIF1;MEF2D;RAD51B;ELF4;CUX1;POU3F1;HOXA4;SOX30;TBX18;TFEB;PPARD;ELF2;SHOX2;SOX9;E2F3;IRF8;BHLHE41;PPARG;HES7;BHLHE40;KLF6;MAFG;RAD50;MEF2B;EGR2;BCL6;KLF12;JUN;IRF5;ZBTB2;SRF;NR3C1;ELK3;MYBL2;ZNF296;CEBPG;GMEB1;ELK4;KIN;XPA;DMRTA2;GMEB2;ZNF638;RAD51AP1;AIM2;DHX9;FOXJ3;MTF1;SP9;SETMAR;ETV4;SP1;CENPX;ZBTB7B;ZNF177;NFATC3;MEIS3;FOXR2;YY1;ZFP41;USF2;PNKP;BCL11B;KLF13;PURA;KLF10;UBP1;ZBTB12;FOXN2;GRHL1;JUNB;ZBTB43;RXRB;HSF1;TERF1;SAFB;CENPS;ZBTB45;HNRNPU;BARX2;XBP1;MBNL2
prerank,MAP kinase phosphatase activity (GO:0033549),0.3829310417084085,0.8360896561193926,0.7015130674002751,0.8767444453791875,1.0,3/12,21.57%,DUSP9;DUSP3;DUSP6
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.37805033211063954,0.8330096094658467,0.7110799438990182,0.8797741804247458,1.0,3/12,11.42%,NDUFS7;CBR1;AIFM2
prerank,insulin-like growth factor binding (GO:0005520),0.36088714695118,0.8323045039229919,0.6972972972972973,0.8790164722303531,1.0,2/15,9.72%,IGF2R;IGF1R
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.32170965204478463,0.8307789197886328,0.7032967032967034,0.8795651557994164,1.0,11/27,31.99%,SIAH2;RNF180;RNF14;DCUN1D4;DCUN1D2;RNF19A;RNF19B;DCUN1D3;ARIH2;AUP1;ZMYM2
prerank,retinoid X receptor binding (GO:0046965),0.3926076490891959,0.8300820988807722,0.7006993006993008,0.8786943034847632,1.0,2/11,4.65%,VDR;PPARG
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.38803758228460583,0.827221268146077,0.7146814404432132,0.8811671761953095,1.0,2/11,10.46%,NEIL2;ALKBH1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3039942032920867,-0.8270575487883516,0.6781609195402298,0.8864607710968064,1.0,3/13,8.36%,EZR;PRKAR2A;PRKAR2B
prerank,Hsp70 protein binding (GO:0030544),0.3195181495848003,0.8270135899281638,0.7191943127962085,0.8795770466975206,1.0,8/31,20.50%,DNAJB14;ERN1;DNAJC8;DNAJC10;DNAJC2;DNAJB12;PACRG;IQCG
prerank,transferrin receptor binding (GO:1990459),-0.31857823224932663,-0.8261304917006933,0.694006309148265,0.8798313894416875,1.0,3/10,16.87%,SNX2;CD81;RGMA
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.3321470841148173,0.8243518285361825,0.7137404580152672,0.8816140013944402,1.0,8/22,27.38%,CPEB2;EXOSC9;CPEB1;CPEB3;ZC3H12A;EXOSC4;ILF3;DHX36
prerank,myosin binding (GO:0017022),-0.2068281623963092,-0.8210115998712263,0.8775510204081632,0.8810548024642261,1.0,7/55,6.99%,STXBP5L;DMD;RAB6B;MYBPC1;RAB3A;RAB27B;MLPH
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2891829145234284,0.8185574170729508,0.7638418079096045,0.8881709672558918,1.0,13/55,22.09%,ATP2B1;CACNA1D;SLC24A4;PANX1;TRPM7;ATP2A2;PKD1L2;GRIN3B;ORAI1;SEC61A1;TMEM165;TMCO1;ANXA6
prerank,leak channel activity (GO:0022840),0.33971262557684534,0.8178422128379652,0.734955185659411,0.887385299227728,1.0,2/18,6.24%,KCNK13;PANX1
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.26722075391263767,-0.8149534785424835,0.717948717948718,0.8837752929359839,1.0,6/17,21.34%,PECR;DPYD;DHCR7;BLVRB;LBR;PTGR1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.3206169684724679,0.8129080728939583,0.7214723926380369,0.8925843050167708,1.0,4/24,12.90%,PTK2B;DAPK1;MAPKAPK3;MAPKAPK2
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3573343510192002,0.8121999654288308,0.7098092643051771,0.8917329538757389,1.0,3/12,20.58%,PIK3CB;PIK3C2A;PIK3CA
prerank,gamma-tubulin binding (GO:0043015),0.32386776222645236,0.8109963232294031,0.72625,0.8916424714756738,1.0,4/22,12.82%,TUBGCP4;GIT1;NDRG1;MARK4
prerank,aminopeptidase activity (GO:0004177),0.31654935894344444,0.809153287743305,0.7515151515151515,0.8923823581023328,1.0,6/26,19.89%,ANPEP;BLMH;MMP17;XPNPEP1;METAP1D;RNPEPL1
prerank,solute:proton symporter activity (GO:0015295),0.3464114197249401,0.8083672425073588,0.7027777777777777,0.8916871828649311,1.0,2/16,7.91%,SLC17A5;SLC25A3
prerank,C2H2 zinc finger domain binding (GO:0070742),0.36822268906176453,0.8027809317542502,0.7090643274853801,0.8979516029048801,1.0,5/11,30.73%,THAP7;ZXDC;SRRM2;EHMT2;TAF9
prerank,chemokine receptor binding (GO:0042379),0.2988199291563473,0.8013621856288858,0.7524509803921569,0.8981020261945979,1.0,4/35,9.76%,CCL4;CCL13;CCL28;CCL14
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.28273787408615636,-0.8011500753891849,0.7481203007518797,0.9001717943876929,1.0,1/14,0.22%,SPOCK3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.2727314844856056,0.7996812957005475,0.8038379530916845,0.898735982882276,1.0,18/72,22.48%,SLC9A1;SDCBP;CAPG;KCNJ2;SYTL2;HIP1R;SESTD1;OSBPL2;SNX18;MAPKAP1;FLII;HIP1;PFN1;KRIT1;SVIL;ACTN2;TIRAP;GSN
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.3538913559634713,0.7980991690837123,0.726158038147139,0.8991278274473583,1.0,5/15,27.82%,ALDH3A2;ALDH3B1;ALDH2;ALDH1L2;ALDH1A1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3666885005819628,0.7919821995239276,0.7423398328690808,0.9058195526327428,1.0,5/12,22.68%,NOCT;CNOT6;PAN3;PAN2;TOE1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.3141053631750682,0.7901163055863825,0.7685534591194969,0.9065068123136762,1.0,6/26,21.08%,SLC6A6;SLC27A1;SLC16A3;SLC16A13;SLC5A6;SLC16A2
prerank,metalloaminopeptidase activity (GO:0070006),0.338575582160253,0.7877489666184015,0.7397622192866579,0.9077924744496553,1.0,4/16,19.89%,ANPEP;MMP17;XPNPEP1;RNPEPL1
prerank,solute:sodium symporter activity (GO:0015370),0.30813541465847544,0.7871562728870641,0.7521472392638037,0.9066978242140794,1.0,5/27,19.24%,SLC4A9;SLC5A3;SLC13A5;SLC4A4;SLC5A6
prerank,MAP kinase activity (GO:0004707),-0.2783470725269208,-0.7861809676420713,0.7848605577689243,0.9177046340671456,1.0,2/14,3.30%,MAPK14;MAPK4
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),-0.22994668511247102,-0.7772596240720997,0.8125,0.9241965035318179,1.0,7/28,14.68%,MAPK14;RPS6KA1;PRKCG;LRRK2;RPS6KB1;MAP2K6;TNK2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.26573362114261684,0.7728318389090147,0.8283828382838284,0.9238701064525582,1.0,17/70,24.97%,LARGE1;B4GAT1;HEXA;GCNT2;B3GALNT2;HEXB;OGT;GCNT1;B4GALT1;B3GLCT;B3GALT4;CSGALNACT2;POGLUT2;B4GALNT1;POMGNT2;B3GAT3;MGAT4B
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.34560529380953764,0.772574454167974,0.7617135207496654,0.9223548033634981,1.0,4/14,22.58%,PRORP;RPP38;POP1;TSEN2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.3066747536796052,-0.7718147477046736,0.756578947368421,0.9249646991381154,1.0,6/10,21.17%,EXD2;DCLRE1B;MGME1;POLD1;FEN1;APEX1
prerank,estrogen receptor binding (GO:0030331),0.2925637358597377,0.7715754755737484,0.7980884109916367,0.9217132648070065,1.0,9/32,23.44%,CTNNB1;PRMT2;PPARGC1B;LATS1;MMS19;MED1;LCOR;NSD1;WBP2
prerank,anion channel activity (GO:0005253),0.27166187309074386,0.7696227397181138,0.8388157894736842,0.9224505066205501,1.0,8/61,11.60%,CLCN7;ANO9;VDAC2;CLIC4;ANO6;GPR89A;GPR89B;LRRC8D
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.33297415637318867,0.7687637257262039,0.7755644090305445,0.9216258037073846,1.0,6/16,24.98%,MTMR12;MTMR14;MTMR6;MTMR10;SYNJ1;PTEN
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.3335322699267379,0.7687450954538017,0.7771664374140302,0.9197611127166195,1.0,7/15,25.45%,ABHD5;LPCAT1;ABHD4;AGPAT1;AGPAT5;AGPAT3;AGPAT2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2682811330827028,0.7682724412826095,0.8286985539488321,0.9184502864068147,1.0,12/60,17.55%,PPM1H;PPM1J;PPP4C;TAB1;PPP3R1;LRRC39;CDKN3;CTDNEP1;CTDSP2;PPP6C;MTMR6;SSU72
prerank,neuropeptide receptor binding (GO:0071855),0.3498709703584585,0.7673449426998111,0.7410958904109589,0.9177801339849946,1.0,2/14,14.18%,NPPA;AGRP
prerank,CARD domain binding (GO:0050700),0.3442015279248346,0.7665853501992755,0.7721854304635761,0.9169715630238296,1.0,8/14,35.78%,CARD10;CARD19;IRGM;CASP4;MAVS;CASP1;RIPK2;CARD9
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2852827888884205,0.7662370735692481,0.7910628019323671,0.915566130056759,1.0,9/34,22.50%,UBE2Q1;UBE2L6;UBE2R2;UBE2L3;UBE2F;UBE2H;UBE2C;UBE2J1;BIRC6
prerank,pyridoxal phosphate binding (GO:0030170),0.3190235132922604,0.7656244420109762,0.7808564231738035,0.9145004550410495,1.0,10/20,33.15%,PDXK;PSAT1;OAT;PNPO;CBS;CTH;SHMT1;PLPBP;SHMT2;ACCS
prerank,iron ion binding (GO:0005506),0.274927576839998,0.7655154512289786,0.823394495412844,0.9127844293641549,1.0,15/48,22.12%,FTL;KDM3A;RIOX1;ALKBH1;EGLN1;MELTF;CDO1;FTO;ALKBH8;PHF2;EGLN3;PHYH;HIF1AN;CYP2R1;ALKBH3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.32226896835238883,0.7653160501099726,0.7866323907455013,0.9111929749349659,1.0,5/20,20.46%,SLC39A7;SLC39A11;SLC39A6;SLC39A3;SLC39A13
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.3381820495779079,0.762867349802674,0.7994467496542186,0.912519694061817,1.0,5/15,21.89%,SLC38A7;SLC25A18;SLC25A13;SLC1A5;SLC17A8
prerank,epidermal growth factor receptor binding (GO:0005154),0.3026287452051002,0.7609569143600725,0.8070175438596491,0.9131560407338433,1.0,10/25,28.96%,GRB2;ATXN2;SNX4;HIP1;CNOT9;SNX1;ARF4;PLSCR1;TGFA;CCDC88A
prerank,ionotropic glutamate receptor binding (GO:0035255),0.3646747798607931,0.7558479232655845,0.776034236804565,0.9176742208415122,1.0,3/10,16.79%,SQSTM1;DLG4;GNAS
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3084268781879876,0.7558476108608705,0.7962025316455696,0.9158461845450152,1.0,5/21,19.15%,AKAP1;ARFGEF2;ARFGEF1;PRRC1;ACBD3
prerank,exopeptidase activity (GO:0008238),0.2686076156825678,0.7539934079378254,0.826427771556551,0.916269234850437,1.0,4/50,5.51%,ANPEP;CTSZ;CTSA;DPP7
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2851377620063976,0.7531841036836566,0.8208588957055215,0.9154716855637132,1.0,9/31,25.59%,UBE2Q1;UBE2L6;UBE2R2;UBE2L3;UBE2H;UBE2C;UBE2J1;BIRC6;CDC34
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.32814372273538805,0.7519863428854734,0.7928759894459103,0.9151214800522728,1.0,3/15,7.35%,HS3ST3B1;NDST1;HS6ST1
prerank,calcium-activated potassium channel activity (GO:0015269),0.34878962367752414,0.750444483852153,0.7883522727272727,0.91520398480116,1.0,2/11,12.42%,KCNMA1;KCNN4
prerank,potassium ion leak channel activity (GO:0022841),0.32256782589902144,0.7493810509431738,0.7965879265091863,0.9145926205371891,1.0,1/15,1.39%,KCNK13
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.28172510055190636,-0.7481729684024617,0.7867647058823529,0.9522155734733265,1.0,8/12,38.51%,ELOVL4;OPN3;GPR88;GPR52;OPN1MW;OPN1MW3;OPN5;OPN4
prerank,cation channel activity (GO:0005261),0.2491231979420947,0.7481619542962671,0.8824763903462749,0.9142223453940111,1.0,9/94,7.33%,CALHM6;ASIC3;CACNA1D;PIEZO1;SLC24A4;TMEM38B;PANX1;TRPM7;ANO6
prerank,hyaluronic acid binding (GO:0005540),0.34960596832693647,0.745360281846864,0.7879699248120301,0.9158207695953947,1.0,3/10,21.37%,CD44;C1QBP;STAB2
prerank,death receptor binding (GO:0005123),0.327518642298751,0.7434765756003938,0.8103225806451613,0.9161251337322186,1.0,5/15,32.17%,BID;TMBIM1;CASP8AP2;FEM1B;MYD88
prerank,5'-3' RNA polymerase activity (GO:0034062),0.2898758726139019,0.7362773900444484,0.8312807881773399,0.9227281147713802,1.0,12/27,28.10%,MED21;POLR1A;POLR2D;TERT;POLRMT;POLR3B;POLR1D;POLR1H;CRCP;POLR1F;POLR1C;POLR3A
prerank,dynactin binding (GO:0034452),-0.26939301279758876,-0.7358193496697122,0.849624060150376,0.9609936095095929,1.0,4/12,16.64%,BICD1;PAFAH1B1;MAPT;BBS4
prerank,cell-cell adhesion mediator activity (GO:0098632),0.26794471882939785,0.7349146393702092,0.8497109826589595,0.9224435167115743,1.0,7/42,15.57%,SIRPA;NPTN;BAIAP2;IGSF9;PALLD;S100A11;BAIAP2L1
prerank,mechanosensitive ion channel activity (GO:0008381),0.33269709869146813,0.7328454708805777,0.8091286307053942,0.9228907616613221,1.0,3/12,23.10%,PIEZO1;TMC6;PIEZO2
prerank,transcription coactivator binding (GO:0001223),0.3012176726763155,0.7286455349807547,0.8209150326797385,0.92577778997516,1.0,4/20,16.25%,PPARD;CCNT2;TERT;ZBTB17
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.2510274548597363,-0.7263829459668704,0.8252788104089219,0.965155236662964,1.0,5/15,27.73%,PLA2G3;PLA2G4C;PLA2G4E;PLA2G4F;PLA2G2D
prerank,DNA polymerase activity (GO:0034061),0.2931189983353928,0.726360548409341,0.8120300751879699,0.9265287790195549,1.0,7/22,27.90%,REV1;POLE;TERT;POLM;POLE4;POLA1;POLG
prerank,transforming growth factor beta binding (GO:0050431),0.2926555861610154,0.7242530514738972,0.835427135678392,0.9270888719128707,1.0,3/23,10.71%,WFIKKN1;NRROS;TGFBR2
prerank,adenylyltransferase activity (GO:0070566),0.2942882593683692,0.7191381595254209,0.8273291925465839,0.9310415788307502,1.0,7/21,27.04%,FLAD1;PAPOLA;COASY;NMNAT3;MTPAP;ABL1;TENT4B
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.28818082729208705,0.7178331648606875,0.8233082706766918,0.9305901291279902,1.0,5/24,16.47%,ZDHHC18;ZDHHC15;ZDHHC1;ZDHHC6;YKT6
prerank,O-acyltransferase activity (GO:0008374),0.27596962947072645,0.716985742438211,0.8475390156062425,0.9296868003465871,1.0,4/30,9.40%,SOAT1;SOAT2;LPCAT1;LPCAT3
prerank,NADPH binding (GO:0070402),-0.2630954488499214,-0.7167090251730138,0.8210526315789474,0.9688693156060926,1.0,7/13,24.89%,QDPR;NDOR1;CRYZ;CBR3;LBR;HMGCR;GRHPR
prerank,peptidoglycan binding (GO:0042834),0.3405575664482596,0.7154593943835575,0.8312056737588652,0.9295233875171071,1.0,2/10,18.20%,RNASE7;HK1
prerank,muscle alpha-actinin binding (GO:0051371),-0.25136720051620337,-0.712439664779438,0.8346456692913385,0.9655509778971746,1.0,2/15,5.92%,PDLIM2;PDLIM5
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.3427483945232135,0.7112262785963175,0.8161764705882353,0.9321552602632228,1.0,3/10,16.98%,RIOX1;RIOX2;KDM2A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.28278581091947697,-0.7096513950740776,0.8461538461538461,0.9605425838754927,1.0,2/10,8.59%,CRMP1;DPYSL2
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.31620316867325426,0.7086087859541739,0.8241758241758241,0.9330852711695425,1.0,2/13,5.75%,GDI1;RANBP1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.3226449079214959,0.7034931131264589,0.8565400843881856,0.9365213568866193,1.0,2/12,13.10%,NUDT5;ENTPD6
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.2882574371879669,0.7028136961320213,0.8507653061224489,0.9354186434736106,1.0,2/18,10.33%,DHRS11;HSD17B8
prerank,phosphate ion binding (GO:0042301),-0.27060392489151486,-0.6981455194796397,0.8343949044585988,0.9653032467755635,1.0,2/10,5.50%,PNP;RELA
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.3159236719257319,0.6967711936876868,0.8613861386138614,0.9397032701419118,1.0,1/12,2.56%,B4GAT1
prerank,general transcription initiation factor binding (GO:0140296),0.27230140426740385,0.6921600392662683,0.870722433460076,0.9423983450576745,1.0,10/25,30.51%,GTF2A2;THAP7;YEATS2;RUVBL2;TBP;PSMC2;GTF2A1;DR1;PSMC5;TAF13
prerank,palmitoyltransferase activity (GO:0016409),0.27174227906287235,0.6894290416989266,0.8855721393034826,0.9432770880440521,1.0,11/28,30.68%,ZDHHC18;ZDHHC15;ZDHHC1;ZDHHC6;YKT6;GOLGA7;ZDHHC4;ZDHHC21;ZDHHC8;HHAT;ZDHHC9
prerank,cAMP response element binding (GO:0035497),0.325052967097727,0.6873526351045024,0.8498498498498499,0.9434348737603879,1.0,2/10,8.48%,CREB3L2;JUN
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3161422434508857,0.6838247916159672,0.8587731811697575,0.9449902261157797,1.0,2/11,16.23%,NUDT5;DCP2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3034150071568362,0.680478091335085,0.8569444444444444,0.946228957034483,1.0,5/14,25.36%,SLC38A7;SLC25A18;SLC25A13;SLC17A8;SLC7A11
prerank,transaminase activity (GO:0008483),0.31718874691770876,0.6802773817931789,0.8518518518518519,0.9446734225082937,1.0,4/11,30.93%,PSAT1;OAT;BCAT2;GOT1
prerank,Wnt-activated receptor activity (GO:0042813),0.29424926801878737,0.6796278899885781,0.8590971272229823,0.9434675069811868,1.0,2/15,8.49%,FZD4;FZD1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.27891728307390495,0.6794267493354523,0.8664021164021164,0.9419097202423465,1.0,8/20,25.45%,ABHD5;LPGAT1;LPCAT1;AGPAT1;DGAT1;AGPAT5;AGPAT3;AGPAT2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.2631991628884203,-0.6776820381390642,0.8689138576779026,0.9775652086480757,1.0,1/11,4.07%,HCN1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.2598899643893865,-0.6774333361029733,0.8791208791208791,0.9698113449007153,1.0,5/12,24.63%,BMPR1B;LTBP1;LTBP4;TGFBR3;ENG
prerank,DNA secondary structure binding (GO:0000217),0.2512307458651545,0.6709719939194919,0.9010989010989011,0.9475783059739735,1.0,2/31,2.01%,KMT2A;RAD51B
prerank,histone acetyltransferase activity (GO:0004402),-0.18696426473257405,-0.6683691096479377,0.9772727272727273,0.9697103488643476,1.0,4/30,7.59%,KAT2B;NAA60;BRCA2;KAT5
prerank,ion channel inhibitor activity (GO:0008200),0.25030230066762704,0.6627790585619959,0.910377358490566,0.9526817730531385,1.0,10/35,25.37%,RASA1;PHPT1;SCN1B;CALM2;FKBP1B;SCN3B;STX7;NEDD4;RACK1;CAMK2D
prerank,damaged DNA binding (GO:0003684),0.2406342522935161,0.6595910497461056,0.9311926605504587,0.9535322308692697,1.0,9/44,18.61%,ERCC1;DDB2;DDB1;DCLRE1A;ERCC4;XPA;PNKP;ERCC2;DCLRE1C
prerank,MHC protein binding (GO:0042287),0.2664409874908415,0.6572739896098941,0.9109947643979057,0.9535196283367752,1.0,6/20,22.36%,TAPBP;LILRB1;TUBB;DERL1;LAG3;ATP5F1B
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.30939015398458036,0.6532931845765696,0.8561354019746121,0.9550396074212746,1.0,4/10,29.60%,EHMT1;ASH1L;SETDB1;EHMT2
prerank,monocarboxylic acid binding (GO:0033293),0.2726228751667922,0.6511453757155548,0.9055627425614489,0.9549005299886942,1.0,2/18,11.42%,PSAP;NAPEPLD
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.29083367516672337,0.6478996946400513,0.899135446685879,0.9556133410820974,1.0,6/13,25.45%,ABHD5;LPCAT1;AGPAT1;AGPAT5;AGPAT3;AGPAT2
prerank,metalloexopeptidase activity (GO:0008235),0.22668784433690872,0.6386127769475041,0.9319196428571429,0.960990878559976,1.0,8/51,19.89%,ANPEP;AGBL5;CPD;AGTPBP1;MMP17;XPNPEP1;METAP1D;RNPEPL1
prerank,death receptor activity (GO:0005035),0.297923814524396,0.6359474843988295,0.8934306569343066,0.9611230918347936,1.0,1/11,5.90%,TNFRSF1B
prerank,TBP-class protein binding (GO:0017025),0.25592513369301034,0.6323677125608349,0.9276485788113695,0.9618856335858711,1.0,11/21,36.66%,GTF2A2;YEATS2;RUVBL2;PSMC2;GTF2A1;DR1;PSMC5;TAF13;TAF12;DRAP1;BRF2
prerank,protein kinase inhibitor activity (GO:0004860),0.22759113972732983,0.632135335847146,0.9425287356321839,0.9603013432658398,1.0,5/42,10.98%,SMCR8;TAOK3;SPRED2;SPRY4;NCK1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.246939419586609,0.6293143121750845,0.9375,0.9604952754311149,1.0,11/27,28.10%,MED21;POLR1A;POLR2D;POLRMT;POLR3B;POLR1D;POLR1H;CRCP;POLR1F;POLR1C;POLR3A
prerank,phosphatidylglycerol binding (GO:1901611),0.2764574813640729,0.6253513316259592,0.9110807113543091,0.9614712960693069,1.0,4/13,26.28%,PITPNC1;PLEKHN1;STOML2;OPA1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.21180367794622526,-0.6237695969101668,0.9330708661417323,0.9951516451646162,1.0,10/16,44.24%,SLC22A5;SLC25A17;SLC5A7;SLC18A3;SLC22A3;SLC25A42;SLC22A2;SLC29A4;SLC22A4;SLC25A26
prerank,phospholipase A2 activity (GO:0004623),-0.18781050296121404,-0.6216870454222644,0.9701492537313433,0.9884695034834224,1.0,10/26,27.73%,ABHD3;PLA2G3;PNPLA8;PLA2G4C;PNPLA3;PLA2G15;PLAAT1;PLA2G4E;PLA2G4F;PLA2G2D
prerank,four-way junction DNA binding (GO:0000400),0.2585122258409756,0.6212471335798141,0.9204851752021563,0.9622978188708882,1.0,4/17,19.61%,RAD51B;GEN1;YY1;BLM
prerank,protein phosphatase 1 binding (GO:0008157),0.2552415266694864,0.6206871028674597,0.9210866752910737,0.9609326938289252,1.0,5/21,27.39%,LILRB1;PPP1R3F;SHOC2;PPP1R9B;PPP1R3B
prerank,antiporter activity (GO:0015297),0.25058942074162593,0.6157386960194882,0.9225967540574282,0.9623608627370993,1.0,5/20,24.70%,ATP1A3;SLC35D2;CLCN4;SLC25A14;TMEM241
prerank,Toll-like receptor binding (GO:0035325),-0.24102501654452482,-0.6138122607357706,0.925531914893617,0.9851835018641611,1.0,4/11,28.69%,UNC93B1;CD36;TLR6;TLR2
prerank,cardiolipin binding (GO:1901612),-0.2447596205488623,-0.6115845305794294,0.9419354838709677,0.9786850800779503,1.0,3/10,16.43%,MME;UQCC3;GSDMD
prerank,MAP kinase kinase kinase activity (GO:0004709),0.28073446514754014,0.6112312767471181,0.897364771151179,0.9634182495398171,1.0,2/11,17.33%,MAP3K1;MAP3K20
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.24648502320011662,0.6068950266966516,0.9233668341708543,0.9643012553155793,1.0,6/21,27.90%,REV1;POLE;POLM;POLE4;POLA1;POLG
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.2332809915853311,0.606069472883788,0.9508393285371702,0.9630613738282817,1.0,10/30,27.56%,CST7;GAS6;CSTB;CAST;BIRC2;NOL3;BIRC6;PRDX3;PRDX5;SERPINB9
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.2561716118984297,0.6021261855111653,0.9373368146214099,0.9636038062602335,1.0,6/18,27.56%,GAS6;BIRC2;NOL3;PRDX3;PRDX5;SERPINB9
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.2646896295195519,0.5963209100144008,0.9384010484927916,0.965034326569679,1.0,5/14,28.54%,PYCR3;MTHFR;MTHFD1;ALDH1L2;AASS
prerank,SUMO binding (GO:0032183),-0.21359287515406433,-0.5717419967846578,0.9505703422053232,0.9900148487325645,1.0,3/13,17.01%,HERC2;TDG;USP25
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.2097590770853645,-0.5661613983878008,0.9584905660377359,0.9843070440183064,1.0,3/14,14.84%,IREB2;ISCU;ACO1
prerank,O-methyltransferase activity (GO:0008171),-0.2287026943326787,-0.5641724476542197,0.9635761589403974,0.9774350816726319,1.0,3/10,22.90%,CMTR2;ASMT;CMTR1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.23702104013804792,0.5632896592076038,0.9552631578947368,0.9791764344286435,1.0,4/18,20.33%,BAIAP2;S100A11;BAIAP2L1;CDC42EP1
prerank,phosphatidate phosphatase activity (GO:0008195),0.25319182869303253,0.550960031716864,0.961864406779661,0.9823002397701445,1.0,7/13,36.04%,PLPP3;LPIN3;PLPP5;LPIN1;PLPPR3;PLPPR2;LPIN2
prerank,R-SMAD binding (GO:0070412),0.23015832429052233,0.5420973326661266,0.9743589743589743,0.9836368817861609,1.0,3/18,17.95%,JUN;PMEPA1;LDLRAD4
prerank,ribonuclease P RNA binding (GO:0033204),0.2518887032636366,0.5203618878386921,0.9622093023255814,0.9883223173348911,1.0,2/10,18.42%,RPP38;POP1
prerank,MAP kinase kinase activity (GO:0004708),0.22790676411064129,0.5156477514130494,0.979108635097493,0.987787048901636,1.0,9/15,34.82%,MAPKAPK3;MAP2K3;MAP3K9;MAP2K2;MAP2K7;MAP2K1;MAP2K5;SBK2;MAPKAPK5
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.2374414726487898,0.515518517042439,0.9787535410764873,0.9860610342524299,1.0,5/13,33.00%,ALDH3A2;ALDH2;ALDH1L2;ALDH1A1;ADH5
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.18658757480389696,0.4780417920540048,0.995079950799508,0.9919580558127137,1.0,7/26,26.41%,B3GALNT2;GBGT1;EXTL2;B3GALT4;CSGALNACT2;B4GALNT1;B3GALNT1
